Episode 96 of Utah in the Weeds features High Times CEO Paul Henderson and Beehive Farmacy Founder Bijan Sakaki.
First, the pair told us about their acquisition of a license to cultivate Medical Cannabis in Utah, a process that took about a year and a half. [02:43]
Next, the discussion shifted toward the business philosophies in Utah’s Medical Cannabis market. [09:11]
Tim asked Paul about his role as the CEO of High Times, and how the company has grown to become much more than a magazine. [12:12]
The discussion then shifted to some of the challenges that cannabis companies can face, particularly with banking. [23:35]
Tim talked about his use of the cannabis strain Ice Cream Cake to treat an issue with his back. He said the strain helped him with muscle relaxation, pain relief, and keeping his mind free of stress. [34:22]
Next, Paul and Bijan talked about their expansion plans and the challenges that some cannabis companies face. They also talked about their biggest cannabis competitor, which they say is the black market. [36:30]
Paul and Bijan then talked about the importance of quality assurance in the cannabis industry. They also told us about some new products coming to Beehive Farmacy in the next few months. [41:54]
Tim Pickett:
Welcome everybody out to episode 96 of Utah in the Weeds, a discussion about cannabis and cannabis culture here in Utah, I’m your host, Tim Pickett.
Tim Pickett:
Today, our interview is with Bijan Sakaki and Paul Henderson. Bijan is the founder of Beehive Medical Cannabis Pharmacy here in Utah, and Paul, also is one of the partners. Paul is also the CEO of High Times, really the largest, essentially media group for cannabis in the cannabis space, and we talk a lot about his High Times’ opening of dispensaries in California, and how that, what started out as a magazine and writing articles has become a full fledged vertical offering in the cannabis space. We also talk a lot about Beehive Medical Cannabis Pharmacy here in Utah with Bijan, really great sess with those two, it was super fun and perfect intro into the week of 4/20. When I was growing up, I was going to rodeos around July 4th, and that was always called cowboy Christmas, and 4/20 seems to be cannabis Christmas or the hippie holidays, whichever you prefer. This is a great week for Utah Therapeutic Health Center, our spirit week as a healthcare company that is focused on bringing cannabis into legitimate medicine. It’s super fun this week for us as well.
Tim Pickett:
Beehive Medical Cannabis Pharmacy here in Utah is on 1991 South, 3600 West. It’s right off of the 21st South Freeway headed west, if you had thought about going up to Windover and getting your cannabis this week, just get off of 3200 West there on the 2100 South Freeway and just stop here in Utah, save yourself the trip and the legal problems with going out to Nevada, just stop here. We’ve got a clinic across the street that will be open all week right there across from Beehive, and it’s a great place. They’ve got drive through, they’ve got online ordering, they’ve got a huge parking lot there, and they’re going to have an event on 4/20 with special discounts, and we’ll be there as well, stop by and see us, stop by and see the other vendors. Just an exciting week all around and enjoy this episode, this discussion with Bijan and Paul.
Tim Pickett:
Your name first because then I’ve got to get that right.
Paul Henderson:
Paul Henderson.
Tim Pickett:
CEO of-
Paul Henderson:
CEO of High Times.
Tim Pickett:
High Times, just High Times?
Paul Henderson:
It was High Times Magazine, some people still refer to it as that name, but yeah, High Times, we’re branching off into a bunch of different directions now.
Tim Pickett:
And Bijan, we’ve had you on the podcast before.
Bijan Sakaki:
Yes.
Tim Pickett:
We even heard about all of your paintball-
Bijan Sakaki:
That was old world. Yes.
Tim Pickett:
Your old world stuff.
Bijan Sakaki:
Old world. I’m Bijan Sakaki, CEO of Beehive.
Tim Pickett:
Worlds best Utah Cannabis Pharmacy.
Bijan Sakaki:
Yes, you heard it from Tim, not me.
Tim Pickett:
That’s right.
Bijan Sakaki:
Yeah. So Beehive Farmacy we’ve got Buzz, we’ve got Beehive Gardens.
Tim Pickett:
Buzz and Beehive Gardens are the brand names, because you’re vertically integrated?
Bijan Sakaki:
Correct. We’re one of the four vertically integrated groups. So Beehive Gardens is-
Tim Pickett:
That’s not well known, I think.
Bijan Sakaki:
Okay.
Tim Pickett:
I think that it’s well known wholesome and Perfect Earth, with True North is Curaleaf now with Tryke. But I think there are a few-
Bijan Sakaki:
Dragonfly is also a vertical.
Tim Pickett:
We’ve got Dragonfly.
Paul Henderson:
But that’s because we did not start out that way, right? We were retailers and we had the chance to acquire the license from Harvest.
Tim Pickett:
And so Harvest was the grower-
Bijan Sakaki:
Was the initial, correct.
Tim Pickett:
… And then you acquired that.
Bijan Sakaki:
Yep.
Tim Pickett:
Paul, were you involved in the whole thing all along?
Paul Henderson:
Yep.
Tim Pickett:
Because we met, I think we met originally-
Paul Henderson:
Maybe around the opening of Beehive in Salt Lake.
Tim Pickett:
Yeah.
Paul Henderson:
Yeah. Not as long as Bijan, but well before the laws had passed, Bijan and I had got together and started talking about what Utah would look like, and then I was going to be a small advisor, just to help out with what I had done in the California market, and then that just kept snowballing into a larger and larger role. And then Bijan and I actually wrote the applications ourselves, we didn’t hire law firms.
Paul Henderson:
And so yeah, I was there all along with the coming in ninth place on cultivation, first loser, all the way through to top application on the retail side.
Tim Pickett:
How does that, I remember that because I was lifting weights with Sean Hammond at the time all those applications were being processed. And then the losers and the winners.
Bijan Sakaki:
They all get their emails.
Tim Pickett:
Right.
Bijan Sakaki:
Like, “Hey, it wasn’t you.”
Tim Pickett:
Yeah, “Hey, it wasn’t you.” What does it look like to lose and then try to get Harvest’s license? How did that play out?
Bijan Sakaki:
I think it’s a longer journey than that. Helping stand some things up and then stepping away from it, and then really digging in with Beehive once retail came through. So, everything comes back full circle, and I wouldn’t say that this was an overnight thing, this is, we’ve been putting in 10 plus years into this thing. So it’s just like the re-evolution of it. We missed out on cultivation, we got retail, and we had a fortunate opportunity to help manage and operate one of them early on. And then given that multi-state operator situation, divestiture of assets, et cetera, we were able to then, while we were already managing it, we were consuming all the output from it anyway. It gave us the ability to now throw metaphorical gas on the fire, and then start increasing the quality and some of the output in the SOPs.
Paul Henderson:
The story is interesting too because I’m kind of a nerd in the cannabis space in the sense that I’ll listen to earnings releases, and I’ll read MDNA, what the companies put out as part of their quarterly earnings releases. And I actually saw in one of those that a Harvest had said that their board of directors and management had come together and decided to divest of a bunch of assets in non-core states. So states out of Arizona and California, and a couple of, where they wanted to double down. Because they only have limited funds and bandwidth, and they can’t be everywhere.
Paul Henderson:
And so when I saw that High Times had actually done a deal with Harvest to buy some retail stores in California, so I reached out to the M&A guys saying, “Hey, I see that you guys are going to divest of non-core assets, you didn’t get retail in Utah, any chance you want to sell your Utah cultivation?” And he’s like, “I don’t know, maybe.” And then that just started the conversation, and it took a good year or so.
Bijan Sakaki:
Year and a half.
Paul Henderson:
A year and a half to actually go through, mostly because it was kind of the first transfer of ownership license in the state of Utah, and nobody wanted to run afoul, didn’t know what to do. So they really took their time from a regulatory process to understand-
Tim Pickett:
That is the department or health over that, or the department of ag over that?
Bijan Sakaki:
That was department of ag.
Paul Henderson:
Department of ag.
Bijan Sakaki:
And they work hand in hand with the attorney general’s office, and it was, they really went through, and the first time you do anything is going to be the most challenging. And so it was a good experience for both people to know what kind of undertaking that requires.
Tim Pickett:
But since you, that transition of ownership with Harvest, and now you’re vertically integrated, you’re not the only ones who’ve done that, right? Then-
Bijan Sakaki:
That’s correct. Curaleaf-
Tim Pickett:
Curaleaf did that with Tryke.
Paul Henderson:
Correct.
Bijan Sakaki:
And then-
Tim Pickett:
Well, and then it did, we went the opposite way with Zion and Bloom.
Bijan Sakaki:
Correct. Zion worked in alignment with-
Tim Pickett:
With the retail operation. And now I guess if you drive down there, their sign even says Zion Medicinal, on the wall.
Bijan Sakaki:
Well, okay. So technically then, the number then would be six, six vertically integrated operators.
Paul Henderson:
I guess, yeah.
Tim Pickett:
Huh.
Paul Henderson:
Wow.
Bijan Sakaki:
While a lot of people think vertical integration is the solution to everybody’s problems, it pauses its benefits, absolutely, but it also has a lot of challenges because then people have a different market strategy. People are cultivating with different intent. Some cultivators here are cultivating strictly for extraction for gummies and distillates. Other people-
Tim Pickett:
I’ve been there.
Bijan Sakaki:
… And there is no right or wrong, it’s just a different strategy.
Tim Pickett:
That’s what’s been so fascinating for me to be on the medical side, but then to also start to get relationships with all these, both retail, the processors, the growers, the vertically integrated, the non-vertically integrated, and see the different personalities of their companies, and what their skillset is, right? What type of products they believe are going to benefit the market or the patient base, and that’s been as fascinating as anything.
Bijan Sakaki:
It’s hard, and it’s hard, and everyone is going to have an opinion. Like what we do-
Tim Pickett:
We do it right, we’re the only ones who do it right, we’re the only ones who make medicine. Oh, no, we’re the only ones [crosstalk 00:09:55].
Bijan Sakaki:
Or if you go this way, you’re going to have five people that say, “Great, they went left.” And half the people say, “Why didn’t they go right?” So no matter what you do, people will always have an opinion. So our strategy is different than other peoples, we want to have, our motto internally is, no buff. No mids, we don’t want any mid grade. If I’m not going to consume it, if our team is not going to consume it ourselves, we don’t want it coming out of our facility.
Tim Pickett:
Do you feel like that’s what somewhat sets you apart from some of the other license holders in Utah, is that history of being somewhat of an expert consumer or in this space, longer than other people?
Paul Henderson:
Yeah, I think so. Bijan, from a consumer perspective, but even, I’ve been in the California space for six years, so understanding just the market and what works, what doesn’t. If you’re everything to everybody, you’re nothing. And so you need to pick a lane, and you need to stick with it, and that’s what we picked. If Bijan won’t consume it, if I won’t consume it, then we’re not going to sell to our patients, even though that’s a low price point, maybe a much lower price point, it just, we don’t feel it’s the right thing to do.
Bijan Sakaki:
And so with that, we’ve got, in our garden we’ve got 60 lights right now, and we’re putting out a decent amount of flower, but over the last six or seven months like this Green Crack that I just cracked open, has definitely, this is our number one. That’s our number seller.
Tim Pickett:
Hand that to me Paul. We’re just sitting just far enough away, oh my God, in the conference room.
Bijan Sakaki:
And then the Ice Cream Cake too.
Tim Pickett:
I love-
Bijan Sakaki:
Like they’re very, very different, and they do very different things.
Tim Pickett:
They’re both so different in the smell.
Paul Henderson:
But it’s also a different, it’s a different growing style, right? So our patients are seeing the difference in what we took over, which was the Harvest brand, and then coming out with Buzz and seeing genetics just different process, right? Layering in some skills and growing from different operators, bringing in some of our friends to overlook things and give us advice and making tweaks, and all of a sudden, the output becomes that much better. And so it’s fun.
Tim Pickett:
How does your background in High Times, well when did you become CEO of High Times? Because we interviewed Stormy-
Paul Henderson:
Yeah, Stormy. Yeah [crosstalk 00:12:23].
Tim Pickett:
He was here in Utah, right?
Paul Henderson:
So I actually joined and consulted with High Times in October of 2019, until January of 2020. I then became president and COO at that time, and I held that position until January of 2022. So about two years, and I was just named CEO recently.
Paul Henderson:
So, fairly new in the CEO role, but I joined High Times to pivot them from just media and events, into plant touching. Retail stores, branded products, and we’re doing a bunch more licensing now. I’ve been there through the whole evolution, so taking on the CEO role was a pretty simple transition.
Tim Pickett:
What do you, we all know High Times is the magazine, originally.
Paul Henderson:
Yeah.
Tim Pickett:
And the events that they put on, like the competition events. And I don’t know much about that. What’s that like?
Paul Henderson:
So we have basically, think about it as business verticals. So we have media, we have events, and then now we have the plant touching world and licensing. And so the media is also the magazine, is still is the magazine, we still produce 10 physical copies a year, we’ve talked about going all digital, but it’s like a staple on a coffee table, people love it. So we still produce that. And then we have hightimes.com, which is online, and then we have all the social media, which I believe we have about 12 million followers across our media channels, social media. And so that’s one business unit.
Paul Henderson:
And then the events, mostly we’re known for cannabis cup events, which basically crowns the best weed by market across the country, and sometimes globally. And so we would, I’ll tell you historically, we would go into a market, the brands would submit all of their entries, which sometimes they are collabs between companies to create the best flower or best concentrate. They submit it to the Cup. We would have 20, 25 well known judges which would consume all the product, and then we would announce the winners at a weekend festival, right? Music, and vendors, and food and all that.
Paul Henderson:
So COVID shuts that whole world down, we had a whole slate in 2020 of those events, so we canceled them, and then we actually pivoted very quickly and we productized the Cannabis Cup. And what I mean by that is we actually had, went to every market again, we had the brands contribute their products to be judged, but we built those into kits, which are actually a Cannabis Cup bag pack, and then we worked with retailers to sell those kits to the public for the first time ever. And then the public actually had the chance to submit their entries for judging. So the public became the judge, so we called it the Cannabis Cup Peoples Choice Edition, and we’ve been running those incredibly successfully over the last two years during COVID.
Tim Pickett:
Do you think the people choose better weed than the judges?
Paul Henderson:
I don’t know. Maybe, maybe not. I’m not the one that’s going say, but at least now we give a voice to the people and it’s all aggregated, and it’s thousands of entries, versus 25. So maybe.
Tim Pickett:
It is the peoples plant, right? Maybe we get to choose.
Paul Henderson:
So we have the events business, and then we are now operating seven retail stores in California, and two delivery hubs which are non-storefronts. So we deliver in Sacramento area and the Los Angeles area. And then also-
Tim Pickett:
How’s that going?
Paul Henderson:
It’s going well. So California is in a bit of a flux right now, it’s in an interesting point in time, mostly around the competition with the illicit market. And I will say-
Tim Pickett:
There’s still a bunch of competition with the illicit market?
Paul Henderson:
Yeah. You’re looking at California’s probably a 10 billion dollar market, and there’s three billion of legal sales, so probably 70% is still in the illicit market there. So it’s pretty wild.
Paul Henderson:
I would say last year you saw stimulus checks being given to people. People were at home, so they were consuming weed even when they were working. The sales-
Tim Pickett:
We definitely had a bump in visits that week, and for the few weeks after. Like a noticeable, every time those checks would come, and-
Bijan Sakaki:
There’s an influx of people.
Tim Pickett:
You’d have an influx of people [crosstalk 00:16:29].
Paul Henderson:
We saw that in stores, people coming in. They had money to spend, they spent their disposable income with us or with the general industry. The problem now is that, that money is gone, and you see the overall market in the legal space down about 20% year over year in the retail sales.
Tim Pickett:
You’ve seen that with stock prices-
Paul Henderson:
Yeah, that too. Even more so, and the market caps are down 50 or 70% of cannabis companies.
Paul Henderson:
And so we feel fortunate because we’re not down that, we’re basically either even from last year or up in many stores. And so I prefix that to say California is in a tough spot, we’re actually doing quite well, and for example, we launched a line of High Times branded products. So flower pre-rolls, vape cartridges, and the brand was selling extremely well in our own store, but we didn’t know if that was because, oh, people are coming to a High Time store, and they buy High Times product. Okay, that makes sense. But we took over a store in downtown Oakland that we did not rebrand as High Times, but we are managing it today. We put the High Times branded products simply on the floor just to see what happens. No marketing push, not budtenders pushing it, and it became a top three selling brand against all the legacy California brands, overnight.
Paul Henderson:
And so we know that the name holds cache, you know people know about it, you just don’t know if it translates into actually buying products in a physical storefront, but it does.
Tim Pickett:
It does make sense, and you’re the only company that I’ve ever heard of that went that direction. Went from the marketing, the advertising, the content, into retail end product branding. And its got to be an advantage-
Paul Henderson:
Obviously it’s a massive advantage.
Tim Pickett:
… You just told the story. Is that coming here?
Paul Henderson:
Not yet. High Times is I think is too recreational for the Utah market, the name just simply-
Tim Pickett:
It probably was in the bill, I’ll have to ask.
Paul Henderson:
You can’t use high-
Bijan Sakaki:
That gives off a recreational disposition, but that also just because Paul works at High Times, we’re not going to try and backdoor a High Times deal out here just for regulators [crosstalk 00:18:42]-
Tim Pickett:
Just for the regulators, right. Okay, got it. That wasn’t the point of bringing Paul.
Bijan Sakaki:
No, no.
Paul Henderson:
I was not at High Times when we first started working on this, I was the CEO of another company.
Tim Pickett:
And I think… So that everybody hears this as a listener and the regulators, we try, we on the medical side, you on the production and the retail side, we do try to keep well within the guidelines of the regulations. We don’t necessarily, of course we want to push the access for more and more people, because we’re all believers and advocates that it’s a safe substance that we should all be able to safely use it in an educated way. But we’re not trying to break the rules, right? We’re trying to live within those rules, and we’re just trying to do what the democracy was designed to do, change the system from within.
Bijan Sakaki:
And on that too, when we have such red tape around what we can do, how do you differentiate yourself between other operators? Like we said before, there is no right or wrong, everybody, every retailer, every cultivator, every processor, [crosstalk 00:19:54] different.
Paul Henderson:
Well you’re trying to tell that story of what makes you different and when you can’t market that story, then how’s anybody supposed to find out, right? So it’s a little bit of a conundrum.
Tim Pickett:
And quickly, you get retailers with reputation without doing anything.
Bijan Sakaki:
For good or bad.
Tim Pickett:
For good or bad.
Bijan Sakaki:
For good or bad.
Tim Pickett:
I think Dragonfly had some good things and suffered in some ways in the beginning, everybody seems like they’ve had that.
Bijan Sakaki:
And to that point, they were the first. So there is, everything, there’s pros and cons to everything. Every operator, every group has their strong suits, I think every store has a different vibe, and so that attracts different patients for different reasons. And I think when you look at home delivery, and I think that is a different experience than what you’re used to right now in the stores. So when you talk differentiation, you lose that experience factor, so you have to go with either product or availability.
Tim Pickett:
We’re going to vape a little on that.
Bijan Sakaki:
Yeah, let me load up this volcano here.
Paul Henderson:
Going back to the differentiation though, what’s interesting, most people don’t realize, one, we took a lot of heat at High Times early on about being a media company and moving into retail, right? We were told, “Hey, stay in your lane, do what you do,” which is media.
Tim Pickett:
Who told you that?
Paul Henderson:
A lot of industry people, because I think they were worried about the competition [crosstalk 00:21:30]-
Tim Pickett:
Of course.
Paul Henderson:
… Crossing over.
Tim Pickett:
They don’t have, yeah. They don’t want, you’ve got 12 million followers, of course they don’t want you involved.
Paul Henderson:
And so it was funny, right? Because, and I always explain that we’re a media company-
Tim Pickett:
You learned how to advertise.
Paul Henderson:
Yeah, we’re a media company that’s becoming a cannabis company, and people like, and I use the example of the time of MedMen, they’re a cannabis company, but they were trying to become a media company, right? So every cannabis company tries to become a media company because it’s an acquisition, it’s a customer acquisition game in California and beyond, in the recreational market. So they, like MedMen launched Amber Magazine, and they’re pushing their social media. Those are all assets we already have, we’re just now slowly transitioning into the actual cannabis space.
Paul Henderson:
So anyway, its been a phenomenal change, and I talk a lot about going horizontal across our business verticals, so what I explain there. For example, we run a cannabis company in California, we crown the best winners of let’s say, the Southern California market, we then guarantee distribution of those winners in our stores and we actually create a separate section for the winners that year, their products in our retail stores. So we’re doing things we’ve never been able to do before, and we’re going across our cannabis vertical and our retail vertical.
Paul Henderson:
Now another perfect example too is Cannabis Cup, if anybody’s listening, has ever been to one in California or beyond, we historically made money through ticket sales, sponsorships and vendor booths, just like any other event company. But now because we’re a retailer in California, we can actually sell the weed directly to the people. So historically, other vendors would have their own retail license, they would sell and we would just say, “Hey, you can go ahead and sell, no problem,” with all the people. So if we bring 50,000 people to an event over a weekend, those vendors going forward, this year and beyond, are going to check their product into us as the retailer, and then we’re going to manage sales across the whole venue. So instead of generating a million in sales per Cannabis Cup, we’ll generate six million over a weekend in cannabis sales and tickets.
Paul Henderson:
So again, horizontal across verticals, we have the audience, now we’re monetizing the audience.
Tim Pickett:
Wow.
Bijan Sakaki:
It’s risky, plant touching honestly sucks from a regulatory perspective [crosstalk 00:23:42]-
Tim Pickett:
I know.
Bijan Sakaki:
… You’re a plant touching [crosstalk 00:23:45]-
Tim Pickett:
No, I’m not plant touching, but I cannot bank, they don’t believe me. They don’t believe me when they look me up online and they’re like, well, you’re a marijuana company. I’m like, I don’t touch the plant, I don’t process, I don’t do anything, just please…
Bijan Sakaki:
Do you need a bank?
Tim Pickett:
No, I bank with you, I bank at the same place you do because they’re the only bank in Utah that understands both sides of it because they understand the producer side, they know a lot-
Bijan Sakaki:
And that’s honestly a big silver lining of our market is you have operators like that in California, it was cash all day, and you imagine the risk you take.
Tim Pickett:
Even in the medical side of things, we’re down, we take a small, a much smaller percentage of cash now than we did before. But in the beginning of the program, people were coming to me for medical visits and expecting they had to pay cash, just right off the front. And I take their HSA card. And that was really wild for people.
Paul Henderson:
Wow. And even before plant touching, even as an advertiser, media and events company, we had bank accounts shut down all the time because you are affiliated, right?
Tim Pickett:
It’s the affiliation, you promote, you sell or tell people where to find it, or something like that and it’s like-
Bijan Sakaki:
But Tim, Paul and I, we’ve both been banned from major banks personally-
Paul Henderson:
Personally because of it.
Bijan Sakaki:
Which is weird.
Tim Pickett:
Yeah, it is. It’s still, I think there’s a growing group of people who think this is normalizing, and they’re really caught off guard when they find out how redundant your businesses have to be, two merchant accounts, two bank accounts. Two of everything that just in case-
Paul Henderson:
Factor.
Bijan Sakaki:
Yeah.
Tim Pickett:
And I think, and High Times probably did that for [crosstalk 00:25:37]-
Paul Henderson:
For decades, yeah. People, they see a state legalize and expect that you can operate like a normal business.
Tim Pickett:
Like a normal business, right?
Paul Henderson:
Forget about the federal rules around 280E and tax deductions, like just simply, I used to have service providers like website development companies refuse to work with me at my previous cannabis company saying, “I’m sorry, I’m not willing to take your money.”
Tim Pickett:
Yeah. [Davie 00:26:04], by the way, Davie won’t take your money. Davie won’t take a normal person’s money if you find somebody online whose related to it. And just, I don’t know. Email, you’re right. Website providers.
Paul Henderson:
So there’s still a long way to go. A long way to go. We can’t advertise, even in California, forget about the Utah rules around advertising, but in California, I wish that I could put up a Google ad to drive people to my storefront. I can’t do it, Google won’t take my money. I can’t advertise [crosstalk 00:26:32], any interstate that crosses state lines, you can’t put up a billboard. So they made that more challenging. But every company has their own rules in what they want to do, and most of them don’t want to deal with cannabis, so they don’t.
Tim Pickett:
What’s High Times, so High Times is now vertically integrated in a way that no other cannabis company really is.
Paul Henderson:
Correct.
Tim Pickett:
With the media company.
Paul Henderson:
Yeah, exactly. So vertically integrated, people generally think of growing, manufacturing, retail. We’re a different vertical, right?
Tim Pickett:
You’re also content.
Paul Henderson:
Yeah, exactly. It’s content and events, it’s customer acquisition really.
Tim Pickett:
How do you do, one of the things I was going to ask you with these events is, when you have them in-person, you can’t have product from multiple states?
Paul Henderson:
No.
Tim Pickett:
How does that work in the US? It’s just like all a regional, meaning a state-
Bijan Sakaki:
State by state.
Paul Henderson:
All state by state. So when we host an event in Detroit or around Detroit and Michigan, we can’t have a vendor come with product unless they show that they’re licensed by the state. We verify, everything has to be a state specific. Then you go to Nevada, California.
Paul Henderson:
So it makes for interesting things because it’s all demographics, right? It’s some weed in California, there’s just different products there than you might find in different states. And we’re crowning different categories of the best cannabis, and it will be all different brands. Some brands through licensing deals, [crosstalk 00:27:58]. So you see the same brand, but it will be different growers.
Tim Pickett:
Do you still see the same genetics?
Paul Henderson:
No, not generally.
Tim Pickett:
Almost-
Bijan Sakaki:
I would say almost never.
Paul Henderson:
Some companies that are working with groups like Seed Junky or others, are trying to create this base of having the same genetics in multiple states, starting from seed. And okay, this brand you know is always starting from the same genetic material, but that’s far and few between right now.
Bijan Sakaki:
But also even then, when you pop seeds, you find a pheno, there’s such a different, there’s a difference in this phenotype.
Paul Henderson:
Or even grower conditions, right? An indoor grower isn’t built the same.
Tim Pickett:
Altitude, or all kinds of things. It’s like coffee, right? Just-
Paul Henderson:
It’s very regionalized.
Tim Pickett:
Yeah. So with Beehive, what products, you’ve got Buzz, is this the only flower you’re growing?
Bijan Sakaki:
No, we’ve got Ice Cream Cake there, we have Green Crack, we’ve got some Mochi Gelato, we’ve got some Lavender Jones, some the of the older legacy strains that-
Tim Pickett:
Lavender Jones.
Bijan Sakaki:
Afghan Kush, Hindi Kush-
Paul Henderson:
But they’re all under the Buzz brand right now.
Tim Pickett:
All under the Buzz brand?
Bijan Sakaki:
All under the Buzz brand right now, and then we’re working through some regulatory speed bumps regarding the Cookies launch.
Tim Pickett:
Oh, right. Yes. How would you, because of the name, because there is some-
Bijan Sakaki:
Well, with this recent legislation, it’s defined as a recreational disposition. Well, that name was included in that piece that would prohibit-
Tim Pickett:
So, for those of you who didn’t hear, that was the episode with Rich [O’Born 00:29:38], where we discussed this in detail, so go back to that one, a couple of weeks here, and listen to that discussion.
Bijan Sakaki:
And so that then puts rule making authority, department of ag, to determine what is recreational or not. And so-
Tim Pickett:
Got it. But that is one of the most popular strains in the country.
Bijan Sakaki:
It is probably the biggest brand in cannabis right now.
Tim Pickett:
Cookies is one of the most well known pain control strains that exists because it’s full of beta-caryophyllene.
Bijan Sakaki:
Strain two. But the brand ultimately, the brand Cookies-
Paul Henderson:
High level brand, and then there’s multiple strains underneath the Cookies kind of parent, right? One of those strains will do something different, but your point well taken, Girl Scout Cookies initially created by that company, together with some of their other strains, are incredibly popular amongst certain patients. And I just heard the same [inaudible 00:30:38] and Maryland as well, as exactly that. Is there’s a certain demographic, or the state also has some regulatory issues, Maryland is very a medical state as well, but once the patients spoke out and they realized what those strains did for patients, they gave the approval and it’s like the top selling strain in Maryland.
Tim Pickett:
Yeah, I think that. But that again with High Times or something that the public or the department has decided sounds too recreational, then they’re really trying to put a… I don’t know. We can get into this-
Bijan Sakaki:
No, no. What it is, everyone’s trying their best. Regulators are moving quickly, laws passed, people have to have a position, it’s just, I think we’ll come to a solution. Because again, by all means, we do not… People have a really big misconception of a medical market of cannabis. Everyone thinks, medical pass, one is regular pass. Honestly, I hope reg never passes here, because things happen in that marketplace that you can’t undo in the medical market. Right now people are saying-
Tim Pickett:
From the medical side, it de-legitimizes it as medicine, when you move to recreational, especially when you move that way too fast.
Bijan Sakaki:
100%.
Tim Pickett:
Right? And that’s I think, what you saw in Oregon, their medical program goes down 20% or 70%, after the adult use passes. But there is, I keep telling people, there is a third of the users here who’ve never used before in their life, and they would not have found cannabis unless it was medical.
Bijan Sakaki:
Medical, right.
Tim Pickett:
Right? So there is an expansion of access with medical.
Bijan Sakaki:
But you also have to look at it from, put your patient hat on now and think, what does recreational tax and the additional burden pass through to a customer? Now these $60 [ates 00:32:37]-
Tim Pickett:
That’s right.
Bijan Sakaki:
Now become $85.
Paul Henderson:
Correct.
Tim Pickett:
Because of regulation.
Paul Henderson:
We [crosstalk 00:32:43] this bill in Utah will have a tax, and excise tax or some type of extra-
Tim Pickett:
You’ve got a really good point. We did the calculation for [crosstalk 00:32:51].
Bijan Sakaki:
There is no adult use Utah bill, just for [crosstalk 00:32:54]-
Tim Pickett:
No, no, no. And there is no plan, there’s no-
Bijan Sakaki:
Correct. But any adult use bill typically, because that’s one of the things that move the needle for people is, okay we can have this additional income.
Tim Pickett:
Well, and you look at the cost, if you’re complaining about the cost of the Utah program, the cost of the medical visit you’ve got, and the cost of the product, you’re thinking is high. If you compare that to driving all the way, even Windover, with gas prices now especially-
Paul Henderson:
And time, and risk.
Tim Pickett:
… And all that time and risk, and then you’re crossing state lines, and then you’re buying it at 22% tax there, and bringing it all the way back, breaking state laws, federal laws. Even the numbers work out to be as inexpensive here already.
Bijan Sakaki:
Yeah, for sure.
Paul Henderson:
And I remember when Utah program, the medical program launched and there was kind this recoil of the pricing, and yet Missouri went live about the same time with $100 ates, that was the cheapest you could find. And so you’re looking at it like a 60 versus 100, it’s like I’d rather be in the Utah program. I feel like because we’re surrounded by recreational states, and states that have had programs for many, many years with prices coming down little by little, year over year, people get accustomed to that’s what you should pay, and so the price is a little bit of a shock. But if you compare it to a state that’s around dry states, if you will, then prices are sky high.
Tim Pickett:
Boy this, I’ll tell you I used Ice Cream Cake when I hurt my back two weeks ago, two and a half weeks ago, my back totally locked up and I couldn’t walk for a couple of days. It happens once every couple of years to me. I should get it looked at. But I had to, I’ll be honest, I had to really use a lot of cannabis to get the pain pretty bearable, which I was surprised about. It seems like we’ve talked to patients and we tell them to use as least amount as possible. But there’s a time and a place, and this is not medical advice folks, but there’s a time and a place where you just got to get basically as high as you can stand, to get through the pain.
Bijan Sakaki:
How’s your back now?
Tim Pickett:
Well, it’s way better. Three days of complete, like I can’t do anything, because the first day I couldn’t walk at all, second day I could make a cup of coffee, and third day I could watch Olympics and eat lunch. But both the muscle relaxation, the pain control, and then keeping my mind away from work, I couldn’t have done that without it. Totally.
Bijan Sakaki:
No, that has been… We were putting that in rotation a little more, so you will see more Ice Cream Cake. I’m excited for peoples reaction on the new menus because I think it’s also important to keep putting out different stuff. It’s challenging too when you have a small garden because you’re also limited, so until we get our expansion up and running, we’re going to be trying to maximize what we have, and [crosstalk 00:36:05]-
Tim Pickett:
Grow really good flower, and the Green Crack.
Bijan Sakaki:
And the Green Crack. The Green Crack is a great one, I think we’re going to maybe put that on ice for a little bit and then bring it back. But we’ll see.
Tim Pickett:
I’m such a lightweight.
Bijan Sakaki:
You’re good.
Tim Pickett:
I’m trying to work on my tolerance.
Bijan Sakaki:
This, I mean the volcano, is very, very effective.
Tim Pickett:
Absolutely. So, what else should we talk about? You guys, dealers choice.
Paul Henderson:
Well, Bijan just mentioned expansion, so for those that don’t know, if you have one cultivation license in the Utah, it allows you to grow in two different locations, so we had been searching high for an industrial warehouse, but with COVID, all the big companies snatched up every warehouse you could find. So that’s been made very difficult. So, we’re working on some options, we might be able to expand at our current spot, and so that will just increase canopy, allow us to bring out more varieties, more strains at the same time.
Bijan Sakaki:
To feed more stores, because right now it’s also a little bit harder where we sell so much at retail. So, if our output is X and our sales are Y, we also have to make sure that other people have enough to eat as well.
Tim Pickett:
Yeah, because if you get… We have a lot of patients move a lot. We’ve been surprised at how people are moving around.
Bijan Sakaki:
What do you think is the driver there? Because a lot of stuff is priced differently at different stores, same stuff priced differently.
Tim Pickett:
Priced differently.
Bijan Sakaki:
Is it-
Tim Pickett:
Yeah, I think people are learning that they can go, if they’re headed home to [Tooele 00:37:41], they’re going to find you. Whereas in the beginning, they were all-
Bijan Sakaki:
People are still finding us though.
Tim Pickett:
They are, but people were going to Dragonfly for a whole year because they didn’t know anybody else was open. Now, God bless him, I love you Kevin over there, but they really didn’t know anybody else was even open. And they would live by one, like [inaudible 00:38:09], they were driving all the way down to Salt Lake. So that’s the problem with the advertising, nobody can really-
Paul Henderson:
Get the word out.
Tim Pickett:
… Nobody can get the word out.
Paul Henderson:
[crosstalk 00:38:17] website, but I can count on one hand-
Bijan Sakaki:
Not to mention Paul, we just got our Instagram shut down.
Paul Henderson:
Oh, that’s [crosstalk 00:38:25]-
Tim Pickett:
That’s right.
Bijan Sakaki:
All you haters, thank you, because we’re just going to make another one, and we will just get that one shut down again.
Tim Pickett:
Every time your reach increases, kaboom, somebody flags you and then you’re suppressed. I’m surprised on Instagram, we’ve had okay success on Instagram, it’s Facebook that we cannot get any reach on Facebook at all.
Bijan Sakaki:
It’s hard, but-
Paul Henderson:
Same company though, just different internal policies, and no armor reason, you do everything right, you follow the rules, you don’t sell anything on Instagram, and you have your license numbers there, so they know you’re legit. And it doesn’t matter, shuts you down, and that is the one voice we had to kind of speak to our patient base, so this is what’s going on, come in. So we’ve just got to start over and do it again.
Tim Pickett:
Yeah, that’s so crazy, how they can even do that.
Bijan Sakaki:
Technically, it’s federally illegal, so they report to bigger people than we do.
Paul Henderson:
Anybody wondering, it’s Beehive Farmacy, with an F, Backup, is our new. Beehive Farmacy Backup is our new Instagram handle, so go check it out.
Bijan Sakaki:
Hopefully we get Beehive Farmacy back up. No, but it is Backup.
Tim Pickett:
Are most people coming through the drive through now?
Bijan Sakaki:
People still do. People still do. People still come drive through.
Paul Henderson:
50% of orders or so, coming through [crosstalk 00:39:48]. Is it that high right now? I don’t remember the numbers.
Tim Pickett:
Do you have delivery yet?
Bijan Sakaki:
We’re about to do delivery.
Tim Pickett:
What’s the name of the delivery service, do you know?
Bijan Sakaki:
We’re going to do it internally.
Tim Pickett:
You’re going to do it yourself?
Bijan Sakaki:
Yeah. It was a build versus buy decision, and-
Tim Pickett:
You decided to do it.
Bijan Sakaki:
We decided to do it.
Tim Pickett:
Can you sell space in your car for flyers for Red Hanger Dry Cleaners?
Bijan Sakaki:
Or for Utah Therapeutics?
Tim Pickett:
Not for me, I’m just thinking like Mo’ Bettahs Food.
Paul Henderson:
I don’t know.
Bijan Sakaki:
I think, well I don’t think, I know all the driver stuff needs to be discrete, non-marked. It’s not like this is a truck delivering weed, and you can get a menu at Mo’ Bettahs.
Tim Pickett:
Right, yeah. I’m always interested in what else can you do at the point of sale.
Bijan Sakaki:
I know originally the advertiser requirements were a little bit undefined for those third party couriers, so we’ve seen our friends, love the billboards, love them, they’re everywhere.
Tim Pickett:
They are.
Bijan Sakaki:
I think it helps raise awareness for everybody.
Paul Henderson:
That cannabis is legal in Utah. I still talk to people every day that have no idea there’s a medical bill in Utah.
Tim Pickett:
Yeah, that’s my billboard, and it’s, no matter how much exposure any other Q&P group gets, it’s totally great for us, because it’s just exposure is that they talk to four or five people, they learn it’s legal here and where they can, if it’s an option for them.
Paul Henderson:
Yeah. We talk a lot about how we’re not really in competition with the other licensed groups, our main competition is the illicit market. It doesn’t matter what state you’re in, I talked about California, but Utah has a big underground market with IED coming through, I don’t think it’s any surprise. So it’s us really educating patients here that, or our potential patients that, hey, this is legal now, you can go through and get your card and come into a pharmacy.
Bijan Sakaki:
But for a lot of people too they’re like, “Why would I do that?” And if you truly are mindful of what you eat and what you put in your body, what you’re consuming, then you want to know that this has been tested. We want to talk about lessons in California, so a lot of things in California that never would pass testing, would allegedly get destroyed. And those things allegedly appear in other markets. So if you really don’t have a grip-
Tim Pickett:
Didn’t we have something like that here coming out of Tooele or something? A huge, huge bust.
Bijan Sakaki:
So Paul’s comment about the 80 and the 15, it is where the 80 and the 15 meet, and so there’s people always getting caught with, you agreed on KSL, 300 pounds of [inaudible 00:42:43] or whatever, and that guy’s going back to Auburn in New York, or wherever he’s from. So you get a lot of questionable product. You have these vape pens back during, “Vape Gate,” the vape gate stuff. So those are full of dillutants, vitamin E acetate, a lot of the actual oil itself had Myclobutanil, pesticides. If you have a dirty flower that doesn’t pass and then you extract it, now all those pesticides are concentrated in that distillate.
Tim Pickett:
In that distillate.
Bijan Sakaki:
And then that’s what’s being used to then make gummies and fill vape carts.
Paul Henderson:
And even before that, if you have a flower in California that pops for a pesticide that Bijan just mentioned, Myclobutanil, or it’s called Eagle 20 as well, and it’s sprayed on fruits and vegetables in California, so it’s not dangerous if you eat it. But if you put flame to the weed, it turns into cyanide and you’re inhaling that.
Paul Henderson:
Talking about being careful about what you’re putting in your body, there’s dangerous chemicals that you can be inhaling if you don’t know where the flower is coming from.
Bijan Sakaki:
And even on the edible side, because we get a lot of people that come into the store and they’re like, “Hey, I bought these gummies and,” they’ll pull a picture on their phone, and they’re like these gummy bears that are rolled around in distillate. And it’s like, you don’t really know what’s in that. With these, you know how much is in one serving and one product.
Tim Pickett:
Are these in your store?
Bijan Sakaki:
These ones are not, we’re actually going to start producing these here the next few weeks. These are going to be, I think a really good product for this market.
Tim Pickett:
You want to talk about them? They’re just empty packages right now, but they’re tablets, yeah?
Bijan Sakaki:
Yeah. So these are pro-tabs by LEVEL. LEVEL was started by one of the smartest guys in cannabis that I know, Chris Emerson, he’s a PhD. Brilliant guy, brilliant team, he and his wife run the company, and they have really formulated a great product, it’s a small form factor, it doesn’t digest in your liver, so the effects are very similar to a flower high. It doesn’t convert into 11-Hydroxy, so it’s not like that meme when an edible kicks in and then you’re like riding that rocket ship. So it doesn’t give you that, it’s a very familiar experience to what you would get if you medicate with flower.
Bijan Sakaki:
So we’re going to drop these, we’re going to have 100 milligram tabs, 25 milligram tabs, single packs, four packs, 10 packs. So I think it will be a really good alternative for people who are familiar with the edible consumption, but are also new to cannabis and maybe don’t want to take something with sugar and gelatin and food coloring and all the other stuff in there, when this is simply just-
Tim Pickett:
Well the tolerance will be a little different because if it doesn’t convert to 11-Hydroxy, then the high, the level of high or that level of psycho-activity, is different.
Bijan Sakaki:
Mm-hmm (affirmative).
Tim Pickett:
Right?
Bijan Sakaki:
Yeah.
Tim Pickett:
But consistent dosing, we do need more products in Utah with consistent dosing, so that you know exactly how many milligrams you’re taking, what it’s likely going to feel like from a medical standpoint. That’s just how medicine should be taken.
Bijan Sakaki:
Understood. And that’s the same approach. That’s why, I’ve known these guys for five plus years, and when this market opened up, we have what, the third or fourth opioid problem right now?
Tim Pickett:
Yeah.
Bijan Sakaki:
And-
Tim Pickett:
It’s huge.
Bijan Sakaki:
And so for a lot of chronic pain people, this is not an unfamiliar method of consumption. Whereas, vape rising flower or vape rising cartridge-
Tim Pickett:
Or even taking a gummy, some people are like, it’s like I’m eating candy, like the gummy vitamins.
Bijan Sakaki:
True.
Tim Pickett:
They feel like it’s not real. Pills are just so much easier for people to understand when it comes to medicine.
Bijan Sakaki:
And part of it too is just watching a lot of these variable doses of edible sell really well and really poorly. And so we’re coming out with a smaller dose market, more of that micro-tier single digit milligrams.
Tim Pickett:
You can see, so as a retailer though, that’s a good point you bring up, you can see what patients want, where the demand is, and then even if you’re a little smaller with the production side now, you’re kind of coming into it in a better spot, where you can develop products that-
Paul Henderson:
It’s just market research, right? It’s like you know exactly what’s selling, you can go back, and you can build what people want to buy. So you don’t have to guess and check, you don’t have to come out with something and test it.
Tim Pickett:
Has that been something that you personally have been able to really influence in Beehive, because of your experience in the marketplace?
Paul Henderson:
A little bit, but I wouldn’t say to that extent. But I think I helped a lot early on, on what eCommerce business, to go with duchy on the front end, so we can take orders online. And like our big sign, instead of the brand name, just put a big green cross, and it’s like the bat signal, right?
Tim Pickett:
Yeah, it is.
Paul Henderson:
Anyway, it was just a lot of those little things that-
Tim Pickett:
It is going down the 201, right? [crosstalk 00:48:13].
Bijan Sakaki:
That’s 201.
Paul Henderson:
And so it was more kind of business related stuff to like, I actually tried and failed and iterated and went through multiple versions of things, to kind of figure out what works. And then we just go the benefit on the Beehive side of like, hey let’s skip all that. And these guys built the best website for cannabis retail stores, so let’s go there.
Tim Pickett:
Sounds cool.
Bijan Sakaki:
And that, again, a lot of how we ran things are relationship based. We work together because we want to work together, it’s not because it was like, oh, this is the only opportunity at hand, and this is a forced relationship. So we’ve got a lot of trust there.
Bijan Sakaki:
But also too, to the earlier point, we can listen at the registers and be like, “Yo, people are asking for more concentrates.” So now we’re going to take all of our trim and we’re going to now make concentrates that everybody that’s going to Windover, doesn’t need to go to Windover anymore. It’s like, we’re going to now have some good cured live resin, we’re going to have some cured resin, we’re going to do some solventless. And again, it’s that comment Paul made earlier, you can’t be everything to everybody.
Bijan Sakaki:
We can’t sell mids and also pretend to sell top-shelf. And then also pretend to sell little [chinsy 00:49:30] like snake oil type items. And so it’s like picking what’s really important to us, like we’re super passionate about the brands we’re bringing, LEVEL is one of them, Cookies is another one. You’ve seen a couple of the other brands that we’ve launched at Beehive, like Proper, like Release Society.
Tim Pickett:
Those two are great brands too. And that Release Society is [crosstalk 00:49:55]-
Bijan Sakaki:
And they have great products too.
Tim Pickett:
Yeah.
Bijan Sakaki:
And part of our strategy on the Release Society carts was, we see a lot of carts come through the store with returns. Bad hardware, bad inputs. So how can we make that tweak a little bit.
Paul Henderson:
And this is the stuff we saw in California, that one dollar Chinese cartridges, they have a failure rate, and you know what it is. So yeah, you can save a couple of bucks, but then your brand gets a bad reputation of your hardware failing all the time. So do you spend some more money? Do you upgrade the hardware? Do you just kind of work with people like Release Society to let them know, this is exactly what works, we’ve already tested it, I’ve already been through all these iterations in California, and use this manufacturer for your hardware, and no returns yet, I guess [crosstalk 00:50:36] today.
Bijan Sakaki:
Yeah, its been great. And so we have the luxury of also, again, put our patient hat on like, would we use this? What issues do we have because we’re using it? Does this hardware need better improvement, let’s try and do something. Is the flower testing well enough? A lot of people are either flavor chasers or potency chasers. So with flavor, you need more [inaudible 00:51:03], you need more resin production, which adds to the medicinal benefit of the actual plant itself. So how can we double down on our environmentals? Let’s change the way we feed, let’s change our schedule, let’s… I’m generalizing here, but the changes we’ve made in cultivating in the last six, seven months, look completely different. And so over the next couple of months, you’ll see the flower quality starting to increase, because once you make a change, you’re not going to see it until the end product, six, seven months later.
Bijan Sakaki:
So, things that we’re doing now, you’re not going to see in market until July-ish.
Tim Pickett:
You guys really are, now that I’ve been talking to you for the hour, you guys are the only owners who know the business top to bottom. You realize that don’t you? Like from clear out to the consumption side, nobody is doing it all the way, or nobody is really involved all the way in the vertical. They’re either involved heavily in the retail and not in the grow and the producing, the production. But you guys seem to be involved all the way.
Paul Henderson:
Yeah, I don’t know enough of the other operators to know that actually, so it’s interesting. But before I was running High Times, I was CEO of a company called Grupo Flor, which was one of the larger vertically integrated companies in California. So I have run 230,000 square feet of cultivation in dutch glass greenhouses myself. I actually worked with the greenhouse companies to convert them from cut flowers to cannabis, so I had to learn everything from lifecycles and we’re talking about environmentals with lights and humidity, and everything Bijan just mentioned.
Paul Henderson:
So, well I’m not doing it at High Times, bringing all those skills together with what Bijan knows and some of our other partners, we’ve been at every single level from-
Tim Pickett:
Yeah, from the first [crosstalk 00:52:59]-
Paul Henderson:
… I had the first ever hydrocarbon extraction license in the state of California, it was in Salinas California, it was me because when we brought the Colorado department, marijuana enforcement division med, spoke with them, brought their fire department consultants out to California, worked at the facilities. You didn’t have a choice but to actually build it, right? So we’re doing the same thing here but we can benefit, Bijan was in California for a while too, so he saw all that. So we’re now owners operators, we now have been involved in every single thing from genetics, through to retail delivery. And I think it shows in our product here in Utah, that we care a lot about what we do.
Bijan Sakaki:
And while we’re not in the garden every day, we’ve got a really solid team up there, and we’re getting better at figuring it out. But when we do make a change, we all know what we’re changing. So, it’s double edged sword though because while we are involved, that may inhibit our growth or our ability to scale to that degree. But I think right now when you’re juggling chainsaws, it’s better to be careful.
Tim Pickett:
You’re juggling some pretty good chainsaws though. You’ve got a very successful, in my opinion, you run a really great pharmacy. Your pharmacies in both locations are excellent.
Bijan Sakaki:
Thank you.
Tim Pickett:
Really involved. Mindy and I talk all the time-
Bijan Sakaki:
She’s great.
Tim Pickett:
… And are involved in a group from Brigham city. And yet your, it almost seems like the best is yet to come still, because you have all of this expansion of grow, the product side, the brands you want to bring on.
Bijan Sakaki:
Yeah, and on top of that it’s just, double down on customer service. Everyone’s trying, so we don’t want our spot to be a place people come because they feel like they have to, it’s because it’s a place they come because they want to, they trust the people that are there as the pharmacist, as the pharmacy agent, as us the owners, because there’s not a lot of people that… I’m very open about, know who you’re supporting. It’s like that whole, know where your food comes from campaign. So we have a pretty small team and I’d say we’re probably the mom and pop underdog.
Tim Pickett:
You will always be.
Paul Henderson:
And you mentioned Brigham city, we haven’t talked a lot about that. But that’s the second location of the retail store, for those that don’t know. We are in Salt Lake off of 201, Brigham city, right in between kind of what Logan and [Ogden 00:55:38], if you will.
Tim Pickett:
Yeah, you’ve got to make the turn off of the freeway to go up the canyon.
Bijan Sakaki:
Take the 1100 South exit, we’re right in the same parking lot as Walmart, next to Subway and the Supercuts.
Tim Pickett:
Yep, right in between there in that strip, like this little strip mall. Your sign’s on the back of the store. I see it every time I drive up.
Bijan Sakaki:
You’ll see the green cross, and if you’re a patient in Salt Lake, all your information is in Brigham city, so you don’t have to see the pharmacist again, unless you want to.
Tim Pickett:
And there’s probably no line there most of the time.
Bijan Sakaki:
Honestly, its been getting a lot busier. Mindy’s been doing a really good job of, she-
Tim Pickett:
She comes by, and make sure our patients know that she’s up there.
Bijan Sakaki:
Well she took over her own ordering.
Tim Pickett:
Oh, does she?
Bijan Sakaki:
So we were trying to run thing central to Salt Lake, and this is an example of areas where we thought we knew, hey, this is the right strategy, we learned it’s not. And so centralizing ordering was great for vendors, but kind of a nightmare for us because the frequency of what was happening in Brigham city-
Tim Pickett:
Was different. Or it would be totally different.
Paul Henderson:
Different, different product selection and stuff.
Bijan Sakaki:
Different demographic. We look at the ratios of what sells flower, [crosstalk 00:56:55], vape carts is different in Salt Lake than it is in Brigham, and we have the same products on the menu. So yeah, Mindy and the crew said Zed, Landon, we had a couple of new hires up there as well. They’ve been holding it down, it’s a new pharmacist, and we’re hoping that we can be kind of that specialty location for, again, that high end top-shelf medicine that you otherwise wouldn’t be able to get at other pharmacies.
Tim Pickett:
Hmm, yeah. Cool.
Paul Henderson:
Yeah. And its been growing month over month, so I think really just as patient count has gone up, we see the results at the end pharmacy.
Tim Pickett:
That’s cool. So tell me your Instagram again, the new one.
Bijan Sakaki:
Beehive Farmacy Backup.
Tim Pickett:
Beehive Farmacy Backup, with an F.
Bijan Sakaki:
Farmacy with an F.
Tim Pickett:
Farmacy with an F. How else can people get a hold of you? What’s the address of the locations?
Bijan Sakaki:
So, beehivefarmacy.com, from there you can either make a registration appointment as a new patient, you can view our menu for both stores and place an order there. Salt Lake’s location, 1991 South, 3600 West Salt Lake City, 84104. So that’s right off the 201, right near [inaudible 00:58:07] Highway. Brigham City is, 1150 South, 870 West Unit C.
Tim Pickett:
I’m testing you right there.
Bijan Sakaki:
I know. Unit C-
Tim Pickett:
I can tell [crosstalk 00:58:21]. Just follow your nose. When you go to Subway, just stop by the medicine store.
Bijan Sakaki:
But you can also call us if you have any questions.
Tim Pickett:
And you can find you at utahmarijuana.org/dispensaries, for anybody whose just looking up dispensaries in Utah, and not medical cannabis pharmacies, you tend to run into us. And we have all of your information, both locations too, and some really good reviews actually.
Bijan Sakaki:
Well great. And I know we’ve got some-
Tim Pickett:
And we’ve done some articles on some of the stuff on utahmarijuana.org.
Bijan Sakaki:
I know we also have some deals for some of your patients-
Tim Pickett:
Oh yeah, new patients if you see us in West Valley especially, you’re going to get a coupon to the pharmacy straightaway. So we did have some patients, we’ve had patients come in, in the morning, and by the time they leave our office, have their card, and be able to come across the street. We’ve actually had that happen.
Bijan Sakaki:
That’s great. So it’s almost the same [crosstalk 00:59:25]-
Tim Pickett:
Because the department of health has been so, almost everybody gets a same day turnaround now, but some people get a two hour turnaround, because the department of health has been really on top of-
Bijan Sakaki:
That location, your location was really popping during the Letters.
Tim Pickett:
Oh, the Letters is great, because you can walk over-
Bijan Sakaki:
You could walk over, yeah. It was…
Tim Pickett:
Yeah, there are some things with the system right now that are, I’m squinting my eyes right now people. Okay, Utah in the Weeds podcast. If you’re not subscribed, then subscribe to the podcast, utahmarijuana.org/dispensaries, Beehive Farmacy. Man, its been great talking to you Bijan and Paul. Congratulations with your store in California, [crosstalk 01:00:09] and your new role here. And-
Paul Henderson:
And for those who don’t know, I live in Utah, so I just never clarified that. This is my home base, I travel for High Times. So my office for High Times is in Venus Beach, but I’m on the road generally three to four weeks out of the month.
Bijan Sakaki:
Didn’t you go to BYU?
Paul Henderson:
I did go to BYU as well. [crosstalk 01:00:28], that’s what I’m saying, I’m not the outside guy coming in, I live here.
Tim Pickett:
And there’s the bells. There’s the church bells. That’s it, all right everybody.
Bijan Sakaki:
Thanks Tim.
Tim Pickett:
Be safe out there.
Episode 95 of Utah in the Weeds features Steve Urquhart, a former state senator who helped to shape Utah’s Medical Cannabis landscape. Steve was one of the co-sponsors of “Charlee’s Law,” the 2014 legislation which legalized CBD oil for people with intractable epilepsy. Steve founded The Divine Assembly, a church whose members use psilocybin mushrooms as a sacrament.
Steve shared a little bit about his current career and his thoughts on Utah’s Medical Cannabis climate. He points out that many Utahns still purchase their cannabis in Nevada. [03:03]
Steve has fought for Medical Cannabis in Utah as both a legislator and advocate. He also founded The Utah Bee, an online magazine focused on covering cannabis, psychedelics, and alcohol in Utah. [05:59]
Steve teaches two courses in the University of Utah’s School of Medicine: health policy & leadership, and health systems. He invites a variety of guests to speak at some of his courses, and he says this helps his students understand life “in the trenches” of public health. [11:15]
Tim and Steve touched on the risks versus the benefits of having a Medical Cannabis program in Utah, and they agree that the benefits far outweigh the risks. [16:27]
Tim asked Steve about the public health perspective during recent years as Medical Cannabis became available in Utah. Steve says public health should be based on good data, but the federal prohibition of cannabis has created a “Catch-22.” [19:45]
Steve believes the federal government will probably remove psilocybin and MDMA from the list of Schedule I drugs before removing cannabis. [26:02]
Steve’s church, The Divine Assembly, encourages members to connect with themselves, others, and “the Divine.” Members can optionally use psilocybin as a sacrament. He told us about his early “healing experiences” with psilocybin that ultimately led to the creation of The Divine Assembly. [28:21]
Steve expanded on the roles of spiritual experiences and psilocybin in healing, saying psilocybin helps the brain to form new neural pathways. [34:39]
Steve talked about having the right “set and setting” for a psilocybin experience. Most unpleasant experiences with psilocybin, he says, happen because the user was not in a good setting. [41:06]
Tim asked Steve about the role of cannabis in spiritual healing. Steve says, because of his experiences with psilocybin, he can use cannabis to reach the same mystical state of consciousness. [47:18]
Steve talked about “entheogens,” or substances that “bring us closer to God,” including cannabis and psilocybin. [50:25]
We wrapped up with a discussion of some local organizations working to incorporate cannabis into group settings like group therapy. [57:12]
Tim Pickett:
Welcome everybody out to episode 95, only five more to a hundred. Today on Utah in the Weeds, my name is Tim Pickett. I am the host of Utah in the Weeds, podcast about cannabis and cannabis culture and medical cannabis. And today, psilocybin, and religion, and God, and spirituality, and experience, with Steve Urquhart. Steve is the founder of The Divine Assembly, a church that is premised on magic mushrooms, and psilocybin, and interacting with the divine. We have a great conversation today. Steve also teaches public health at the University of Utah, School of Medicine, in their Public Health Department. He was a state senator here in Utah, represented Washington County down South, and is a phenomenal guy.
Tim Pickett:
Lots to say, got him fired up there at the end, if you get all the way to the end. Couple of guys just talking about cannabis program and really the opportunity that we have to move things forward with society, spirituality, heck, we could even bring back God into the community. For those of you who are not subscribed to Utah in the Weeds, it helps us out a ton. We’ve got more and more subscribers every week. We’re so happy with the response. And heck, we’re coming up on a hundred episodes, so stay tuned. Next week, Bijan and Paul. Bijan is the founder of Beehive Medical Cannabis Pharmacy here in Utah, and Paul Henderson, the CEO of Hightimes, and also one of the partners in Beehive Pharmacy in Salt Lake City, Utah.
Tim Pickett:
That is our 420-week, spirit week, cannabis Christmas coming up for all of you who are part of the cannabis program here in Utah. And for those of you, three of you who listen outside of Utah, thanks for being a part of this. Enjoy this episode and reach out to us on Discover Marijuana on YouTube, I know there’s a lot to remember. Discover Marijuana on YouTube, that’s the place to get a hold of us, all of these episodes are uploaded there. And there’s another place for you to subscribe and learn more about cannabis and medical cannabis, and all the sciencey stuff about cannabis. So enjoy this episode with Steve Urquhart. This is one of my favorite conversations. So Steve Urquhart, what are you up to?
Steve Urquhart:
So I’m a lawyer, and I still practice a little law. Mostly that’s just friends and family stuff. I have a few paying clients, and I teach up at the U of U Medical School. I teach in the Division of Public Health, teach health policy, and I’m busy running my mushroom church, The Divine Assembly.
Tim Pickett:
Were you involved in the legislation this spring, when they were trying to develop the, was an allocation to study whether or not they should let psilocybin into Utah?
Steve Urquhart:
I can’t really say I was involved in that at all. Very, very peripheral to… Probably not even saying I was involved at all. Just followed it, talked with some folks and gave a few suggestions here and there. But I’m happy with it. I like the composition of who’s on the task force, and I like the direction of the task force. Even before it starts, I like that it destigmatizes psychedelics to some degree by being worthy of study by the state. So yeah, I think this is a big step forward.
Tim Pickett:
What do you think about the cannabis law here in Utah?
Steve Urquhart:
That’s a very complex issue there, my feelings on that. At this point, I think it’s decent. The Utah legislature does a good job when moneyed interests are involved, and now that there’s money in it, I think that the law keeps improving. And I’m not a patient, so I sure don’t want to speak on any patient’s behalf. I’m not part of it. I go to Wendover to get what I need, and as I think, tons of Utahns do, and it’s amazing. The revenue we’re giving away, that parking lot is full of Utah plates, as I assume, the Mesquite Dispensary is too.
Tim Pickett:
Oh yeah. I mean, it was built… I know the owner, or know a little bit about the owners and the group. I mean, it’s built for us.
Steve Urquhart:
Yeah. No, it is. I mean, I usually talk with the people who are there at the cash register, the people grabbing it, and ask them about all the Utahns, and they say, “That’s all we get. That’s our business.”
Tim Pickett:
Right.
Steve Urquhart:
But, so obviously, it’s not working completely well if that’s the case, but I think that it’s doing okay by patients. It’s probably better than nothing.
Tim Pickett:
Yeah. What makes you not want to be involved, or is that just out of convenience? Or?
Steve Urquhart:
Well, I was very involved in the legislature, I ran the CBD bill in the Senate, and then helped with attempts in the Senate, Mark Madsen’s bill. And then the initiative, when it started to go wonky there at the end, and the LDS Church started to play, and I think they were absolutely playing games. Just they wanted anything they could call a compromise, whether people agreed to sit at a square table or a round table, they were going to hold up something like Lion King, holding up Baby Simba saying, “Here it is, we have a compromise, you don’t need to vote for this.” And I think that was… I think that was dark and dirty.
Steve Urquhart:
I think it was a cheap attempt to get people to vote against the initiative. And then if it failed, despite all their promises, they would’ve said, “Oh yeah, people don’t want it.” And so I think it started out dishonestly, stupidly, and then the bit about the state was going to dispense a schedule one federally-illegal substance. That was-
Tim Pickett:
Yes. Still comes up-
Steve Urquhart:
It was that-
Tim Pickett:
Still comes up. They were trying to protect kids who had these conditions and keeping it in elementary schools and high schools where these kids are… This is in a locked case. And may I remind listeners that schools are like pharmacies, they have a ton of medications in them all the time. But they were saying the same thing. You’re going to dispense federally-illegal substance, you’re going to let us carry around, they compared it to heroin.
Steve Urquhart:
Yeah. Well, and if you remember, the state was going to be the pharmacies as they call them. And-
Tim Pickett:
Yes. Central fill.
Steve Urquhart:
And I just… Yeah, central fill. And so I really don’t think that the people involved are that dumb, I think that it was something that they knew could be locked up in the courts for years, and the state would ultimately lose, which they would have. So I worked with TRUCE and Christine Stenquist, to just try to get the truth out. And my wife and I started The Utah Bee. The point of that, we started it during that campaign, to try to get, I’m sure what you’re doing, to try to get truth out there. Utah journalists are overworked, I think that. You look at the trip, for example, a lot of great, young journalists, but I cannot believe their workload.
Steve Urquhart:
They need to get out so much work product, that it’s difficult for them to dig deep on many studies. And here, there’s just no time because it was on the ballot. So knowing how the church works, knowing how the legislature works, we wanted to get out some truth, get out some stories quickly, knowing that the media would at least read it and it would help give them a start on where they could look with their superior skills and resources. And so, yeah, The Utah Bee is out there, and we still run it. We call it altering the hive, and it’s about cannabis, psychedelics and alcohol, and I have a lot of fun with that.
Steve Urquhart:
But that was my involvement, was working with Christine and TRUCE to try to battle about a lot of the dishonesty that was coming from the legislature and the LDS Church. And we give ourselves right or wrong, we all need to be the heroes in our own stories. And the Utah Bee, we give ourselves a little credit for helping keep that above the 50% level in the vote.
Tim Pickett:
Yeah. And Christine’s been an activist clear through, even til through today, really involved with TRUCE, in trying to get their message out. And I don’t… Is it wild that I just about said what they consider truth, as if our political system has biased me so much that truth is relative to the position that you speak from?
Steve Urquhart:
Well, to some degree, that’s all of us. I mean, my version of how this passed, what it was about, that’s a truth to me, based on what I saw. Is that an objective truth? Probably not.
Tim Pickett:
Yeah. So, okay. Yeah. Fair point. What you teach at the University of Utah, I’m fascinated with education. I feel like if I was… I could retire tomorrow, and I’d be a lifetime student somewhere. You teach in the Medical School and the Public Health Department, they’re on Wakara. Yeah?
Steve Urquhart:
Right. Right.
Tim Pickett:
What-
Steve Urquhart:
You spent some time there. Right? That’s where the PA program is.
Tim Pickett:
Yeah. Yeah. Spent a significant amount of time right there. And I think we were underneath you guys, in the basement, for a while. What courses do you teach?
Steve Urquhart:
So I only teach two. I teach health policy and leadership to medical students and PhD, public health students. And then two years ago, I picked up a course on the Korean campus, just via Zoom, and that’s health systems. It’s great stuff. We go after the essential premises of public health, we go over social determinants of health in the PhD-MD course. We go over start, well, just the history of public health, what it is, and then we get into Medicare, Medicaid, move forward to the ACA. And it’s a pretty interesting course. We get to bring in a lot of public health practitioners. And when I inherited the course, it was kind of a who’s who? Who in Utah has done big things in public health? And I tried to keep those big prominent players, but I also am a big believer that I have friends in low places, borrowing that from Garth.
Steve Urquhart:
And I brought in some folks who really were down-and-out in life, and then have risen above, and went on to get some degrees, and done prominent things in the community. I mean, for example, I bring in Christine to talk about medical cannabis and the fight for that. She was a bedridden patient for 16 years, and then kind of a Mr. Smith goes to Washington, Erin Brockovich’s story. She came way up to the capital, and I think as patient zero, she had a huge part changing the state. I bring in Mindy Vincent, who was a 17-year IV drug user, in and out of jail, just really a litany of difficult things there. And she went into the court program and got some life skills, has got two master’s degrees, started the Utah Harm Reduction Coalition.
Steve Urquhart:
I bring in a former sex worker. And to me, that’s public health. Public health is in the trenches. Yes, we have the officials who run it out of nice offices, with big titles, but public health is a lot about the people who are down in the trenches. And community health workers, as a state, we just recognized community health workers as a discipline, as a certified group. And that’s where the rubber meets the road, public health. And so I’m really excited to introduce those people and those concepts to a lot of students who largely have been in academia. Right? And-
Tim Pickett:
Right. Their whole life.
Steve Urquhart:
Yeah. And some might not know any sex workers, might not know any IV drug users. And they really love those people. Mindy, it’s so funny. She’ll drop 10 F bombs on them, and that’s just who she is. She’s just seen so much of life, and she talks like who has seen it, wants others to understand it. And the students really just love her and love Christine, love people who’ve been out doing and experiencing and achieving.
Tim Pickett:
It’s one point of the medical cannabis program that I think is, it’s always important to showcase or to get these individual stories out because there’s so much still, a stigma, with the cannabis program, especially that there’s just a bunch of who want to get high and we’re just creating this gateway so they can do that. And there is a decent portion of the cardholders here in Utah that I would say might fit that mold. However, you might… Look, you’ve got to have, or else the 72-year-old who was addicted to opioids and changed their life around, or somebody with neuropathy… I’ve got an interview in May, somebody with neuropathy, so bad, they couldn’t walk, gets help. I’m okay if 10,000 people get access to something that’s relatively safe, if I can help those four or five people.
Steve Urquhart:
Yeah.
Tim Pickett:
I feel like that’s where public health, the balance is, you constantly are fighting for funding and for programs to help the few, really help the few, and then there’s always this fight against the fraud and abuse argument, the fraud and abuse.
Steve Urquhart:
And we always have to weigh relative cost, relative risks. And what I tell them when I bring in Christine, is to talk about her fight and the fight for medical cannabis in Utah. I tell them, “Look, in big ways, you’re not going to get this, because you’re going to take for granted what she did, what she’s talking about, because things have changed so much.”
Tim Pickett:
Right.
Steve Urquhart:
It was only very few years ago that lawmakers thought the only people who used cannabis were stoners. And given how this state leans, they were degenerate stoners. I mean, these were not people we wanted to associate with. I mean, that really was, not only the predominant view, almost the universal view of the legislature, and just pure misinformation, pure stigmatization. We take so much for granted now, but when you really can look at it dispassionately without the stigma, it’s very low risk. I mean, cannabis is a low risk to society, when you legalize it. I mean, the big risk when it’s illegal is, well, then it is underground.
Steve Urquhart:
And you do have outlaws who are dealing with it. Your risk comes from the fact that it… I mean, I picked this up from Mindy, and I know she picked it up elsewhere, but this stuff isn’t because it’s dangerous, it’s dangerous because it’s illegal.
Tim Pickett:
Yeah.
Steve Urquhart:
So-
Tim Pickett:
There’s a lot of truth to that. In fact, it’s more dangerous now because the potency… for that exact reason. It’s been illegal for so long that there’s been a monetary incentive to make it stronger and stronger and stronger, so you have to smuggle less of it to the US.
Steve Urquhart:
Yeah. And so now we’re bringing in the other cannabinoids that have really been breeded out, because people wanted to get stoned off, it was off THC. But so from a public health’s perspective, my biased perspective, the risk of cannabis in a good program is very, very low. And so, as you say, there are people who absolutely benefit from it, I would say, absolutely need it. I mean, for example, we are really concerned about the opioid epidemic in this state, well, chronic pain is a real thing, and you need something to help.
Steve Urquhart:
And cannabis, for a lot of people, is that help, and it is so benign compared to opioids, that the risk of this stuff is very low, and the benefit of it for some people is very high. And so, as you say, if part of it is that some people are going to go to paper factory, paper mills, and get the car that they might not really merit, if we’re going to have people using it recreationally, who cares? I mean, seriously, who cares? The risk is so low and the benefit is so high for some people, you need to air on that side of, “Well, let’s make sure we’re doing what we need to do to get it into the hands of people who need it.” Which course largely includes cost. And that’s where the Utah program is not doing a great job. Our costs are still much too high.
Tim Pickett:
From a public health standpoint and cannabis policy, do you feel like the velocity or the speed at which things are changing is increasing? Because it feels like that on my side. Like you said, five years ago, there was this almost universal feeling and thinking that it was terrible and you weren’t going to legalize it at all, you have the compromise and then you have the industry now involved. And is that… I don’t know. How does public health policy deal with this and change with this?
Steve Urquhart:
Yeah. I think that things are moving rapidly. It’s just insane to me that it’s still federally-illegal when a huge majority of the states have de-criminalized. People want to say states have legalized it, well, they really can’t, it’s decriminalized states, that if you use it according to X, Y, Z, then yeah, we won’t consider a crime, but it always is a crime. And so first off, that creates a weird situation for public health. It’s still very difficult to get good data, good science, and public health should all be based on data. And we’re still struggling to experiment with cannabis because it is federally, a schedule one. And you need the research, you need the data to move it off schedule one, we’re just caught in a catch-22 there.
Steve Urquhart:
So public health likes to deal with data, it’s tough to do that with cannabis. So you have to look past that. Maybe you don’t have the best data, what data you have? And how can you work with that? And I think it comes down to what I just said. The risk of this is objectively low. The benefit seems to be quite significant for folks. And so from a public health perspective, what I’m concerned about is, okay, how do we get it to the right people, get the wrong people out of the business, and how do we get it to people in a cost-effective way? And that’s where I would like to see our system improve.
Steve Urquhart:
I don’t care, I really don’t care if it’s ever adult use, or as people say recreational in Utah, because it’s pretty easy to get. I mean, my perspective, thank you, Oregon for just flooding all of the West with black market cannabis.
Tim Pickett:
Yeah. They have an abundance. It is spilling out by the hundreds of pounds.
Steve Urquhart:
So recreationally, anyone really can get it, public health perspective. What are you getting? Do you know what you’re getting? Do what’s really in it? It’s better if it is loosely regulated, if it’s monitored, but Oregon’s-
Tim Pickett:
Well, yeah, because then you could keep it. Wouldn’t you think that better public health policy, in that regard, better regulation, you could keep the wrong people from using it, if we want everybody under 21 not to use it?
Steve Urquhart:
Well, I mean, let’s go back to the opioid crisis. Let’s go back to H, let’s go back to the deadly one, heroin, injection centers, injection sites. God, I’m blanking on the term, but safe consumption sites, I think we properly call them. Not a single person has ever died at a safe consumption site. And heroin is absolutely deadly because there, they’re taking it at a place where the dangers can be mitigated in significant part. So yeah, if we can look at things objectively and deal with them on the basis of data and harm prevention, great things can happen. And cannabis, for the longest time, we weren’t using any harm reduction principles, it was just now, right then.
Steve Urquhart:
And now that that is becoming somewhat looser, by action of the states and largely by destigmatization, we’re having a lot of harm reduction principles come in. And that’s why I’m saying the risk of cannabis, it’s getting lessened by the day. That’s really a good thing. If the feds would come to their senses and move it off schedule one and we could have real science, then, oh my gosh, this could be… It is a miracle to so many people, but broadly to society, if we could loosely regulate, if we could conduct research, if we could bring costs of legal cannabis in line, it’d be great things, it wouldn’t do great things for big pharma. And I’m not really a conspiracy-minded person, but to what degree is that part of the hang-up on the federal level?
Tim Pickett:
Yeah. I think you’ve got to be onto something. It just doesn’t make sense, objectively, that it’s still on the federal, the schedule one list, unless there’s something behind it with a lot of money, I just don’t think.
Steve Urquhart:
Yeah. And-
Tim Pickett:
Doesn’t sense to me any other way.
Steve Urquhart:
Well, I mean our current president, last president, I think combined age is 2000. They come from a different age.
Tim Pickett:
Yeah. Fair.
Steve Urquhart:
So maybe [crosstalk 00:25:21]-
Tim Pickett:
And the Senate does.
Steve Urquhart:
Yeah.
Tim Pickett:
Yeah. The whole Senate does. There’s no way… When the MORE-
Steve Urquhart:
Average age of the Senate I think is 132.
Tim Pickett:
Yeah. It’s probably right up there. And I think the MORE Act, it’ll pass in the House again and again, but there’s no interest in the Senate, and-
Steve Urquhart:
Which is amazing. I mean, which is amazing. A majority of those senators come from states that have decided it’s okay, to some degree.
Tim Pickett:
Yep.
Steve Urquhart:
And it’s just so bizarre that they’re not even in line with their own states on cannabis policy.
Tim Pickett:
Do you feel like psilocybin… Switch gears with me here. Do you feel like psilocybin can leapfrog cannabis?
Steve Urquhart:
It already has. You look at the amount of research going on with psilocybin, it’s night and day. We know so much about psilocybin, just because we are allowing scientists to do their thing. Even though it’s on schedule one, the difference is, you can go out and you can psilocybin to do your studies. And cannabis, up until very recently, you couldn’t. I’m sure you know the name Dr. Sue Sisley. Dr. Sisley has been approved by the FDA forever to study cannabis on veterans with PTSD, but she couldn’t get the cannabis. And that’s changing a little, but you had to get it from the feds, your research cannabis. Well, they’re shit growers, they don’t know how to grow it.
Steve Urquhart:
They don’t really have incentive to grow good stuff. And whereas psilocybin? My gosh, you have universities that are dedicating so many resources to it. And what I say is, if you have a big project, you want to involve academia. Don’t ever leave them in charge, because it’ll never get done, but you want to involve academia because there’s expertise and genius there that you just don’t find in other sectors of society. And so the fact that we can allow these brilliant researchers to dig deep on psilocybin, oh man, the things we’re learning. So the barrier on the Oregon’s drugs, the barricades, was cannabis, that was the devil’s lettuce.
Steve Urquhart:
And it just still carries the stigma to Joe Biden, to Donald Trump, to people who are in charge of things. And psilocybin was overlooked. So yeah, psilocybin is going to come off schedule one before cannabis, MDMA, which known by a lot of people, the club drug Molly. That’s going to come off schedule one before cannabis. So yeah, cannabis research is lagging behind, and if research is lagging behind, then society’s lagged behind on that issue.
Tim Pickett:
Looking back at your arc with The Divine Assembly, it seems like you were ahead of the times-
Steve Urquhart:
Yeah. Maybe, I don’t know.
Tim Pickett:
… with this.
Steve Urquhart:
So yeah, for your listeners, Divine Assembly is a church with mushroom sacrament, magic mushrooms. We have one tenant, which is, you can commune directly with the divine, and that being the one tenant. No one else has to tell you how to live. We don’t need doctrine, we don’t need dogma, we don’t need hierarchy, just commune with the divine, it doesn’t need to be through psilocybin, it can be through yoga, music, meditation. There are various ways to get there. And at the end of the day, for me, it’s really all about community, so I love the community that we are building.
Steve Urquhart:
And the way that started is, I started my psychedelic journey in January, 2017, right after I got out of the legislature, and was just having these incredible healing experiences. And so I figured, “Wow, if there’s anything on earth that I’ve seen, that I’d call religion, it’s this.” And having fought against the LDS Church to better secure LGBTQ rights in Utah, we were fighting against what they called their religious liberties. And so I gained some expertise on the First Amendment, and on the Religious Freedom Restoration Act.
Steve Urquhart:
And figured, “Okay, if that protects other religions, this should protect what I consider to be my religion.” So we formally established… I do believe we were the first formally established, out in the open, public, psilocybin church. Not that I really care one way or the other, but yeah, it shocks me, but first, psilocybin, clearly, we were early on that.
Tim Pickett:
Originally, when you set up the church, of course, you had to make sure that you came out and said, “No, we don’t promote the use, sale, acquisition of a schedule one drug.” What’s that look like now?
Steve Urquhart:
Yeah. Thank you for that question. We’re still learning. We’ve only been around not even two years, and a lot of that through the pandemic. Well, I guess all of it, if we consider we’re still in the pandemic. And our first in-person ceremony was a year ago, and that really scared me. What I want is a safe place for people to experience this. And we usually get people who are older, they live pretty quiet, reserved lives, they’ve read about this or heard about it from kids or grandkids, and they want a safe group to do it with, other people, younger people.
Steve Urquhart:
Well, they have friends and they’ll just go do it in a friend’s basement. And so I’m like, cool, we can do this, a safe environment. And our first ceremony, I didn’t know what I was doing, we didn’t know what we were doing, and so I really backed off. And now we’re to the point, we don’t in… A ceremony that “The Divine Assembly” runs, we don’t ever distribute. We do sound baths, we’ll do Hapé ceremonies, we’ll just get together, kind of a potluck. Because the conclusion that I reached, and those of us who are really involved in it, is people are safer when they’re participating in ceremonies with people who they really know and know well, because that just takes out a lot of the danger factor.
Steve Urquhart:
Let’s talk about sexual predation, start with that. It can largely remove that. Also, if someone has a bad experience, if they are working with a guide, or a shaman, or someone with a lot of training and more of a formal ceremony, there probably will be some immediate integration, but what will the contact be a week later, a month later? And what we’re finding is, if people meet each other, they become friends, they really have an organic relationship, well, if something comes up, they call their buddy, “Hey, I’m having these dreams, or I’m having… What do we do here?”
Steve Urquhart:
And then the guides, the ones I’m thinking of, who are operating on the TDA platform, they know what they know and know what they don’t know. And so they can send out a medical said, “Hey, head of ceremony, someone’s struggling with this. Who can we talk with?” So really becomes… We tried to pattern it after the mycelial network, the growth pattern of the mushroom.
Tim Pickett:
Of the mushroom?
Steve Urquhart:
Yeah. You consider the roots of the flowering mushrooms, the fruiting mushrooms, but really that is the fungus, it’s the mycelium. And that’s how we view The Divine Assembly, where we have a lot of touch points. And so if someone’s struggling then, we’re probably going to know someone who they can talk with and get some help. And we’re really excited about the community aspect of it.
Tim Pickett:
It’s something that I haven’t heard about with cannabis, but man, if you were describing the same situation and you were talking about cannabis, I feel like it would be the same. A lot of young people, they just go into their friend’s basement and do it. But one of the things I think people struggle with, in the destigmatizing cannabis as medicine, probably the same thing with psilocybin to an extent, is this fear of not knowing what it’s going to feel like, and not being around somebody who can help or understand, not knowing that you could get paranoid, and what are you going to do?
Tim Pickett:
Is there a lot of that with psilocybin? As a medical provider, I am fascinated with psilocybin. And I have been secretly quoted as saying things about the psilocybin research, like you say, it’s leapfrogging cannabis, from a research standpoint. I’m fascinated with the idea of the brain and how it resets. Do you feel like spirituality is one of the key ways to… I guess I should ask a different question. What’s the goal of… Is the goal to destigmatize psilocybin and get it more accessible?
Steve Urquhart:
Yes. And I’m going to go back to the question you were about to ask, I think. What is the role of the experience, and I would even say the spiritual experience, in the healing process? Is that what you were-
Tim Pickett:
Yes. Yeah.
Steve Urquhart:
And I talk about that with my students. And remember, every single student in my class is far smarter than I am. I mean, these are brilliant students. And what I say to them, as I say, for the first time in human history, we actually can start to talk about a cure for depression. And the way that works, medically, is psilocybin, it shuts down the default mode network. The default mode network is the part of our brain that, it keeps us alive. I mean, thank God for this default mode network. I mean, we react to danger before we even realize it’s danger. I mean, these are our instincts, and that’s the stuff that keeps us alive. And it filters out, think of Buddy the Elf, when in… Oh my gosh. What’s it called?
Tim Pickett:
The Chris-
Steve Urquhart:
Elf. Yeah.
Tim Pickett:
Yeah, Elf.
Steve Urquhart:
So Buddy the Elf, he goes to New York and he’s just freaked out by all of it, and just amazed by all of it. And that’s a brain where the default mode network, it’s not that formed. Right?
Tim Pickett:
Yeah.
Steve Urquhart:
Buddy the Elf hadn’t seen a lot of trauma, hadn’t seen all this. So he’s just… It’s all new to him. Whereas a typical new Yorker just walks down the street and, man, they don’t notice anything, and the way that works is, our default mode network, it just filters it out. We hear an ambulance, we hear things that normally would freak out a baby or someone who hadn’t seen it, and our brain instantly tells us, “This is not dangerous.” And then other things is like, “This is dangerous.” And so a lot of that is great, and a lot of it is really bad, because it also factors in the messages we got from maybe an abusive father or from times we failed.
Steve Urquhart:
That part of our brain is saying, “Don’t try this. You’re just going to be sad, you’re going to be… You can’t do this.” And so it’s a blessing and a curse. And psilocybin, the way it works medically, is it shuts down that part of the brain, so other parts of our brain can get to know each other, they can develop true neuronal connections like, “Well, hello stranger, I remember you from when I was five years old.” And we really can rewire our brain. And that is an important part of it, but I don’t think that is all of it.
Steve Urquhart:
And this is what I ask my students. I say, where you are now in academia, you’re allergic to conversations about religion and spirituality in the classroom, academia, unless you’re in a theology class, we just don’t discuss it. But what do we do as public health professionals? When we see that it is curative of depression, and a lot of folks, and then 70% of those folks, when we, as researchers, as professionals, talk to them, they want to talk about God, they want to talk about the divine, they want to talk about spirituality. What do we do? And so public health, we’re going to have to entertain God concepts. And to me, that is such a fascinating thing, that God has worked his way back her way. Sorry. That’s how I visualize her. God has worked her way back into academia, through psychedelics, through magic mushrooms.
Tim Pickett:
And potentially to extend that thought, God could work their way back into society.
Steve Urquhart:
Yeah.
Tim Pickett:
Right. In a big way.
Steve Urquhart:
And-
Tim Pickett:
And not just the society that’s already embraced an idea of God from the conservative side, but a way God can enter through the scientific side, through the objective side. This whole swath of the population, that basically discounts religion and discounts God, those are the people that psilocybin can introduce God back to.
Steve Urquhart:
Well, you just described-
Tim Pickett:
Or God, back through.
Steve Urquhart:
You just described The Divine Assembly’s reason for being. I was having these experiences that I think they compare to the religiosity, the wonder of anyone who’s ever walked the earth. But then what I quickly say is, anyone walking the earth can have similar experiences. And the language that we hang around those experiences, it is religious language. And so I was telling my wife, Sarah, “To protect this, to allow other people to experience the divine, I’m going to start a church.” And I’m telling my best friends and universally, they’re like, “No, you’re not. No.” I was-
Tim Pickett:
Yeah. Knowing your background, where you lived, I mean, come on.
Steve Urquhart:
Because I grew up Mormon, and most of them did too, my wife did. And when people leave the Mormon faith, they don’t go to other churches. They largely are like, “I was defrauded, I’m done with God.” And then they take psychedelics, and they’re like, “Oh, maybe I just misunderstood the divine.” So it’s interesting to see people who were just jaded against religion, against God, find this incredible spirituality. It’s an awakening, and it is so much fun to be a part of.
Tim Pickett:
In your experience, is there percentages of people that have good versus bad experiences? Is it a learning process on how to experience these things?
Steve Urquhart:
Yeah. I love your questions. Set and setting, that’s what is always talked about in psychedelia. Set is what do you bring to the experience. What is your situation? What is your state of mind? And then setting is where are you doing it? Who are you doing it with? Is it safe? Is it secure? And I had someone just last week, a couple, they wanted to meet with me, because she had a “bad experience” with mushrooms. And so I’m like, “Well, tell me about that.” And she’s saying, “Well, all the stuff from my childhood came up, I had forgotten, but it came up and it was just horrible.”
Steve Urquhart:
And that’s the way this stuff works, is parts of our brain that don’t know language, they show us images, they show us memories, saying, “Please heal me, deal with this.” And the way I see her situation is, oh my gosh, that shouldn’t have been a bad experience, that could have been a miraculous experience if she had been properly held, if she had been in a setting where people could help her process and deal with that, and she still can. I mean, that’s what I was talking about. I’m like, “Okay, let’s integrate that. Let’s find the right people.” And so I was just having coffee with someone this morning, who they’re getting together tonight, someone who I considered great in a integration.
Steve Urquhart:
I’m like, “Talk through this. What was your mind trying to tell you? What does your mind want to heal? And so most of these… If bad experiences, largely, I mean, you’re in the wrong place, you’re with the wrong people. And if you had been in a different place, with different people, it might have been extraordinary. Am some of my biggest leaps as a human being were with psychedelics, and the stuff that came up was sad, it was horrific. It was my mind saying, “Please deal with this, you’ve been cramming, please deal with this.” But I was in situations where, man, I’m just this gooey puddle on the floor, I’m just sobbing, remembering it, and thinking about it, just feeling so lonely.
Steve Urquhart:
I was just really held well and could come home with, Sarah, my wife, and just talk about it, just continue to integrate and process. And we cram a lot of this stuff down, we try to forget at it when we have the opportunity to see it, and work through it, and learn lessons and improve, and do things differently. So bad experiences, for the most part, are just bad settings.
Tim Pickett:
Do people typically with The Divine Assembly or with psilocybin experiences, are they using low doses, high doses? Is there a protocol, that you’re jumping in with five milligrams, or is it grams, milligrams?
Steve Urquhart:
Yes-
Tim Pickett:
Or do people micro-dose and then do big experiences?
Steve Urquhart:
Yeah. Yes and no to everything you just asked. So Divine Assembly, where we typically end up is, we’re pretty low-dose, we’re a gram or two, maybe three of… Three, you’re starting to get heavy. So micro doses typically are half a gram or less, and then what they call heroic doses. I just call it a full send, that’s five grams. And I’ve done much higher than that. I haven’t recently. For like a year, I haven’t done a big dose, and I think it’s about time. So you can find magic and wonder in all of it. again, part of the reason, again, Divine Assembly, people are looking primarily for a community, they’re looking for a safe, initial journey.
Steve Urquhart:
I don’t feel any need for people that I personally work with, for first timers, I don’t feel a big need to do a full send. It’s just like, let’s dip your toes in the water and get you comfortable with it. And again, this is part of set. If you go in super nervous, then, man, who knows what’s going to end up? But if you figure, “Okay, I have a loose steering wheel here. I know where gas, pedal, and brakes sometimes work.” You’re just going to be more relaxed. And so I think it’s, we’re not in a rush on this. And so I like the idea of people going in with one or two grams, let’s see some pretty lights and some shapes, and maybe some cool things. And then next time, let’s go a little deeper and see how that goes. And so my wife and I, we were full sent. We started on ayahuasca, and-
Tim Pickett:
You went all the way.
Steve Urquhart:
Yeah. We jumped in the deep end, and I’m glad we did. My biggest best experiences were with really heavy doses, and I really went deep, but thank heavens, I was with people who could hold me, because it could have got messy, could have got sloppy were they not there. But like I said, I haven’t taken a huge dose for a long time, because, in part, there’s a laziness, because it’s a lot of work. But also maybe I’m just justifying avoiding the work, but I think a gram, gram-and-a-half, two grams, my brain knows where I want to be now, and it takes me there, and I can do considerable work with a pretty small dose.
Tim Pickett:
It’s literally like we’re talking about cannabis, in a lot of ways.
Steve Urquhart:
It is.
Tim Pickett:
Starting slow and set and setting and the hallucinogenic effects of cannabis, which are definitely different than psychedelic. But-
Steve Urquhart:
I’m going to debate you there.
Tim Pickett:
… you think. Well, see, and I’ve read a little bit, and again, fascinated with this idea of using these substances to assist in experiencing life and the spirituality. How does cannabis fit in then, for you?
Steve Urquhart:
So I talk about this with everyone. I talk about this with a lot of people, cannabis as a hallucinogen, now that I have had a number of psychedelic hallucinogenic experiences. And by that, I mean tons, over a hundred, easily. My mind knows where I want to be, it knows where I encounter the divine. And I call that… I mean, I steal it from Henry James. It’s the mystical state of consciousness, that’s where the divine dwells. Cannabis can fully get me there. And I was not having these experiences with cannabis before I experienced psychedelics. And now, with cannabis, if I’m in the right place with the right people, or by myself, just walking around downtown, I can have a full-on psychedelic experience with cannabis. My brain’s like, “Okay, I know what you’re trying to do. We’ll get you there.”
Tim Pickett:
It’ll take you the rest of the way.
Steve Urquhart:
Yeah. And I think that’s probably a huge part of the reason that I’m not doing big doses of psilocybin, is because cannabis is helping me get there.
Tim Pickett:
Awesome. I’ve experienced some pretty strong spiritual and hallucinogenic experiences with cannabis, and I think people can. Frankly, sometimes people will be in such acute pain that that’s where they need to go. And there’s a lot of metal providers who are a little scared to tell people that’s what you’ve got to do, because you don’t quite know what their set and settings are.
Steve Urquhart:
Right.
Tim Pickett:
And even though it is a community, it’s not a formal community, and there’s still lot of stigma. And I think the more people, maybe this is the case, that the psilocybin community almost has to be a little tighter, and it’s smaller, and it can be. I don’t know if that’s true at all. And the cannabis community is getting so big and dispersed. It’s hard to get people to communicate. But target against myself, most of the people I know, who are elderly, who want to try cannabis, it’s with their sons, daughters, it’s with somebody younger, who’s going to help them with that set and setting piece.
Steve Urquhart:
Yeah. I mean, I think so. I love the term entheogens, and an entheogen is something that brings us closer to God. I mean, maybe the original entheogen was alcohol. We sure know the Greeks used it heavily, and they believed that that was a way to interact with the gods. And cannabis, we see that all over the world. And I think part of it’s, you look at the pathway of those two substances, they did become more recreational. Man, I need a better word. I have no problem with recreational use. Fun is a way to worship, it’s an important way to worship. But I guess you look at all the alcohol ads, you look at the bars, you look at, let’s start there, you just see a lot of unhealthy use of alcohol to where, is it an entheogen?
Steve Urquhart:
Well, I think maybe naturally it is, but it’s abused in a lot of unhealthy ways. Cannabis being forced underground, there’s a lot of that too, but I think they can be very, very powerful entheogens, it’s just, again, set and setting. A lot of people use cannabis because they want to get stoned, they want to drink because they want to get drunk. Whereas yeah, grandma and grandma, when it’s time to use psilocybin, well, they want to heal. And so they approach it with a different set, a different mindset.
Steve Urquhart:
And so they end up having spiritual experiences that I think are fully there, can fully be there with cannabis as an entheogen and alcohol as an entheogen, is just the way we approach… We always do, even if we don’t realize it, we always do have some steering wheel, breaking gas, on these trips. What are we going to do with these entheogens? And with The Divine Assembly, people approach magic mushrooms as a sacrament. This is a way to encounter the divine and to heal in that mystical state of consciousness. So that tends to be the experience they have.
Tim Pickett:
It’s a pretty cool way to think about cannabis in that “medicinally” but in that experiential, that spiritual setting as if it were more like a psilocybin substance. I think people would get a lot more benefit out of it, medicinally, if they were just 10% more mindful.
Steve Urquhart:
Yeah. I mean, let’s go back to what we were talking about earlier. Cannabis can fully get us into that mystical state of consciousness. Okay. I guess, why does it get me there? Because that’s where I want it to get me, and that’s what I want from it. And so our minds are incredibly powerful. And I think these entheogens, we evolved with cannabis. We have the endocannabinoid system, for heavens sake. Our body knows what to do with this substance. And I think cannabis is an incredibly, wonderful, powerful spiritual entheogen, it is something that absolutely can bring us closer to God. And when I’m talking about people healing from depression, with psilocybin, they quickly, 70% of them want to talk about spirituality.
Steve Urquhart:
They want to talk about the divine, because that’s what they’re hoping to find. They’re hoping to find something beyond the mundane. And if cannabis users, like I do now, like many people do, I think if that were the set, they probably would find it. And if they’re properly held, if they’re with people in a place where that is the expected outcome, then I think we would find it more often. So yeah, even, yes, we’ve medicalized cannabis in other places, and heavens, we call it recreational use, let’s call it full-on spiritual use. And I think we’re going to get there as a society. We’re going to rediscover the magic of cannabis, the spirituality of it, see it more as an entheogen, and it’s going to become even more curative than it is now.
Tim Pickett:
I completely agree with you on that one. And I hope we can together make that happen, a little bit at a time. I think that’s a project we can work on together.
Steve Urquhart:
Yeah. I would love to do that. I’ll tell you an interesting thing. Again, let’s go back to, have mushrooms leapfrogged cannabis? Oh a hundred percent. The Divine Assembly, we are fully entitled to all the religious protections of the Baptist Church, of Muslim, of any religion. And I think the courts would see that, like they have with ayahuasca. There’s some very important, strong ayahuasca cases. If someone wanted to start a church with cannabis, that’d be a different issue, because, to the courts, it still is the devil’s lettuce. They don’t see the entheogenic, the God-breeding qualities of it. They think, “Ah, these are just stoners trying to pull something off.”
Tim Pickett:
Yeah.
Steve Urquhart:
And you look at the… Now, I don’t know anything about this church in Oakland. Maybe it’s the shadiest thing ever. I just can’t speak one way or another. Maybe it’s the best thing ever. But in Oakland, where they have decriminalized cannabis or sorry, decriminalized magic mushrooms, a church out there was rated, but it wasn’t really rated for the mushrooms. What I can tell, it was rated because it was giving out cannabis as a sacrament, and they’re saying, “We have a legal program for doing this in California, you’re outside the program.” So even though a mushroom church was rated, my understanding is, it was rated more for the cannabis aspect of it. So-
Tim Pickett:
Wow. That doesn’t surprise me though, because that’s where our society is. I couldn’t imagine a cannabis church, because I would think that, I mean, the neighbors, the cops, everybody’d be up in arms.
Steve Urquhart:
Well, I’ll tell you what would be fun, with Divine Assembly, I tell people, we’re entitled to religious protection, but don’t be stupid about it. This is schedule one substance. Let’s be smart, let’s not flaunt it, let’s make sure we’re not diverting it to kids and to outside of a spiritual setting, let’s be smart. And so how could you do a cannabis church in a smart way? I think it would be great for, in Utah, medical cardholders. So not me, but people who have their medical cards get together and worship with it. And don’t do in a way where you’re just messing around, do it in a way where you’re safe, where you’re sincere, and see what comes out of that. And I bet, absolute magic could come out of that. And the police, they can’t mess with that, if cardholders are getting together and enjoying it together.
Tim Pickett:
Enjoying it together. There’s been just this year here, Steve, a couple of groups to start working on that project together. There’s a yoga group out actually in Central Utah, That’s doing it next week for cannabis Christmas 420.
Steve Urquhart:
Perfect.
Tim Pickett:
Starting that off. And there’s some therapy groups that are thinking of doing it, and I’m involved in one, called an infusion group, that we’re trying to figure out just what you said. How can you create the set and setting? Maybe a therapist, to make sure that people are held as you’re… Very good way to put it.
Steve Urquhart:
Well, how can I help? I mean, get in touch with me. I have some legal skills and a lot of research in this area. I would love to help because, again, personally, I think that cannabis is a very powerful entheogen. I’m using it, illegally. I’m using it as an entheogen, and it shouldn’t be illegal, but it is. That’s just how it is for me right now. I don’t qualify for a card, I’m not going to go lie to get one, if people do whatever, I’m not trying to be judgy, but I don’t want to do that. I’m trying to walk through the front in life these days, and I haven’t always done that. And so I don’t have a card, I’m using cannabis illegally, but for people who can use it legally, to get together and worship with that. And to me, worship means connecting with ourself, others, the universe.
Steve Urquhart:
Oh, and that just makes me excited. I think that there’s so much magic that can be had there. And I want to reclaim religion. I’m sorry. I’m just going to… You got me fired up here, so I’m just going to-
Tim Pickett:
You got-
Steve Urquhart:
I view God as a rat-infested crack house with good bones. I think that people have co-opted the name God, the concept of God, and they’re doing it for control and for base reasons. And I think that some of us can… God is a reclamation product. I think that people create gods, it’s not the other way around, and we can create some very worthy gods and some very worthy religions. We can worship, we can achieve rapture. We can be part of the divine by things that we create by proper set and setting. And I think that that absolutely can happen with cannabis. And I’d be very excited to help friends out with that project.
Tim Pickett:
Yeah. That’s awesome. We’ll definitely reach out to you. Is there a way that people can connect with you in general? Is your Facebook page, The Divine Assembly page, is that a good place to interact or find out more about this and the psilocybin aspect, learn a little bit about it. Do you want to do that?
Steve Urquhart:
Well, I do. I am a flawed human with some mental health issues. And so a lot of social media scares me. Part of my story, I don’t know if you know this. I really fell apart when I was in the Senate. And part of that was, not opening mail for eight months, and I still don’t open mail. I have people help me with that. And so emails, they scare me. And so I really do want to connect, but it becomes difficult to connect with me, even people I really love and want to connect with just part of, Steve, being Steve, as I hide from that. So you can see what we’re doing on The Divine Assembly dot org.
Steve Urquhart:
And if someone emails, The Divine Assembly dot org, people will look at it, and they will respond, and things that I should respond to, they will work with me to help me respond. That’s a roundabout way, but I just don’t want… Talking about holding people, it’s important to me. And if I don’t get back to people, know that it’s just something that I battle. But I do now have people at The Divine Assembly, they will get back, and they will work to get me in touch with them. That’s a shitty answer, but that’s-
Tim Pickett:
You know what, that’s okay. And for people at the Utah in the Weeds Podcast, if you watch us on Discover Marijuana on YouTube, or you listen to this podcast, that channel on YouTube, Discover Marijuana, all the podcast episodes are there. And you could go there and make a comment on the video, and my team would help find that too. So The Divine Assembly dot org, Utah Marijuana dot org, or Discover Marijuana on YouTube, comment on a video, and we’ll help as well.
Steve Urquhart:
Yeah. That would be great. I struggle to give my church, my people, the attention that they really deserve as wonderful human beings. And so, if I’m now flooded with a bunch of cannabis-
Tim Pickett:
Sure.
Steve Urquhart:
… concerns, then oh, wow, this is even more out of control. And so yeah, if they want to go through you, your podcast, the magic you’re making, and then we interface, that would be wonderful.
Tim Pickett:
Yeah. That would be great. Well, Steve, is there anything that we’ve missed?
Steve Urquhart:
How many universes have we missed? But we have covered some good things.
Tim Pickett:
Yes, we have. Well, thanks for coming on. I really appreciate this discussion. I think that it’s just so important for people and me to listen, learn a little more.
Steve Urquhart:
Well, what a great discussion. Thank you. And thank you for the work you’re doing, and let’s make some magic together.
Tim Pickett:
Absolutely. For those of you who aren’t subscribed to the podcast, this has been a great discussion with Steve Urquhart, and Utah in the Weeds, you can subscribe on any podcast player, you can also listen to all of our episodes on Discover Marijuana on YouTube. Stay safe out there.
Everybody likes to save money, right? Given the current state of the economy, every dollar saved is valuable. We get it. We also know that Medical Marijuana is not cheap. We want to help in whatever way we can, so we have come up with a coupon code program to help you save at the pharmacy. One of the best ways to save money at Utah’s cannabis pharmacies is to take advantage of any coupon codes that might be available.
Here are a few ways to save money on Medical Cannabis:
The first step toward utilizing cannabis as a medicine is obtaining a state Medical Cannabis Card. To do that, patients are required to visit with a Qualified Medical Provider whose job is to verify the existence of a qualifying condition and recommend Medical Marijuana as an appropriate treatment. With a QMP’s recommendation, the patient submits an application and pays a small registration fee. The state then approves the application and issues the card electronically.
The relationship between QMP and patient is an important link in the chain. Patients need to be able to visit with QMPs they can trust. The QMPs at Utah Therapeutic Health Center work hard to earn the trust of each and every patient we see. We give patients access to QMPs at clinics located around the state.
When you visit one of our clinics, we want you to feel right at home. We strive to maintain an open and transparent environment where you can receive sound advice and assistance navigating the Medical Marijuana Card program without feeling like you are being judged.
We are also here to answer your questions, so don’t be afraid to ask. We know a lot about the effectiveness of marijuana as a medicine, but there is still plenty we do not know. All of us are learning together – medical science, medical providers, and patients.
Your relationship with us does not have to end after your Medical Cannabis evaluation. In fact, we don’t want it to end. We want you to stay informed of all things related to Medical Cannabis so that you can make sound decisions about your health. You can do that by signing up for our newsletter in the section below.
Our newsletter is packed with useful information to expand your knowledge and answer your questions about Medical Cannabis.
One way or the other, we are confident that our newsletter will help you better understand the entire Medical Marijuana concept.
Remember, ways to save money at Utah’s cannabis pharmacies are not always easy to find. And with prices as high as they are, a little financial help can go a long way.
Episode 94 of Utah in the Weeds features Michelle Spear, Tim’s youngest sister. Michelle suffers from colon cancer and is new to using Medical Cannabis. In this episode, Tim teaches Michelle to use Medical Cannabis to relieve the side effects of chemotherapy.
We began the episode with an overview of Michelle’s battle with cancer, which began in 2016, when she was 32. [03:33]
Next, they talked about cannabis tinctures, which are liquids containing concentrated cannabis extracts. [11:43]
Then, Tim taught Michelle about cannabis gummies. [18:12]
Cannabis vape cartridges are useful for fast-acting relief, and there are some that contain no THC. [26:58]
Tim Pickett:
Welcome everybody out to Utah in the Weeds. This is Tim pickett, and this is episode 94. 94 with my youngest sister Michelle. So, Michelle is 38 years old. She is going through chemotherapy for the third time for colon cancer. She has colon cancer that came back not once but twice. And she’s got four children. She is a spitfire. Okay? And I don’t get the chance to see her very often.
Tim Pickett:
And with her chemotherapy being very … Causing a lot of nausea and her pain getting a little worse, I was able to go up to see her and visit her. And we recorded the interview, and just me teaching her how to use cannabis. Because I thought that would be interesting for people, if you’re interested in that. And give me a chance to interview my sister without causing a lot of emotional stress on both of us. Frankly, I’m a crybaby.
Tim Pickett:
So, I didn’t think interviewing my sister was going to work out really well for me. And my sister also is a go-getter. She does not like to slow down. When we were there, for example, she picked me up from the airport. We went to Costco, bought a bunch of strawberries and candy. Yes, she loves candy. And went to lunch, went home, unloaded everything. She started making strawberry jam, because she was out, needed to make some.
Tim Pickett:
Proceeded to make 15 bottles of strawberry jam, do this interview, and learn about cannabis. Then we were going to dinner. It’s just busy, busy, busy. She nonstop taking care of her kids, building Nerf gun battle setups in the backyard, traveling with her husband. That interview I’d like to do it, but it would be very difficult for this situation I think. So, here is an interview with my sister, Michelle. A little housekeeping before we get into that interview.
Tim Pickett:
If you’re not subscribed, subscribe Utah in the Weeds. We appreciate the subscriptions and the downloads and it makes a difference. We have a subsidy program, utahmarijuana.org/uplift. You can donate money, we match it. We have it matched now eight times. And that gets people through the process of getting cards, and getting education, and getting discounts on products in Utah. So, utahmarijuana.org/uplift.
Tim Pickett:
And without further delay, here’s me teaching my sister Michelle, how to use cannabis for nausea and pain. So, I’m up here, little insight into what we’re doing today, one day maybe we’ll post this for the Utah in the Weeds podcast, maybe not. Depends, but I’ve come up here to my sister Michelle’s house. A little insight into the why you get into cannabis medicine. My sister, Missy. Okay. So, here we have … So, you’re doing chemo. Right?
Michelle Spear:
Yes.
Tim Pickett:
For the third time [crosstalk 00:04:09].
Michelle Spear:
Second time.
Tim Pickett:
I mean, it’s really the third time. Right? Because you had the HIPEC.
Michelle Spear:
That’s true. That was internal chemo. So yes, this is the third time. About fourth time I’ve had cancer, because radiation-
Tim Pickett:
What was the first time?
Michelle Spear:
First time was my colon.
Tim Pickett:
Well, that was when you were 32?
Michelle Spear:
Yep.
Tim Pickett:
Right? Six years ago.
Michelle Spear:
Yep. And then-
Tim Pickett:
About right now, right? Six years ago you got diagnosed in December?
Michelle Spear:
Nope. After I had Scarlet in March.
Tim Pickett:
So six years ago, right now?
Michelle Spear:
Yep. Six years ago right now I got diagnosed and had chemotherapy for six months, and then 18 months later it came back on my ovaries and my uterus. So, I had that removed, but it erupted so that’s when I did the HIPEC.
Tim Pickett:
That’s when I was working in surgery with Akin.
Michelle Spear:
Yep.
Tim Pickett:
And I remember thinking, “Oh my God, the HIPEC. That’s a major deal.”
Michelle Spear:
Yeah.
Tim Pickett:
So, everybody was researching it. That’s a big surgery where they open you up all the way, top to bottom. They fill you with chemotherapy fluid and try to kill it all.
Michelle Spear:
Yep. It’s heated chemo.
Tim Pickett:
What do you think about that now? Do you think that was a good thing?
Michelle Spear:
I think that saved a lot of my life. Yeah.
Tim Pickett:
Yeah. I mean, I think so too. This time though, you had a bowel obstruct last what, October?
Michelle Spear:
October.
Tim Pickett:
No, it was before that-
Michelle Spear:
But before that I did radiation.
Tim Pickett:
Because November we went to Disneyland. So, it was like August.
Michelle Spear:
That’s true. I did have it bowel obstruction, and I went into the hospital twice in one month. They just did IV fluid and did bowel rest because they didn’t want to open me up. But then the third time I went into the emergency room, they were like, “Well, this obviously isn’t healing itself.”
Michelle Spear:
My doctor that actually did the HIPEC also, he was like, “We got to open you up and see what’s going on.” And so he opened me up and took out two, four inches of my colon or not my colon. I don’t have colon.
Tim Pickett:
No. And how do you figure out … What do they call it now? They can’t call it colon cancer, you don’t have a colon.
Michelle Spear:
It’s true. But they still do. Yes.
Tim Pickett:
Because that’s where it originated.
Michelle Spear:
That is where it originated. So then they did-
Tim Pickett:
So, then he took that piece out, which was obstructed.
Michelle Spear:
Yeah.
Tim Pickett:
And that was like a ball of scar tissue?
Michelle Spear:
Yep. Two balls of scar tissue they took out, and then they put my … The rest of my intestines in a hammock.
Tim Pickett:
So, now you have a-
Michelle Spear:
Now there’s-
Tim Pickett:
Intestine hammock
Michelle Spear:
I have an intestine hammock.
Tim Pickett:
Does that feel different? Did it feel different at the beginning?
Michelle Spear:
No. I never-
Tim Pickett:
For those of you who are listening, our mom is in the kitchen over here on the other side doing the dishes. Don’t be sorry. It’s fine. But that’s the water you hear. We’re in the kitchen in Spokane and we just got back.
Tim Pickett:
So, I came up here to see you really, but also I’m using cannabis as an excuse to come up here and see you. To give you a little bit of a lesson on some tools in cannabis stuff. Because this time the chemo seems like it’s been worse.
Michelle Spear:
Yes. Which they say after your body has already experienced it, it just reacts more potently, I guess. Because your body’s like, “Oh, I remember this.”
Tim Pickett:
And then, “Oh, I remember that this is like poison.”
Michelle Spear:
Yeah.
Tim Pickett:
So, when we talked last week, you were not feeling very good?
Michelle Spear:
No, I have a lot of nausea and pretty much I sleep a lot during the chemo. Because I’m on for three days, well for 48 hours. I take home chemo, and that is when I’m the most sick.
Tim Pickett:
So, you don’t have to go to an infusion center, they just bring it to you?
Michelle Spear:
No I do. I go in and I’m there for about four hours and I do two kinds of chemo there.
Tim Pickett:
Do you remember the names?
Michelle Spear:
One of them is 5FU and FOLFOX.
Tim Pickett:
FOLFOX. Yep. The 5FU and the FOLFOX, that’s the chemo that has been in around for really a generation, I think. Maybe probably more. I worked in GI surgery and we didn’t do the orders for the chemo, but we were very … We had a lot of people with colon cancer that would do that. And then you have a different one that you do also.
Michelle Spear:
You take home. Yep. After the four hours, they give you a chemo that you just … It’s a fanny pack and it slowly puts 0.1 milligrams into your body every minute.
Tim Pickett:
Through your pick? Not your pick, but your port, which you’ve kept all six years.
Michelle Spear:
Yep. Actually this is my second port.
Tim Pickett:
Really?
Michelle Spear:
I got my first port taken out.
Tim Pickett:
Because you were cured.
Michelle Spear:
Because I was cured. And then when I went into the HIPEC, they were like, “Well, since you’re already under, we’re going to put in another port.” And it never got used until now. So, I’m just washing it for the four years.
Tim Pickett:
For the past four years.
Michelle Spear:
Yeah.
Tim Pickett:
Okay. So six years ago you got diagnosed with colon cancer, you had the entire colon removed after having your baby. I mean, that was really a mess. Right?
Michelle Spear:
Yes.
Tim Pickett:
You were on TPN for nutrition because you needed to continue the pregnancy for another couple of months. Then you had the baby. You’re already obstructed with cancer. Then you heal from the baby. Then you have your colon removed completely. And by the way, for people who … So, you have a ileostomy bag. Right?
Michelle Spear:
Yes.
Tim Pickett:
Because you had a total colectomy with a proctectomy, so you have an ileostomy bag. For those of you who’re out there who think that living with a bag is death, I mean, you are really listening to a person who swims with her kids, goes water skiing.
Michelle Spear:
Skis. I would recommend it actually to people that are-
Tim Pickett:
Well, it’s not like-
Michelle Spear:
It changes your life. Because then all of a sudden you’re not a target going, “Oh, I know where the bathroom is.” Every place you go when you have Crohn’s disease, you know exactly where every bathroom is. I mean, if you’ve ever pooped on the side of the road, I have. But now with the bag you can just…
Tim Pickett:
So it’s not the end of the world, right?
Michelle Spear:
No, it is not the end of the world.
Tim Pickett:
It’s interesting. Your perspective on things has always been pretty interesting, and you’ve always been extremely active. I mean, literally you have a bowel obstruction, you have part of your colon taken outlast fall even. You barely let yourself recover before you went to California.
Michelle Spear:
Yes.
Tim Pickett:
Hiked up and down all those stairs. I remember your husband John, he’s worried because we had all these stairs going down to the beach.
Michelle Spear:
Yes. And he was like, “You better be careful, hold onto the side.” And I’m like, “I’m fine. Whatever.” Yeah. Well and after the HIPEC-
Tim Pickett:
Having Nerf gun parties in the backyard.
Michelle Spear:
After the HIPEC, I went to Hawaii with my kids a month and a half later. I told him, I said, “I got to get out of the hospital because I have Hawaii tickets.”
Tim Pickett:
Wow.
Michelle Spear:
And he’s like, “Oh well, okay.” And he let me swim and…
Tim Pickett:
Interesting.
Michelle Spear:
I don’t let it slow me down.
Tim Pickett:
Well, that’s for damn sure. Okay. So, we’re going to talk about … And this is going to be a lot of stuff that people can’t see. But in front of me laid out, we have just been to the dispensary in Spokane, we’ve been to Cinder. Great people there, different products than in Utah.
Tim Pickett:
Some products that I’ve tried before that I really, really like, and I wish were in Utah. And some products that … Most products that are definitely not in Utah. So, you’ve been using some little mints.
Michelle Spear:
Moxey mints.
Tim Pickett:
Moxey mints, which are one milligram of THC and a little bit of CBD. But you were saying they’re not strong enough. But then when you take too much, you’re-
Michelle Spear:
I feel like I’m on a rollercoaster and I’m like, “I can’t close my eyes. I’m going to go down the hill and it’s going to make me dizzy.”
Tim Pickett:
Really? So when you stand up, is that a problem?
Michelle Spear:
No, it’s more when I close my eyes actually.
Tim Pickett:
When you close your eyes you feel like you’re on a roller coaster?
Michelle Spear:
Yes.
Tim Pickett:
But you’ve never smoked weed ever. I mean, I’ve known you my whole life, I know you never smoked weed.
Michelle Spear:
No, I watered it when you guys were kids.
Tim Pickett:
That was not mine that was Katie’s. That was Katie’s on the porch or on the deck.
Michelle Spear:
[inaudible 00:12:56].
Tim Pickett:
You were little though. I mean, we’re talking … Katie was in high school. Right?
Michelle Spear:
Yeah.
Tim Pickett:
So you were in junior high. You’re six years younger than me.
Michelle Spear:
Yep.
Tim Pickett:
I’m 43, you’re 38.
Michelle Spear:
Yep.
Tim Pickett:
Well, I mean five and a half. You’re exactly five and a half years younger than me. Okay. So, here we have a tincture. Okay? So the first thing we talk about is, with this type of stuff, is you’ve got to build up some tolerance. Okay? You can barely take five milligrams of THC, and you got to build up some tolerance.
Michelle Spear:
Yeah.
Tim Pickett:
Okay.
Michelle Spear:
Probably, yes.
Tim Pickett:
Because then you can take two and a half milligrams as a micro dose most of the day, and not feel like you’re in a roller coaster when you close your eyes. So we’re not going to try to … For those of you at home, we’re not trying to cure cancer with this cannabis, we’re just trying to feel better.
Tim Pickett:
But it’s relatively safe, so we might as well … I mean, if you can get a lot of cannabinoids in your body and it slows the tumor growth, then why the heck not? So there are cannabinoids we want to think about, CBD. We want to get a bunch of CBD in your system. Okay? CBG, we want to get a bunch of CBG in your system. Then THC, we want to work up to where you can tolerate 10, 15 milligrams of THC per dose. Okay?
Tim Pickett:
So that’s a whole gummy. So we have a tincture here, it’s made by green revolution. It’s a water base tincture, which is cool because that means it’s emulsified in water so it will absorb fast. For one dropper full, it’s going to have 12 and a half milligrams of CBD, and 2.5 milligrams of THC. This is actually going to be pretty dang good for … And it has a teeny bit of CBG.
Tim Pickett:
So this is good for all the time. Half a dropper full at a time, is the same as your Moxey Mint. Okay? Half a dropper full … That’s not true. One dropper full is the same as your Moxey Mint.
Michelle Spear:
The red ones?
Tim Pickett:
Yep. One dropper full. I don’t know what flavor or what … Let’s taste it.
Michelle Spear:
Does it taste like dirt?
Tim Pickett:
It probably tastes like skunks and dirt. Take just a drop. we’re not going to get high, just to taste it. Just a drop.
Michelle Spear:
Under my tongue or on top?
Tim Pickett:
It doesn’t matter because we’re just tasting it. That’s one drop, thank you. Put the lid back on.
Michelle Spear:
That’s not too bad. It’s lemony.
Tim Pickett:
Yeah, it feels lemony. Now a full dropper you’re going to, “That’s in the back of my throat, it’s like oh.”
Michelle Spear:
Yeah. I can tell.
Tim Pickett:
It’s a little planty. You can mix this with stuff.
Michelle Spear:
With a big Mac?
Tim Pickett:
You can mix this with a big Mac. I know you love big Macs.
Michelle Spear:
Wait, no my peanut butter.
Tim Pickett:
Peanut butter and jelly. Nana over there, so for those of you who are now listening, if you want a Christmas card with a cannabis flower on it or marijuana norm that’s Nana, sock monkey, everything. She’s making strawberry jam over here.
Michelle Spear:
We are not going to put any cannabis.
Tim Pickett:
No cannabis, because the kids are coming home. So the marijuana norms and the cards are pretty popular. So not runny jam, just regular good strawberry jam. Because at Michelle’s house, they go through a bottle of jam, how often?
Michelle Spear:
Every two weeks.
Tim Pickett:
A bottle of strawberry jam every two weeks. And we just got home from Costco where you literally bought six bags of those ding, what are they?
Michelle Spear:
The Reese’s chocolate eggs.
Tim Pickett:
Because why?
Michelle Spear:
The eggs are fresh? The peanut butter is fresh. You know when you go and get a Reese’s bar and you’re like, “Oh this is pretty still, it’s been here for six months.” But those ones are the hearts at Valentine’s, and the Easter ones are fresh and they’re yummy. And I eat them.
Tim Pickett:
Place we went when I show up in the … On the airplane, we go from the important to Costco. She goes in there, she shows her ID card. The eggs are at the front. She just starts loading the bags into the cart.
Michelle Spear:
I think I got six or seven support.
Tim Pickett:
Okay. Tincture is a five to one. You can take one dropper full at a time and not get roller coaster. Okay?
Michelle Spear:
Okay. That wasn’t too bad. I haven’t tasted any [crosstalk 00:17:42].
Tim Pickett:
It’s not terrible. Okay. That’s going to last you six hours. Okay? So you can do that three, four times a day, that’s fine. But you need to do something like that every single day to build up some tolerance. Okay?
Michelle Spear:
Okay.
Tim Pickett:
Like a half a dropper in the morning, every single morning only to build up tolerance, and to get some CBD in your system. Because the CBD will help overall. Okay? Now, we’re going to move on to this Wyld some gummies. In Utah these are called [inaudible 00:18:15].
Tim Pickett:
So Wyld, W-Y-L-D this is one of my favorite brands. They’re totally natural. They’re peach, this one’s a peach gummy. Why are they in a bag? This is dumb. Hey, do you have any-?
Michelle Spear:
It has a zipper?
Tim Pickett:
So child-proof ziploc bags, you push your … You put your hands and then you twist it. When you open a gummy or a flower package-
Michelle Spear:
Or a Moxey Mint even they do natural.
Tim Pickett:
They have these little childproof bags, and you can’t open the bag just by pulling the bag open. You have to push your fingers on the opposite sides of the zip lock, and then you twist it.
Michelle Spear:
You’re snapping your fingers.
Tim Pickett:
Like you’re snapping your fingers, and it will slide the Ziploc open and it will open your bag.
Michelle Spear:
I cut mine sometimes too.
Tim Pickett:
Everybody cuts them open. So inside here, all of these are individually wrapped. What a waste of plastic. They are two to one CBD to THC, but these are 10 milligrams per gummy. That is the same as-
Michelle Spear:
Full dropper.
Tim Pickett:
Four droppers full. Four droppers full is the same as this. So now we’re cutting these into quarters. Right? Now, this will last you eight hours. This will last you eight hours. And it takes a little longer to take effect. So you want to plan ahead.
Tim Pickett:
So cut these into quarters, and you take one of these, is the same as a Moxey Mint. But they taste better and they have two times the CBD again, because CBD is the sandpaper to THC. It’s smooth is out the rough edges. Okay? These are going to be super good. And I already-
Michelle Spear:
I’m getting a marker.
Tim Pickett:
Yeah. Can you write all this stuff down?
Michelle Spear:
Yeah. Maybe just-
Tim Pickett:
So you can make a list.
Michelle Spear:
Because I can’t remember my own name sometimes.
Suzi St. Jeor:
[inaudible 00:20:30].
Tim Pickett:
Tincture is going to act in … I would say this one where it’s water-based, is probably going to act within 20 … It’s going to start acting within 20 to 45 minutes. Where a gummy would take 45 minutes to an hour and a half to take full effect for most people. Some people with a gummy it’ll take two plus hours.
Tim Pickett:
But the Tinctures, the water-based Tinctures tend to work a little faster. Oil-based Tinctures tend to work a little slower. So the Tinctures again, half a dropper, three times a day, totally fine. One drop is 2.5 milligrams THC and-
Michelle Spear:
So it build up that one?
Tim Pickett:
So build up. That’s the one that you are using to build up the tolerance. Then you have the peach gummy, which is pretty similar, but you only want to take a quarter of the gummy at a time.
Michelle Spear:
And it lasts eight hours?
Tim Pickett:
It’ll last eight hours. And it takes a long time to take effect. I’m going to put the gummies inside the medicine bag. Okay? I’ve got a medicine bag here. It’s a skunk pilot bag, it has a little lock, little luggage lock, kids don’t get in. It keeps all the medicine away from the kids. Do you want these in the cute box?
Michelle Spear:
No, it doesn’t matter.
Tim Pickett:
Or do you just want them here?
Michelle Spear:
Yeah, just in there. Right now I keep them with my dog treats.
Tim Pickett:
Yes.
Michelle Spear:
Because I’m hoping my kids don’t eat dog treats. [crosstalk 00:21:54].
Tim Pickett:
As a side note, if you want to protect your children from the gummies, just keep them with the dog treats.
Michelle Spear:
Exactly. That’s what I do.
Tim Pickett:
Okay.
Suzi St. Jeor:
[inaudible 00:22:07].
Tim Pickett:
Right? Well I guess, unless you want to give the gummies to the dogs. Okay. Second one is the Wyld pair. This is cool. This one I really like, it’s got CBG and THC. Okay? So one to one. So this is going to be different. This will feel different.
Tim Pickett:
People call this a bubble bath for your brain. With the CBG same thing, you’re going to cut this in quarters. You’re going to cut this in quarters. And I think you’re going to like these a lot for the daytime.
Michelle Spear:
And do they last eight hours?
Tim Pickett:
Yes. I would consider this one to be my pain gummy.
Michelle Spear:
Okay.
Tim Pickett:
My pain gummy during the day.
Suzi St. Jeor:
Your what?
Tim Pickett:
The pain. Because CBG tends to be a little bit better for pain. Right?
Michelle Spear:
You’re trying to get rid of my oxycodone?
Tim Pickett:
Yeah. I mean, you don’t have a colon so you … So poop moves through faster.
Michelle Spear:
Yes.
Tim Pickett:
So the oxycodone does have a benefit, because it slows you down.
Michelle Spear:
Yeah.
Tim Pickett:
And we’re not really worried about you getting addicted at this point. Right? But you don’t take that very often.
Michelle Spear:
No, I only … I don’t.
Tim Pickett:
Because your right hip, your left knee … And what else was it?
Michelle Spear:
My back.
Tim Pickett:
Your back hurts. Is that new starting chemo?
Michelle Spear:
Yeah. My hip has always hurt. I think we dance. But it’s weird because it’s not my knee that I tore my meniscus on, it’s my other knee.
Tim Pickett:
What about your back?
Michelle Spear:
I think my back is because I sleep with my dogs.
Tim Pickett:
And then you just don’t sleep very well, your dogs are all over the place?
Michelle Spear:
Yes. Always sleep on my back or my face.
Tim Pickett:
Okay. So green is the CBG. That’s the pain, we do that one for pain. Right?
Michelle Spear:
Yes.
Tim Pickett:
The peach one is a balance. Okay? That’s good. This is fun, this is like Christmas. Okay. Now, we’re going to move on. We’re going to add this CBD Tincture. Okay? CBD Tincture. This is the one I brought from home. It’s a Zion medicinal CBD Tincture. This one is a little bit pepperminty from the taste, and it’s an oil based Tincture.
Tim Pickett:
And this one has, let me see, for a full … A full dropper full is going to be 30 milligram CBD. You really need to take one of these at least one full dropper a day. This will not get you high at all. Okay? So I’m going to put a whole milliliter in the dropper full, put it in my mouth and then it is … I don’t I just eat it.
Suzi St. Jeor:
You say that [inaudible 00:25:13].
Tim Pickett:
Yeah, the under your tongue will absorb a little bit better, but honestly I don’t get too crazy about that. I’m much more practical, I feel like that’s … I don’t know.
Michelle Spear:
My zone friend that’s what … They’re always like, “Underneath.” I’m like, “Yeah, I’m just sticking it on my tongue.”
Tim Pickett:
Just chew it. It absorbs pretty quick.
Michelle Spear:
Well, on the roof of your mouth too. So I just stick it to my roof.
Tim Pickett:
Instead of up your nose, you put the cocaine under your tongue. Yeah. Well, okay. Thanks. Thank you. I never really tried it, so I don’t know. Most people haven’t tried that out, but yes, it will absorb faster.
Tim Pickett:
So try that. I feel like that’s like a Starburst, it’s oily. I mean, take a half a dropper, I promise it’s not going to get you high.
Michelle Spear:
Yeah. It’s like oil.
Tim Pickett:
Yeah, it’s MCT oil it’s … Which is a coconut oil thing. So see how it coach your mouth a little bit?
Michelle Spear:
No, it’d be good for my mouth sores. You never know.
Tim Pickett:
So you want to build up to where you’re taking a dropper in the morning and a dropper in the afternoon. Doesn’t have to be full, it just has to be … I tell patients, “Just take a slug of it in the morning and a slug of it in the afternoon.” We’re building up cannabinoids in the system. Okay? We’re building up cannabinoids in the system. No high. Okay? Could help your pain long term.
Tim Pickett:
It’s a little bit anti-inflammatory, it could help your … I mean, it can help your anxiety, reduce the use of a lorazepam if you took that. Okay. Now, we’re getting into the real deal and I know this is out of the wheelhouse for you, but I brought up vape pen. Okay? A vape pen, I brought some flower too. We’ll talk about that in a minute. So this is called a battery.
Tim Pickett:
This is a Yocan pro battery, and this is what you put the vaporizers in. Now, I brought up two clean leaf vape carts. These little cartridges will not get you high. Okay? They won’t get you high, but they’re pretty strong. Okay. Have you ever tried one of these mom?
Suzi St. Jeor:
Well, I vape.
Tim Pickett:
Yeah. But this is CBD only. So this one is called Balance. Okay? You have one that’s called Balance and one that’s called Uplift.
Michelle Spear:
What I would say is, why would I?
Tim Pickett:
Why would I use a non … A cartridge that would not get me high? Well, I’ll tell you why.
Michelle Spear:
Okay.
Tim Pickett:
If you have a super low tolerance to THC, or you’re trying to get off of a medication and you’re just trying to chill out, or you get way too high from the gummy. And you’re like, “Oh my God, I’m I like … I think I need to go to the ER, I’m pretty anxious about this.”
Tim Pickett:
Then you take a nice inhalation off of this vape pen and it just will … Smooths out the rough edges of what’s going on. Okay? You’re fighting with everybody, go in the garage and you take a little head off those things. And you’re like, “Oh, I’m not high. I just feel a little bit better.” What are you doing?
Suzi St. Jeor:
What’s that called?
Tim Pickett:
This one’s Balance. So I sell these in the clinic.
Suzi St. Jeor:
Okay.
Tim Pickett:
Because Kyle Eggbert is the guy who makes these and he’s just … He’s a good guy. He knows what he is doing. He makes strong vape carts like this, they’re non THC. This one has CBN, CBG, CB … It’s like CBDV.
Michelle Spear:
Yeah.
Suzi St. Jeor:
So what is the-
Tim Pickett:
CBD, CBG, CBC, CBN, CBDV and THCV, this is all good … These are all the best cannabinoid.
Suzi St. Jeor:
I have a vape pen, but what’s [crosstalk 00:29:17]?
Tim Pickett:
This one is a little bigger and the battery will last a little longer. So I use this one because it’s foolproof.
Suzi St. Jeor:
It’s cute.
Tim Pickett:
It’s simple, it’s gold, it’s … Is that mov? What do you call it?
Suzi St. Jeor:
Yeah. Natural rose gold.
Tim Pickett:
Rose gold. At the bottom of the vape cart there’s a … What’s called a five 10 thread. See that little thing? I think your neuropathic fingers can put this on there. Did you lose the ability to knit?
Michelle Spear:
You know what, actually, I can knit, but holding my hands closed for too long hurts. So I actually don’t knit anymore.
Tim Pickett:
Can you feel the ends of your fingers?
Michelle Spear:
Yeah. If they get too cold or too hot, they hurt like pain.
Tim Pickett:
Your feet too?
Michelle Spear:
Yes. My feet are more sensitive than my hands.
Tim Pickett:
When did that happen?
Michelle Spear:
After the first round of chemo I did, the Oxaliplatin and they … That gives you neuropathy.
Tim Pickett:
Forever?
Michelle Spear:
Forever. It got better after six months, but it … I don’t like to get pedicures because I don’t like people to touch my feet because it … You can feel them touching your feet, but it’s a weird sensation.
Tim Pickett:
Is it like pins and needles?
Michelle Spear:
Sometimes yeah. I always have to wear shoes.
Tim Pickett:
Even in your house?
Michelle Spear:
Even in my house.
Tim Pickett:
Just because of the-
Michelle Spear:
The feeling of it being-
Tim Pickett:
Is there like a burning?
Michelle Spear:
Yeah.
Tim Pickett:
Mostly a burning?
Michelle Spear:
Mm-hmm (affirmative).
Tim Pickett:
And that’s the hands too?
Michelle Spear:
My hands aren’t as bad, but I have to be careful because I can touch hot things and not know that I’m touching hot things.
Tim Pickett:
And then you get burned?
Michelle Spear:
Yes.
Suzi St. Jeor:
One time she stuck something in her leg and did not know it was bleeding.
Michelle Spear:
Yeah. I did stuck a X-acto knife in my leg one time and I was like, “Oh dang.”
Tim Pickett:
Wow. Okay.
Michelle Spear:
And then it was bleeding at a baseball game and they’re like-
Tim Pickett:
Hey Michelle.
Michelle Spear:
“Michelle you’re bleeding.” And it was bleeding into my shoe.
Tim Pickett:
Wow. Okay. Well-
Michelle Spear:
Good thing I had a first aid kid in my car.
Tim Pickett:
This has been sitting for a little while. So you see how it’s crystallized, so we may have to use a blow dryer or something warm to … Go ahead. Yes, you’re raising your hand.
Suzi St. Jeor:
I know it won’t work for you, but put it in your bra-
Tim Pickett:
It will not work for me.
Suzi St. Jeor:
I put my [inaudible 00:31:49] if there was sticky.
Tim Pickett:
Yeah. So the crystallization just is something that sometimes happens. And so you can heat it up and you can reactivate the oil in there. So you turn the five, 10 thread onto there and then you just drop it in like that. And then it just magnetizes to the bottom. You can turn that if you want to lock it in, and then literally you just push this button and it’s on and you let go and it’s off.
Tim Pickett:
But five clicks turns it on, and five clicks turns it off. Okay? Five clicks turns it on, five clicks turns it off. I never turn it off. So I never really have to worry about this, because it just shuts off on its own. And the battery will last three weeks.
Tim Pickett:
And then you see the number on the screen there, it’s 2.7, it will go up. So the higher the number, the harsher the inhalation. So you want it at about 3.0 is my low. Okay? And then you push the button.
Suzi St. Jeor:
Hey, do you have to hold it a long time?
Tim Pickett:
No. Total myth. There is so much surface area in your lungs, you do not need to hold your breath. You just-
Suzi St. Jeor:
Even the THC?
Tim Pickett:
Yeah, you do not do that. Okay. So all you’re going to do is-
Suzi St. Jeor:
My whole [inaudible 00:33:24].
Tim Pickett:
You’re just going to push this button, you’re going to … I don’t know who’s calling you, but I’m sure it’s not important. Maybe it is important. Okay. You’re welcome to try this.
Tim Pickett:
This is not the one that gets you high, so you don’t need to worry about that. Yeah, that’s the CBD oil. It’s good. Well, yeah, it looks the same than [crosstalk 00:33:49].
Michelle Spear:
Okay, one more time. You hold the button down.
Tim Pickett:
Yep. You hold the button down and it’s activated-
Suzi St. Jeor:
And just suck it in.
Tim Pickett:
And then you just … Not big, just [crosstalk 00:33:58].
Michelle Spear:
No [crosstalk 00:33:58].
Tim Pickett:
So you sip.
Michelle Spear:
But you don’t swallow?
Tim Pickett:
That’s right. But you’re but you’re thinking about it like sipping it. You’re not going to suck it in. Okay? Just a little bit.
Michelle Spear:
I’m so going to cough.
Tim Pickett:
It’s just a little. Okay just push the button just a little. I know, it’s weird. Yep. Now it’s on, now you in … That’s too much now. Yeah blow it out, oh my gosh so you got it in your mouth. So that’s good.
Suzi St. Jeor:
Did you get it in your lungs?
Tim Pickett:
No, she didn’t get it in her lungs, but that’s okay.
Suzi St. Jeor:
So just make sure that you’re breathing all in.
Tim Pickett:
That’s twice as much as you need.
Michelle Spear:
So wait, you hold it less?
Tim Pickett:
Yes.
Michelle Spear:
Let me do it again.
Tim Pickett:
So look, I’m inhaling, then I’m exhaling.
Michelle Spear:
Because I can feel it in the back of my throat now.
Tim Pickett:
Yeah. Because you took it into your mouth, but you didn’t let it get into your lungs. So you sucked on it, but you didn’t inhale it. Okay, just not as big.
Michelle Spear:
Okay.
Tim Pickett:
So breathe in your belly, just a little.
Michelle Spear:
This is like voiceless.
Tim Pickett:
This is like voice lessons. I know this [crosstalk 00:35:14].
Michelle Spear:
Wait, push your belly out?
Tim Pickett:
See you just did it, you breathe. Just put that to your mouth while you do that.
Michelle Spear:
Like that?
Tim Pickett:
Yeah. Just do that. Just normal breathing, just hold the button down. Pretty much. Okay. You’re doing it pretty much. There you go. This is how you teach your sister how to smoke weed.
Suzi St. Jeor:
You need to get a little bit more than that.
Tim Pickett:
Yeah, but that’s okay. We started-
Suzi St. Jeor:
But it’s normal breathing.
Tim Pickett:
But it’s normal breathing. Okay? Two second inhalation. Okay?
Michelle Spear:
Okay.
Tim Pickett:
I mean, I tried smoking before, we’re smokers so in the past. So I take it into my mouth and then I inhale it, that’s a smoker thing. That’s what mom does.
Suzi St. Jeor:
That’s what I do. [crosstalk 00:36:02].
Tim Pickett:
Because that’s a smoker thing I think.
Michelle Spear:
Wait, let me see it again.
Tim Pickett:
So just suck inhale it.
Michelle Spear:
I can see that.
Tim Pickett:
Yeah. Okay. Try it one more time. This is like the [inaudible 00:36:18] thing.
Suzi St. Jeor:
I do that, I didn’t know that time.
Tim Pickett:
I can totally feel that calming the situation. Yeah. Perfect. You did it. Okay. No more. You’re going to get too much CBD. Don’t want you to get crazy on the CBD. Okay. I mean, people say that CBD is not psychoactive, but it does calm people down, which by definition is psychoactive.
Tim Pickett:
So you have one that’s called uplift. Okay? That’s going to be energy day time. So not high, just energy nausea during the daytime that’s uplift. Okay? And then you have the other one called balance.
Michelle Spear:
Like red bull. That’s what it should called.
Tim Pickett:
This black one is called red bull.
Suzi St. Jeor:
So if you take it out of the package and you don’t keep it in the package, you’re not going to know which just which so [crosstalk 00:37:16].
Tim Pickett:
So just write down black daytime, white I don’t know.
Suzi St. Jeor:
Relaxation.
Tim Pickett:
Chill. Yeah. White is chill.
Suzi St. Jeor:
In the couch.
Tim Pickett:
In the couch. Now, I have two more of these that are a little different. Okay? But we only have one, five, 10 thread. That’s the one drawback with these batteries, just don’t lose that because these things go together. So now I have powered by … It’s a Zenergy balance THC and CBG. So remember the pair ones that we talked about with CBG?
Michelle Spear:
Yes.
Tim Pickett:
This is exactly the same thing just a vaporized cartridge. This is pretty cool. I was really impressed with these, the way they describe it. So this one says balance Zenergy pain. Okay? Pain. Because that one’s the CBG one. And they come with these little … They come with these little caps on them, which is fine if you want to put those back on and you put them in here.
Tim Pickett:
See there’s a little … In the skunk bag there’s a little thing, and you can just put them all in here. So pain. Now, you inhale this one, you’re getting high. Okay? But could be better for if you’re doing chemo day. If you’re not doing chemo day, these might be great. And these might be great with this. All right? I don’t know. These are just, you just have to experiment with this.
Michelle Spear:
Okay. So always put this on the bottom?
Tim Pickett:
Yes. So screw that on. We’ll give this one a shot.
Suzi St. Jeor:
[crosstalk 00:39:03] keep one in the thing and that way you’ll never lose the battery.
Tim Pickett:
Of course. Yeah. You always want to keep one cartridge loaded in the battery.
Michelle Spear:
Okay. And then you just drop it in?
Tim Pickett:
Yep, drop it in. Then you push the button, suck inhale and you’re there. And see how the top of that one’s round, so you can tell. Round, going to get me a little high.
Michelle Spear:
But the ones that are flat-
Tim Pickett:
Well, this one’s flat too and it’s going to get you high if you try this one too. So all different.
Michelle Spear:
It’s not necessarily.
Tim Pickett:
No, it’s not universal. I’m going to open this one. So that one is CBG. That one’s going to be good for daytime and pain. This one is sativa, so daytime. So both of these vape cartridges are both daytime. This one is very similar to the other one. Where did we put the other one? So see the black one it looks the same.
Michelle Spear:
I have labeled it. I’ll Just label those.
Tim Pickett:
Yeah. Label this one as daytime. This one’s daytime, but this one has THC in it. Okay?
Michelle Spear:
So the balance Zenergy is for pain? That one is for-
Tim Pickett:
Balance Zenergy, pain. This one is going to be … I mean, this was basically like … This is a THC vaporized cart, a sativa dominant vape cart.
Suzi St. Jeor:
So it’s not a downer though?
Tim Pickett:
It’s not a downer, this is an upper. Because you were saying you get really tired on that. And I know you, you tend not to want to be tired. Right? I know. I didn’t really buy … We didn’t buy a lot of downers.
Michelle Spear:
As soon as I hit the pillow man-
Tim Pickett:
You’re out.
Michelle Spear:
I’m out, snoring. [crosstalk 00:40:57]. Two seconds?
Tim Pickett:
You may have to turn it up, a couple of notches. Cotton candy, that tastes like cotton freaking candy.
Michelle Spear:
Yummy. I like cotton candy.
Tim Pickett:
It does huh? So that cloud right there you saw from her, that’s way too much for you. Okay? Way too much. Her tolerance has been built up over months and years. Okay? So you can taste this. So taste this, but don’t really inhale a lot. A little more than that. Oh my gosh.
Michelle Spear:
You said little.
Tim Pickett:
I know. And to your credit.
Michelle Spear:
I can taste the cotton candy. Yeah.
Tim Pickett:
So the one that tastes like cotton candy is the pain one. I’m glad you’re taking notes.
Suzi St. Jeor:
THC too?
Tim Pickett:
But it’s THC. And then this one, let me just see what this one tastes like. These vape carts they’re just so convenient, because they’re not going to smell up your house. And if you get too much, these are one to two hours of effect. These are not going to knock you out, so you can’t go pick up the kids.
Tim Pickett:
If you need to eat lunch and you’re doing chemo and you just need to get rid of the nausea so you can have a little energy, and get a little stuff done around here, and eat lunch, and then be sober to go pick up the kids, the vape cart is the answer. Right? The gummy is going to last you a long time. So the gummies are good for microdosing throughout the day and the night.
Tim Pickett:
And then you can use these on top of the gummies. And put your coat on it’s cold. You keep your house cold anyway. I mean, this one tastes like weeds. It doesn’t taste like cannabis, but it just tastes like grass. Okay. I’m going to leave the cotton candy one in. Okay?
Michelle Spear:
Yeah. Hello, cotton candy is way better.
Tim Pickett:
I know because we were talking about the eggs, the sugar. This is going to be interesting.
Suzi St. Jeor:
So the cotton candy is THC though?
Tim Pickett:
Yeah. Cotton candy is THC. So that’s your battery.
Michelle Spear:
Well, this is why I haven’t lost weight, see because I eat my Moxey Mints and I eat all my candy eggs.
Tim Pickett:
So that one I’m going to put in here. See, it’s a silver bottom with black top THC, black bottom black top only CBD. I’ll put that in there. You’ll be fine, you can call me.
Michelle Spear:
I’ll label those later.
Tim Pickett:
Okay. Charger. Okay? There’s a charger for your battery that just plugs into right there. Okay? Normal USB. Okay. And mostly you can just put that in your purse and then you’re good. So final thing, you don’t have to use this, but you should have access to it, flower. So I have an eighth of flower that’s 3.5 grams of cannabis flower.
Tim Pickett:
And I have a DaVinci IQ2, this is the top of the line, medical grade, dry herb vaporizer. This is an oven for weed that will bake it so that you can inhale the vapor, get all the magic, but you won’t have the burning in your lungs. This is not smoking. Okay? Okay. I’m going to-
Michelle Spear:
This is more vaping?
Tim Pickett:
This is called vaping, but it is dry herb vaping. It is not oil. Okay? It’s the real flowevr. So inside the box is what’s called a little straw. So I’ll pull this out. Okay? So see then this just flips over, and now it looks like it looks like a joint or a vape cartridge.
Tim Pickett:
Right? It looks like that’s the place you put your mouth. Same thing you push this button five times, I don’t know who came up with five.
Suzi St. Jeor:
I don’t know but they’re all the same.
Tim Pickett:
It’s totally random they’re all the same five times. And on the front, on the IQ2, it will show you how much the battery is and what mode it is. So this is on the mode where that’s three, that’s four, so this is the temperature. So for you, I would say probably a temperature of two is going to be fine.
Tim Pickett:
Two or three. Okay? That’s going to be between 350 degrees and 430 all the way to the top. And then this will heat up and it will vibrate when it’s ready. And then it will stay on for about eight minute. Okay?
Suzi St. Jeor:
Vibrate when it’s [crosstalk 00:46:19].
Tim Pickett:
When it’s ready, so it’s hot.
Suzi St. Jeor:
So you haven’t put the-
Tim Pickett:
No, I have not put the pot in the base. There’s a bottom little dial that I think you don’t really need to worry about. It affects how much air flow is coming through the chamber.
Michelle Spear:
Okay. So you to turn it five times on, click it on, and then you push the button to cook it?
Tim Pickett:
Nope. With this once it’s on it’s cooking.
Michelle Spear:
It’s going to cooking.
Tim Pickett:
It’s cooking the weed in the oven.
Michelle Spear:
You don’t have to push the button until you-
Tim Pickett:
You don’t have to push the button until you want to turn it off, five times. Okay? You’re only turning the temperature up and down on this one, because you want … So now let’s show you where to put the flower.
Tim Pickett:
So all you do is you just push it open like that, and then there’s a little chamber in the bottom. You see that little chamber?
Michelle Spear:
Yes.
Tim Pickett:
You put your weed in there. Okay? Now, the there’s a couple of options to put the flower in there. This is a little stir stick. It’s an extra stir stick because inside the top of the DaVinci, they have a stir stick already. Because when you use these-
Michelle Spear:
You’re going to have to take it out.
Tim Pickett:
Well, you have to clean it out. So you have to dump it on the lawn. You know what I mean? On the lawn. You can save it, but don’t worry about that right now. You can save the old vape grindings and make them into oil. But it’s not worth it right now. We just want to keep things simple. Okay? Keep it simple because this is already as complicated. I’m sure when you’re looking at this as it possibly can be.
Tim Pickett:
So let me put this back together. Okay. So that’s an extra stir stick, and it comes also with these little ceramic … The ceramic container. So if you want to, I think your fingers would have a hard time with this. So I don’t don’t know that this is going to be perfect for you, but you can try it. You can grind the flower and you can put it in there, and then you can put this on like that.
Tim Pickett:
And it’s a little container. It’s a teeny, tiny little container of weed, and then you drop that inside. So some people really don’t want to put weed in there because it gets it dirty, and so they really want to keep it clean. I don’t care. You can clean this out with alcohol and it’s fine.
Tim Pickett:
But you can use that. And if you are concerned about dosing and how much weed you’re putting in there, then you can use this little thing. Shit that thing is hotter than mother. Careful. Yeah. That oven is-
Michelle Spear:
I’ll touch it my hand is-
Tim Pickett:
That’s so stupid. That’s so funny.
Suzi St. Jeor:
That’s not funny. Are you okay?
Tim Pickett:
So that’s ceramic, so it won’t give off any taste. So the taste of the weed still stays. Your home teachers?
Michelle Spear:
No, it’s my delivery.
Tim Pickett:
It’s Amazon. Yes. Okay. So open that and smell it.
Michelle Spear:
It’s going to smell gross.
Tim Pickett:
Okay. That smells exactly like weed right there.
Michelle Spear:
That’s very strong.
Tim Pickett:
It is. So this is pretty strong. This is totally organic, totally pesticide-free, including natural pesticides that they use essential oils and stuff. Because I think for you where you’re immunocompromised, you really want to reduce the number of things that you put in your lungs that are contaminants. Right?
Tim Pickett:
So clean things really important for somebody like you. For everybody, but somebody like you. That’s a bud, that’s a nug, okay, and you’re just going to press that into the grinder so it sticks.
Michelle Spear:
Okay.
Tim Pickett:
Now, you can watch YouTube to figure out how to do this. Then you’re going to take the top of the grinder, and I’ve got you a baby grinder. And you put that down and then you just twist this like this back and forth. There’s the sound of it. And then you tap it for good luck.
Michelle Spear:
Tap.
Tim Pickett:
You got to tap it for good luck. I always tap it. I always tap the grinder for good luck, it’s the thing. Yeah it’s the grinder you put the nug of weed in there. Whoopsy, we’re making a mess. You put the nug and then you grind it. And then you open up the second chamber and that’s where the grindings are.
Michelle Spear:
So easy.
Tim Pickett:
Ain’t that weird. So this is essentially an herb grinder. Right? That you’ve used for Weed, but it’s an aluminum herb grinder.
Suzi St. Jeor:
That [inaudible 00:51:32] was hella fresh.
Tim Pickett:
When you get your time and you’re doing it. So at the bottom, there’s a little container.
Michelle Spear:
Spoon.
Tim Pickett:
Yeah. A little spatula and people put … This is where the … What falls in there is called kief. You don’t need to write this down. It’s called kief. It’s just the trichomes fall down in there, and it’s really potent down in there. And some people smoke enough weed that they actually accumulate a lot of kief. And then they’ll use it in their joints or in their flower as a boost, it’s like an octane booster.
Tim Pickett:
You will never need to worry about kief. Okay? And I think most people need to just forget about it as a thing, they just need to get over it. But that’s my personal opinion, thank you very much. Okay. So you’re going to open this up. Okay. Now everybody learns how to do this in a certain way, but you see I put my thumb right there, and then I hold this so between my thumb and my third finger, and then I tip it and I use my finger to fill that.
Tim Pickett:
To fill that DaVinci on the bottom. And then I tap the DaVinci with my finger, because the DaVinci is shaped like a funnel. So everything falls in there, and you just fill it up to the white line. See that white line inside? I just fill it up to about the white line loose.
Tim Pickett:
Now this there’s a round nubbin on the end of the DaVinci that heats up as well. So you’re getting heat from both ends. And then you’ll just close that like a magnet, and now it’s loaded up ready to go.
Michelle Spear:
And then you click five times to-
Tim Pickett:
And it will heat up and then when it vibrates, we’re going to do the same thing with this as we did with the vaporizer pen, the battery. Right? We’re going to just inhale it, and we’re going to exhale it. Okay, that is how to use flower. I’m going to put this in the little thing, and I’m going to tell you the reasons why is people choose flower over the oil. The flower is the natural plant.
Tim Pickett:
So a lot of people really like the natural thing. Flower the sensation’s different, it’s called the entourage effect. It’s going to be more like … To me, it’s the difference between eating canned tomato sauce and an heirloom fresh ripe tomato from the vine. Flower tends to be a little bit more rich experience, whereas the vaporized oil tends to be a little more grocery store, convenience store experience for when you build up tolerance and send you start enjoying this.
Tim Pickett:
Okay. And the smell becomes not so gross. Flower will last longer too, it will last three to four hours. The effects will last three to four hours and it is much more mild. The flower is 20% THC in here, but the vaporized cartridge is 77% THC. So the same inhalation is much more powerful with the oil. It’s three times more powerful than the inhalation with the flower.
Suzi St. Jeor:
So if you-
Tim Pickett:
For the same amount of product.
Suzi St. Jeor:
If you heat that up and smoke it, then it … That is just done?
Tim Pickett:
It looks like coffee grounds.
Suzi St. Jeor:
But can you heat it back up and [crosstalk 00:55:20]?
Tim Pickett:
You can use this, for somebody like you could get at least two to three sessions out of one loaded DaVinci, two to three sessions. For somebody like me with a small amount there, I would use it up all in one. You might use it up all in one. Right?
Tim Pickett:
Because you’re going to use … You’re going to inhale … Michelle, you’re going to inhale three or four times with this and be totally fine. Maybe even two times and be totally good. I’m going to burn it down. Right? I’m going to use up the whole thing. Because when I hurt my back, I wanted 50 milligrams of THC inhaled and you want five. Right?
Michelle Spear:
Yeah.
Tim Pickett:
There is an app you can connect the DaVinci to your phone, but I don’t really think that’s important right now. That will tell you exactly how many milligrams you’re inhaling.
Michelle Spear:
Oh really?
Tim Pickett:
It’s really cool. So that when you want to dial it in, then you can say, “That’s how I know I had a product that was 27% THC.” You put that in your phone, then as you inhale it tells you, “Okay, you’re at eight milligrams. Okay, you’re at 16. Okay, you’re at about 20. Okay, you’re you’re jacking it up. Okay, you’re 48. Okay, watch out you’re getting … Mayday, mayday you’re going to get too high.”
Suzi St. Jeor:
So that’s really good because then if you’re thinking one time this is perfect.
Tim Pickett:
Well, then you could look at your phone and you could say, “Oh yeah, that session I was 30 milligrams or I was 10 milligrams.”
Suzi St. Jeor:
[inaudible 00:56:53].
Michelle Spear:
Or nine.
Tim Pickett:
So that is flower. Okay? This is really why this bag is so nice because this bag will take all of that smell and keep it inside. Okay?
Suzi St. Jeor:
There’s also the toilet paper roll with that. So if you inhale [crosstalk 00:57:17].
Tim Pickett:
This grinder is so little that there’s still always going to be a little bit of grindings in there. And it’s not that big of a deal, you can just dump them out somewhere, but you can store it in there. You want to grind about as much as you want to use or within a few days, because it’ll dry out in here and then it’ll become a little bit more harsh.
Tim Pickett:
Okay. So that can all just stay right there. Okay? I think the important things seem to be gummies, the Tinctures, and then this vape cartridge, because it … You can layer the microdosing of the gummies with the inhaled method on top. And you can just try it.
Michelle Spear:
And notes in here.
Tim Pickett:
And you can put your notes in there. Now, I don’t know when you want to put all these. I’ll put this DaVinci thing here. What do you think about all this?
Michelle Spear:
No, I think it’s going to help. Yeah.
Have you heard that Utah’s much-anticipated Limited Medical Provider (LMP) program has finally launched? The LMP program is a fantastic upgrade that should prove beneficial to patients who may not have access to a QMP near them. That being said, your regular doctor or advanced practice nurse may not be willing to act as an LMP.
Cannigma contributor, medical doctor, and Medical Cannabis proponent Dr. Daniela Garelick, M.D. discussed provider reluctance in a post published a couple of years ago. Even though some time has passed, her comments are still relevant today. They certainly apply to the situation here in Utah.
Garelick suggests three reasons medical providers may still be reluctant to recommend Medical Cannabis. Before we get to them, a quick word about the LMP program: thanks to changes in the law, any physician, nurse practitioner, physician assistant, or podiatrist with prescribing authority in the state can now recommend Medical Cannabis for up to fifteen patients at a time. That is it in a nutshell.
Moving on to the reasons doctors may be reluctant to get on board, the first cited by Dr. Garelick relates to ongoing legal questions. Medical Cannabis may be completely legal under state law, but cannabis is still an illicit substance under federal law. This puts medical providers in a position of not understanding their own legal status.
It is completely understandable that legal questions would deter a provider from getting involved. No one wants to be on the wrong side of the law. But for medical providers, legal problems are more serious because they affect everything from licensing to insurance and admitting privileges.
Medical providers base their decisions on a combination of experience, general medical knowledge, and clinical data. A lack of clinical data makes it more difficult for doctors to advise. And unfortunately, while multiple studies investigating the benefits of Medical Cannabis have been done over the years, much of the data is inconclusive about specific medical conditions.
To put it in simple terms, medical providers already lacking sufficient knowledge of the endocannabinoid system may not see enough clinical data to convince them that recommending Medical Cannabis is the right way to go. Though it can be frustrating, do not fault them for this. Medical Cannabis is still relatively new compared to most of the other therapies doctors rely on. It is going to take time for doctors to fully embrace cannabis.
Last but not least are worries about potential patient abuse. Some such worries are the result of hearing anecdotal evidence from other providers. Yet we cannot discount the stigma effect, either. For the better part of fifty years, cannabis has been considered an illicit substance. Doctors have a tendency to equate illicit substances with abuse.
The potential for abuse exists with virtually every prescription drug on the market. Medical Cannabis should not be singled out simply because of its federal status. But again, do not fault doctors for their concerns. They are a product of their times.
It remains to be seen just how many professionals take advantage of Utah’s new LMP program. Here’s hoping that most providers with prescribing authority will get on board. That would be extremely helpful for patients who otherwise have to travel great distances to see a QMP.
Meanwhile, if you are a patient looking to get your Medical Cannabis card and you live anywhere near one of our locations, make an appointment to see one of our QMPs. We will do what we can to help you.
You have completed all the steps to obtain a Medical Cannabis Card. Now you are getting ready to head to your local pharmacy for the first time. That’s great. You are embarking on a journey that could literally change how you view your health and the condition that makes you eligible for Medical Cannabis. But here is a quick word of caution: start slowly.
The slow approach to Medical Cannabis is the wise approach. Jumping right in and going full bore isn’t likely to cause serious harm. But it could make it more difficult for you and your Pharmacy Medical Provider (PMP) to treat your condition appropriately. If you want to get the most out of cannabis, we strongly recommend taking a slow and thoughtful approach.
To our knowledge, there has never been a reported death attributed to overdosing on cannabis. There are a number of reasons explaining why, but it’s mostly due to cannabinoid receptors, where in the body they are located, and how the body reacts when those receptors are activated.
With all that said, not being able to overdose on cannabis doesn’t negate the possibility of using too much in too short a time. That is entirely possible. Using too much is always a concern among new patients. It can result in something known as “greening out.”
Greening out is the cannabis equivalent of blacking out, although actually losing consciousness is rare. People experience this phenomenon in different ways. Some of the more common symptoms include
As a new patient, greening out may produce any number of symptoms that may or may not be similar to someone else’s experience. Regardless, chances are you would find the experience at least somewhat unpleasant. Some people find it a bit frightening, too. So doing your best to avoid greening out is smart.
Greening out is really the extreme of using too much cannabis in too short a time. Even if you never experience it, there are still valid reasons for taking the slow approach. For instance, there is no way to know how your body will react to certain types of Medical Cannabis products and delivery methods without actually trying them.
A Qualified Medical Provider or Pharmacy Medical Provider may have specific recommendations for you as a new Medical Cannabis patient. For example, the QMP or PMP may suggest trying an inhaled form or an edible form of cannabis.
One form may have a much better therapeutic benefit for you than another. But the only way to know for sure is to try both. So you start out slowly, taking stock of how the drug affects you. If the effect is positive, you may decide to gradually increase your doses. The goal is to find a comfortable and effective dosage.
If the initial suggestions don’t seem to be effective, your PMP might recommend something different, like a tincture or a capsule. Once again, the standard recommendation is to “start low and go slow.”
If you want to get the most out of your Medical Cannabis treatments, we strongly encourage you to keep a journal. Write down the strains, delivery methods, and doses you’ve used, along with their effects. By keeping track of what works, and what doesn’t work, you can maximize the therapeutic potential of your cannabis use.
If need be, you might even try combining doses and delivery methods in order to layer the effects of the drug.
What it all boils down to is the reality that your body is going to react to Medical Cannabis in its own way. Since you do not know what that will look like right from the start, the idea is to go slowly until you figure it out. The slow approach will help you zero-in on the best delivery method and dosage while avoiding the possibility of accidentally greening out.
Episode 93 of Utah in the Weeds features Donna Froncillo, who uses Medical Cannabis to treat her cystic fibrosis.
We started this episode with a discussion of Donna’s diagnosis of cystic fibrosis at age 42. Before her diagnosis, she suffered from several other health conditions that left her feeling confused about their cause. [02:10]
After she was diagnosed with cystic fibrosis, Donna started taking a large variety of medications. Within three years, she says, her doctors prescribed as many as 19 new medications for her. She says the meds interfered with her thoughts and moods, and she didn’t feel like herself. [06:27]
Donna’s life began to change when a friend from California encouraged her to try a cookie made with canna-butter. The cookie relieved her pain and helped her sleep, so she decided to make cannabis part of her medical routine. Because she was on so many medications at the time, Donna checked herself into a mental hospital for help with weaning herself off most of her medications. She says she was able to stop using 13 of those 19 medications. [08:11]
Donna says she prefers indica varieties of cannabis in tincture form, which she makes herself using cannabis flower and olive oil. Donna also uses a vaporizer when she needs fast-acting relief from headaches. [16:08]
Donna also uses cannabis to reduce symptoms of stress, joint pain, colitis cramps, insomnia, and bone pain. [24:00]
Donna talked about her initial experimentation with cannabis medicine, and the products and delivery methods that work best for her. [29:42]
Tim asked Donna about the perception that cannabis can change a person’s self-identity. Donna says the real “her” disappeared when she was taking large amounts of prescription meds, and cannabis helped her feel like herself again. [34:41]
We wrapped up this episode with a quick discussion of Donna’s favorite products for treating cystic fibrosis. [40:54]
Tim Pickett:
Welcome everybody out to Utah in the Weeds. This is episode 93. We are coming up on 100. Seven more episodes after this, stay tuned. Stay subscribed to Utah in the Weeds on any podcast player that you have access to. And you can listen to the podcast on Discover Marijuana, YouTube channel, which we are doing a YouTube giveaway this month, coming up on the final week of the giveaway. You need to be subscribed and comment on the most recent video to be entered into the contest. We’re giving away free visits to Utah Therapeutic Health center for cannabis related healthcare. Also a DaVinci IQ2. That is a $300 dry herb vaporizer, extremely well put together. Ceramic bowl, glass tube, the taste is better than any other vaporizer that I have tried, and some other swag items too giving away. Discover Marijuana on YouTube. Slam that subscribe button.
Tim Pickett:
Today’s interview and discussion is with Donna Froncillo. She is a Utahan now, she moved here and is a cystic fibrosis patient. She found cannabis, well, I’ll let her tell this story and how many medications she was on and how cannabis has affected her. What she has found works for her. Another really great conversation with somebody who is legitimately using cannabis as medicine in a way that makes sense, in my opinion. Otherwise, I really appreciate all of you. Appreciate you subscribing to the podcast, Utah in the Weeds. Again, my name is Tim Pickett. Enjoy this episode.
Tim Pickett:
So how did all of this process of cystic fibrosis kind of come about?
Donna Froncillo:
Okay, so 15 years ago I had a bout of pancreatitis and I ended up in the hospital for a month. Well, the doctors were kind of baffled about it because they didn’t know why. There was no reason for it. It just came about, I didn’t have a long history of drinking or doing any drugs or doing anything that would… My diet was pretty healthy, too. Not as healthy as it is today, but anyways, so I was in the hospital for a month. Well then the following year I got pneumonia and I couldn’t get rid of the pneumonia. It went on for 16 weeks and they kept giving me antibiotics and sending me home and giving me antibiotics. And then finally after 16 weeks the same hospital that I kept going to the ER, they said, well, why don’t we just keep you? And why don’t we do some testing because you’re not getting rid of this pneumonia that’s in the base of your lungs. So that’s what they did. They brought a lung doc. What is the lung doctor called? I don’t even know. Lung doctor?
Tim Pickett:
Lung. Yeah, lung doctor’s fine.
Donna Froncillo:
Okay.
Tim Pickett:
Pulmonologist is the word, pulmonologist is the word you’re looking for.
Donna Froncillo:
Pulmonologist. That’s the word. Yes, right. So they brought him and he said he was going to do a bronchoscopy. Well, when he went in there to discover what he did, he had to send that, which he said was the worst thing he’d ever seen, but he had to send that to the CDC to be tested, to see what was in there. And that’s when he came back and said, you have microbacterium abscessus and it came back.
Donna Froncillo:
And at the same time, I had asked him to diagnose me, to see if I had cystic fibrosis, because I did have a third cousin who had died from it. And he wasn’t going to because I was 42. And he said, we’ll do it based on family history. And sure enough, I had it and it was positive. And that was it. And then I was on three years of different medications to get rid of the microbacterium abscessus and an IV. I had the pick lines for a few months, along with some other oral antibiotics and yep. So I think there was a straight two plus years of oral antibiotics after the IV pick line. And they told me they did not think I was going to make it. They said, this is really bad. This is the worst thing you could have got. Worse. And I was like, “Whoa, I’m thinking I’m going to die.”
Tim Pickett:
Yeah, no kidding. And really cystic fibrosis is a lung, it has a lot of effect on the lungs. The pancreas is involved. So this kind of fit the whole picture all of a sudden.
Donna Froncillo:
It did every thing, everything. Everything from my sinus problems in my early twenties, to my infertility of not being able to have a child. IBS, getting diagnosed with IBS when I was in my upper twenties, my thyroid went nutso when I was in my early thirties. I was premenopausal at 35. I mean, there was some weird things going on in my life that I had. I was like, I didn’t know. I just was confused for years.
Tim Pickett:
Yeah, I bet. So how long ago were you diagnosed?
Donna Froncillo:
I believe this is 15th year. That would bring us back to what year? 2008?
Tim Pickett:
Yeah. 2008 would be 15 years from now or 2007.
Donna Froncillo:
I think it was 2008, because in ’07 is when I had pancreatitis. And I think in ’08 is when I had the pneumonia. And then that’s when I found out. And then I finally got Medicare approved in 2010.
Tim Pickett:
So what changed in your life once you were diagnosed and you kind of knew this was the case and you started to realize these symptoms came from a place of this chronic illness that you had.
Donna Froncillo:
Wow. What happened? A lot of strange happened. When I was put on these medications, I hadn’t been on many medications. I had just been introduced to Synthroid a couple years prior. And so I wasn’t really on medications. Well, what happened was I started getting side effects and I was on a new medication. Then I was on another medication. Then I was on another one. Before a three-year period, I ended up on 19 different new medications, 19. And I just started feeling like I just wasn’t me anymore. There was something wrong with me. I was thinking different thoughts. I was having these different moods. I was crying a lot. There were things that it just wasn’t my normal. And I was on something for going to sleep. I was something on for stress. I was something for fibromyalgia. Then they gave me something for stomach cramping. And then I was on a muscle relaxer. And then I was on, oh pain pills. And then I was on pain pills. They were giving me like seven of those a day.
Donna Froncillo:
And I was just like, it just seemed like I was getting worse and worse and worse. So that went on for about three years. And finally, and this is in Florida. I had this friend who had come from California and she said she wanted me to try a marijuana, she called it cannabis butter.
Tim Pickett:
Yes.
Donna Froncillo:
So she called it cannabis butter. And she said she wanted me to try a cookie. Well, I did. And I slept well that night. I ate, I wasn’t in any pain. I felt like I was normal me again. And I was like, whoa. And it was made of Girl Scout cookies. I’ll never, ever forget it was Girl Scout cookies. Because I remember asking her “What was the name of that thing you gave me?”
Donna Froncillo:
And so what I had realized was something was up with that medication. So then now I had a dilemma on my hands because now I had this new drug and with all these other drugs. So what I did is I did something that’s kind of not normal. I took myself to Tampa General Hospital and I asked them to admit me to the psych ward.
Donna Froncillo:
And I came with a laptop. I thought I was going to be in there for a week. Just a vacation. They’re going to help me out here. No, no, no. It was a different shock altogether when I got there. So anyway, laptop was not going with me. I couldn’t bring anything upstairs with me and they wanted to know why I was there. And I said, “Well,” I said, “I have to get off of all these drugs. And I know I need to do it, but I don’t want to do it by myself because what if I do this and something happens to me?”
Tim Pickett:
Right? I mean, you’re on 19.
Donna Froncillo:
I mean this is a lot of drugs.
Tim Pickett:
Yeah. You’re on more than 10 drugs. There’s all kinds of side effects from taking all the drugs. There’s bound to be side effects from coming off of them.
Donna Froncillo:
Right. Right. And I didn’t know what to expect. And so I thought the safest thing would be, is be under medical care. So I went, they admitted me. I saw the doctor the next day and he asked me what exactly I wanted to do. And I told him, I said, “I don’t need all these drugs.” I said, “I need my nebulizers. I need my Synthroid. I need the basics. But the rest of these, I don’t think I need these.” And he says, “Well, we’re going to have to stabilize you with something.” He said, just because this is a lot we’re going to wean you off of. And I said, “Okay”, so we agreed on Prozac. But then I did ask him about marijuana. I said, “I would really like to try marijuana.” And he gave me Marinol. Which didn’t work. It didn’t work. And that next morning I told him, I said, “That didn’t work. That wasn’t the same as the butter my friend gave me.”
Donna Froncillo:
So anyway, so I just went through my five days. It was a five-day thing. He did put me on Prozac. He wanted me to stay on that until further noticed, because keep the chemistry normal. So I got out of there. I was relieved. And that was so basically 12 years ago was when I started using it, which I know a lot of people find that hard to believe. They’re like, “Didn’t you use it? Weren’t you smoking it when you were a teenager, weren’t you out there?” And I was like, “No.” I grew up in a house where it was bad. And when you grow up learning that this is a terrible, terrible drug, don’t ever try it. It’ll turn your brains to mush. You’re going to kill your brain cells. So I had all this fear about it and yeah, so 12 years ago, so I wiped out of the 19, I would say, because of what I still have to do today, I would say 13 are gone.
Tim Pickett:
Wow.
Donna Froncillo:
So that was good. It was good.
Tim Pickett:
Do you feel like you got a little bit of your life back, a little bit of normalcy back?
Donna Froncillo:
Yes. And I tell people that and I’m like, I know that there’s a lot of people who don’t understand cannabis and there’s a stigmatism to it. There’s still people that I’ll approach and they’ll say, “Oh yeah, you just want to get high. It’s a good excuse to get high”. No matter what, you’re a stoner that’s it and I’m like you just don’t get it. You don’t understand that it’s more to it than just somebody who just wants to sit around getting high all day long.
Donna Froncillo:
Anyway so it seems like I’ve had to, really in order for people to understand it and they don’t. They don’t want to hear it or they don’t get it. But yeah, telling people that over and over and over is that cannabis gave me my life back. And in a sense, I owe that to God, because I believe that God put this here as a healing plant for us. And I’m not a person who can take a lot of medications because my pancreas now hates pill. It hates anything manmade. It hates processed. It’s the weirdest thing. It’s like my pancreas is dictating my whole life. And if my pancreas, if I take a regular pain pill, I get pain.
Tim Pickett:
Do you?
Donna Froncillo:
And I’m like so what good is that? I can’t do that. If I eat say, let’s say I decided to eat a donut, it wouldn’t be good. I’d be like. So I’ve had to change my diet. I’ve had to completely change my diet. I’ve had to completely change my lifestyle. I’ve had to add things into my life and I’ll tell you what, they’ve told me anything that ends with the word -itis I’ve been diagnosed with. Yeah. Arthritis, bursitis, tendonitis, colitis, gingivitis at one time. Sinusitis. It goes on and on and on.
Tim Pickett:
You’re a bag of inflammation.
Donna Froncillo:
Right. And that’s what CF is. And see and that’s the big thing that I wanted to touch base with is that there’s something, and I don’t know the mechanism of the drug. I don’t know that end of science. All I do know is that it does conquer inflammation. And what causes inflammation? I mean, you got your joints, your stress, you’ve got foods that you eat, medications you take, sugar. There’s a lot of things that inflame the body. So it’s not just about, oh, I’m going to just take this cannabis here and I’m going to be fine. There’s more that comes along with that. Not only do you do the cannabis, but you may have to also cut back on the sugar or you might have to stop drinking the alcohol. So anyway, so I just want to hit some bases on this inflammation because inflammation is what triggers cystic fibrosis. And then we end up sick. So if you can control the inflammation, you can control the sickness.
Tim Pickett:
Yes.
Donna Froncillo:
And I don’t like to be sick. So I have a fight against. My fight is What’s the term I use? My fight is against inflammation or the itis. Yes, my fight against itis. Itis fight
Tim Pickett:
It’s like a foe, it’s like you’re going into the ring and you see this in a pretty complete picture too, because I think a lot of people don’t, or wouldn’t, see this as cannabis is one part of the solution. It’s not the whole thing. It gives you some options. What do you feel like cannabis does for you, for your day-to-day life?
Donna Froncillo:
Well, I’m an indica person. So basically, it keeps me balanced. So what I do is I think we discussed, this is what I do is I do tinctures and I do them about every four hours I’ll do one ML. And now I bought this one time because I told you I would try it. This was $80. But what I do is I tend to buy this. It is going to sound like not much, I buy this it’s 3.5 and then I take my own olive oil and I actually just cook it on the stove for like five hours. And then I make my own little oil.
Tim Pickett:
Yeah. You were showing me an eighth of flower, right, of trike flower here.
Donna Froncillo:
So this is 3.5 grams.
Tim Pickett:
Right. 3.5 grams of flower. And then you take that amount, you put it in some oil and you decarboxylate it, you make your own.
Donna Froncillo:
Yes. Yes.
Tim Pickett:
You make your own oil.
Donna Froncillo:
Right. And then I take this and I use this and-
Tim Pickett:
Little dropper.
Donna Froncillo:
And then it, yep. And it’s a 1.0. And I do that every four hours. And that keeps me balanced.
Tim Pickett:
Do you feel like that’s better medicine or do you feel like that’s cheaper for you? What makes you want to do it by yourself? Make your own oil?
Donna Froncillo:
Well, because honestly I can’t afford $80 a bottle. I cannot afford.
Tim Pickett:
So you feel like it’s a little bit cheaper to take your own flower, make your own oil, and then that’s going to give it a nice…
Donna Froncillo:
Well, it’s not going to be as strong. It’s going to be weaker. And I already know that it’s weaker and it is what it is. It works for me, but it works, but it also takes a long time. It could take up to two hours. So doing it every four hours keeps it going.
Tim Pickett:
Keeps you level.
Donna Froncillo:
That’s what I noticed. Right.
Tim Pickett:
And if it’s weaker and you’re doing it more, I really like this idea. I really like this idea, especially for you. This is good.
Donna Froncillo:
And it’s olive oil. So olive oil’s one of those things that I can actually digest because I’m limited with what I can digest anymore. So then I have the other one. Now this deal was a buy one, get one free.
Tim Pickett:
Okay.
Donna Froncillo:
So when it’s a buy one, get one free. I can do this. And it’s more economical for me. And it’ll last me a couple months. Now I also buy another indica, which is a stronger indica than this one. This one is during the day, the other one is going to knock me right out. That one is one ML. I take it and within an hour I’m out and it’s a 70/30 indica.
Tim Pickett:
Okay.
Donna Froncillo:
It’s pretty strong and it’s the same thing. So, but it was a buy one, get one free. And when you get that kind of a deal and you do it cost dollar for dollar, it works out pretty well. It keeps that-
Tim Pickett:
For sure.
Donna Froncillo:
Keeps it in the budget so I can afford it.
Tim Pickett:
Yeah. Well, okay. Side question. How bad does it smell up your house when you make the oil,
Donna Froncillo:
It’s a good smell up for about six hours.
Tim Pickett:
Then it kind of goes away?
Donna Froncillo:
Yeah.
Tim Pickett:
Your house smells like it.
Donna Froncillo:
Yeah. It’s about six hours. We’ve timed it.
Tim Pickett:
Have you? That’s funny.
Donna Froncillo:
We had to because there’s somebody in the house that really doesn’t want the smell in the house. They don’t really care for it. And so we have to make sure that person’s gone for at least six hours so that she doesn’t have to smell it.
Tim Pickett:
I see.
Donna Froncillo:
So anyway, but yeah. And then now, sometimes I still have to use my vaporizer, which yeah. I like the Davincis. I did go and look at them because I hear you talk. Yeah. I was hearing you talk about them. They look great. They’re great. But I bought something that was just a little bit, it’s cheaper and it’s faster. And last night I had the worst headache and it came on and I ignore it. I can’t take Tylenol. I can’t take ibuprofen and aspirin doesn’t even touch it. So I said, fine, I’ll vaporize. And I only need to vaporize it for like 10 minutes and then my headache’s gone and then I can go upstairs and I can go to sleep.
Tim Pickett:
That’s cool. Same strains you’re using in your oil, your indica strains. Which are nice. They can be really good for headaches for people. And I like that a lot. I think that’s a smart way to do it.
Donna Froncillo:
Well, I think that’s the medical way to do it, but then, okay. Let me see. So here’s I was going to tell you too, is that, so I had to get through a time period of actually believing that I wasn’t doing something that was wrong. And I had a hard time with my family. I come from a family of law enforcement, so they’re not into marijuana. I’m like that black sheep.
Tim Pickett:
So when you started to use this medically, were they still not into it?
Donna Froncillo:
No. That was the funny thing is they all mentioned how well they thought I was doing and you’re [crosstalk 00:22:06] Keep it up.
Tim Pickett:
Yeah. You’re doing great. What are you doing? And you say, “Well, I’m using marijuana.” And they’re like, “Ah!”
Donna Froncillo:
Right.
Tim Pickett:
“How could you?”
Donna Froncillo:
Yeah. They’re all in New York state.
Tim Pickett:
Oh yeah. You know in New York they just adjusted their law. They have an open consumption law. Now they’re one of the only places in the country that you can smoke cannabis. You can smoke cannabis anywhere you can smoke cigarettes, out in the open. Yeah.
Donna Froncillo:
In New York, huh?
Tim Pickett:
One of the only places. They actually use more. I mean, trivia with Tim. Is they use more cannabis in New York City than any other city in the US. 77 metric tons of weed a year goes through that city. Yeah. Bigger than LA, San Francisco. All the California cities. Yeah. They use a ton of it there and now you can smoke it in public in New York. I got to go on vacation there just to see this, just to see it.
Donna Froncillo:
Well, I would too. See, because I’m from Buffalo. Buffalo, a whole nother place.
Tim Pickett:
Oh, I’m sure.
Donna Froncillo:
It’s not even anything like New York City. In fact, New York City would be weird to them. “Ugh. New York City’s weird!” Yeah. No and here’s the thing, this is what I’ve noticed now okay, even medications, here’s the thing is even medications that I was on that caused me severe joint pain and edema. I’m talking about the Levofloxacin family. The floxacins. Yeah. So what did I have to, when I called up my doctors during that time, I said, “What can I possibly take?” I didn’t even know what to take anymore. And they said, “Just get some edibles.”
Tim Pickett:
Oh, wow.
Donna Froncillo:
That was the CF center. So that was cool.
Tim Pickett:
Yeah. That is cool.
Donna Froncillo:
So, but here’s the thing what I noticed that it helps me with. First off, it helps me with any stress situations, brings me right back down. My body stays calm. It’s all about keeping the body calm for CF. If you can keep your body calm, you won’t inflame your lungs. And if you can eat the right foods and get the right nutrition through the pancreas, without upsetting the pancreas, the pancreas will stay nice and calm too. But so what I’ve noticed is I’ve noticed appetite, because I have an issue with malnutrition. So I’ve lost a lot of weight and now the endocrinologist is actually doing some testing to see what exactly is happening. So sometimes I’ll have like no appetite, none. I’ll just be walking through the day. Like what do I want to eat? What do I want to eat? Anyway so I get an appetite, major appetite, especially with this one, this Who Dat Cush Orange or something it’s called. I’m like, “Who Dat orange? That stuff is making me eat all the time!”
Tim Pickett:
That’s great.
Donna Froncillo:
It is, if you want an appetite, get some Who Dat Orange. Anyway, whatever it’s Who Dat Orange Crush. All right. So appetite, joint pain, colitis, cramping. My headaches, when I get them. The insomnia, the stressful situations. Lung exasperations, when my bones start to hurt. When I get pancreatitis, when I get pancreatitis, the only thing I can do is vaporize. That’s it. There is nothing else in this world. I don’t even care. Morphine, oh, except for when I’m in the hospital and I get on an IV, they have to give me morphine because it’s an equivalent. That’s the level of pain. Yeah. It’s horrific. So anyway it helps with that.
Tim Pickett:
Pancreatitis can be really, really bad. My background’s in GI surgery and we would admit you, and that would be the general surgery service or something that would potentially admit you. And yeah, that was me. And we would just fill people up with IV fluids and anti-nausea pills and Dilaudid or morphine, or just the heavy-duty stuff, because we didn’t have access to cannabis. It’s horrible. But you make a really interesting, I believe cannabis to be one of the best medications for pancreatitis, you get the pain control, you get the nausea control, you get a little appetite. You don’t get the slow down in the GI system. I mean, it’s as if it was grown for pancreatitics like yourself.
Donna Froncillo:
I am in awe. There’s so many times that I’m in awe because it was something I avoided for so long in my life. And I met with a, I think it was a psychologist at one point, and we were touching base on the marijuana and where were we going with that? Well, first off he made a comment that he doesn’t believe that it would’ve affected me in this way if I had been a partaker of it in my youth. That it wouldn’t have worked as well, because I didn’t have a history with it.
Tim Pickett:
Do you believe that?
Donna Froncillo:
I don’t even know what to think, because I’m just saying to myself, I can’t believe that I was made to feel like this was such a criminal thing.
Tim Pickett:
I know I don’t-
Donna Froncillo:
And it’s not, it’s a good medical thing.
Tim Pickett:
Yes. It is. I agree.
Donna Froncillo:
So I don’t know.
Tim Pickett:
I don’t know if I buy that. I mean, I there’s something too that I guess if you were to use a ton of it when you were really young, screw up your endo cannabinoid system. Yeah, maybe. I think that’s a stretch a little bit. I guess I would say we don’t don’t really know, is the bottom line.
Donna Froncillo:
Well, the other thing too is they questioned me heavily about what it does to me. How it helps me escape. And I’m just like “Escape. Escape from what? I mean, I didn’t know. He said, “Well, people do it because they have some emotional pains they don’t want to deal with.” And I’m like, “No, no, no. See I’m in pain and I need something for pain and this is what I take. And there’s nothing to escape because reality’s going to be there. Reality’s always there. How can I escape it?” I can’t escape reality.
Tim Pickett:
Yeah cannabis does not make you escape reality. Does it?
Donna Froncillo:
That’s what they want to know. That’s what they asked me-
Tim Pickett:
Yeah. What do you want to escape? What do you, what do you?
Donna Froncillo:
Yeah.
Tim Pickett:
Yeah. No, I want to be in the present
Donna Froncillo:
Pain. I don’t want any pain.
Tim Pickett:
Yeah I don’t want to have pain, but I want to be here. I want to do stuff I want to do today. And I don’t want to feel like crap while I’m doing it.
Donna Froncillo:
Right. Right. And so when I’ve told people, then they’ll say, “Oh, well, well you’re you just want to get high?” Hmm. Okay. Well, first off I wake up high. I mean, I wake up and I’m happy to wake up. I’m like, if I take my little blinders off, because I wear a mask. I’ll take my mask off and I’ll see that it’s light out. And I’m like, “Yes!” So I get up and I’m all excited. I’m already like that. So I have to do indica. Now I have experimented because I had to start trying all these different strains and doing these different things because I was so new to it I didn’t know what I was doing. So I was trying some sativa and Ooh, that wasn’t for me. Because I was already excitable. I was already high. I already had so much serotonin. And I always said, I have an abundance of serotonin in me and serotonin and dopamine.
Donna Froncillo:
So it was too much. It was so much that it actually gave me the shakes and I was like, and that’s how I had to get to know what worked for me. So I go through this whole three year trial where I was trying this, trying that, vaping this, eating that, rubbing this on, doing this patch. I mean I did everything and sometimes I wanted to see if I could do what other people said they could do, which was, they said they would get a head high and they called it headband.
Tim Pickett:
Yeah.
Donna Froncillo:
And I’ve tried and I can’t get there for some reason. I can’t get high in my head like people describe. And it’s always baffled me.
Tim Pickett:
That’s very interesting. You’re not the first person
Donna Froncillo:
Is it not get-
Tim Pickett:
No, you’re not the first person I’ve ever met that has said that. Most people build up a lot of tolerance in order to do that. But there is something about the blood brain barrier that’s not getting crossed maybe by the THC and who knows. And maybe it’s just like when somebody describes this to me, I compare it to Adderall or Ritalin. So for an ADHD person, you have all of this neuromodulation that’s going up and down and up and down and up and down. And so Adderall will raise all of the signaling up and it levels it out for people. And for people with severe ADD or ADHD that actually makes them feel more calm. And it actually kind of lowers their sensation of things and for you, but for somebody else who doesn’t have ADD, or that they can take Adderall and it’s very stimulating to them, their wide awake, they think. They describe the contrast as more.
Tim Pickett:
And so I wondered if it would be the same type of thing. You are using THC and it’s actually just becoming a modulator, right? So you’re not feeling that head high sensation because almost like you need it, you need it to modulate you, it finds your balance. It makes you balanced. You describe that in the beginning. You take an indica and now you feel like, “Oh, I’m me.”
Donna Froncillo:
Yeah. But even if I take more and more and more, even if I took? It doesn’t matter. It doesn’t even matter. It just doesn’t, it never mattered. It’s never mattered. The only thing that I noticed was if it’s more of a sativa strain and say I get a 50/50, the only thing that’s going to happen is I’m going to laugh a lot. I’m just going to be laughing and laughing and laughing. And that’s only if it’s more of a sativa. And so that’s the side effect. And one time I remember my father telling me, he said, because he knew about the marijuana because at that time I was making cookies. And he said, “If this is the only side effect that you are getting is you’re getting the laughs and you’re laughing like this and you’re happy”, he said, “Then it’s okay. It’s okay.” And it took a lot for my father to say that because of him being in law enforcement. Because I know he’s still anti-marijuana but he did tell me that. And that made me feel like at that time that was his blessing. You know what I’m saying? I’m giving you my blessing. Just don’t ever drive under the influence.
Donna Froncillo:
And he’s made that clear because he was a recovering alcoholic. He hasn’t drank in like 55 years. No like 52 years. And so he’s always told me that. Whatever you do, do not eat your cookies and put anything on social media and do not eat your cookies and do not drive when you eat your cookies.
Tim Pickett:
This is good fatherly advice. This is very good fatherly advice.
Donna Froncillo:
So every time I do have something to say and I did medicate. I’m like, Hm, I better not get on Facebook. I’ll just stay off.
Tim Pickett:
I’ll just wait on this one. We’ll wait on this one just a little bit. That’s good.
Donna Froncillo:
Just in case, because I don’t know. It doesn’t feel like I’m saying anything wrong or anything, but I have that little voice in me telling me be careful.
Tim Pickett:
So you don’t ever feel like you’re really, people are very scared when they start cannabis or when they’re exploring cannabis that it’s going to change who they are when they use it. Do you feel like it, I don’t feel like that, but to you, Donna, do you feel like this changes who you are at all in a negative way?
Donna Froncillo:
No. No. I never even thought about it changing me. No, when I went into it and I decided to do it, I just wanted to have myself back because myself was gone after all those pills and all those drugs being pumped through me and all that was going on. I was gone. Me, the real me, and I just wanted me back. And so even through prayer. I’ve prayed. I pray a lot for every answer I want. And I always get led to holistic approaches. Like right now I’m studying iridology and foot reflexology. And I also have a lot of data that I’ve been collecting on foods and healings of foods and herbs. I’ve got a collection of herbs now that I’m going to make my own tinctures. And I keep being led into the direction of holistic approaches.
Tim Pickett:
That’s really cool.
Donna Froncillo:
But I’ve never, I’ve always just wanted to maintain who I was and this is who I am and I didn’t want to lose that. And that’s what I felt I was losing through pharma.
Tim Pickett:
Yeah.
Donna Froncillo:
I was losing me and I wasn’t me. And yeah, it was really weird. It was a very strange time in my life. And if it wasn’t for, there was a doctor in Tampa Bay and my doctor sat me down after this three-year period of me being on all these different medications and he sat me down and he said, “I don’t know what to think. What’s going on right now.” And he said, “I’m concerned about you.” And he said, “I’m concerned about how many pills you’re on now.” He said, “I’ve been your doctor all these years. And you were only on two medications.” He said, “And I want you to really think about what’s going on right now because you’re on a lot of medications”, and if it wasn’t for him, bless his heart because he’s a normal PCP, for him to do that, he really made me stop and think, what’s wrong? What’s going on with me? And so he ultimately led me to get my life saved. So yeah. Yep.
Tim Pickett:
Thanks for sharing that.
Donna Froncillo:
Yeah. And he wasn’t in the cystic fibrosis community and see, that was the other thing too, is with the CF doctors, they’re normally lung doctors.
Tim Pickett:
Yeah.
Donna Froncillo:
So what happens when you go, they start treating your lung issues, but they can’t help you with your pancreas, with your kidneys, with your bladder, with your GI. So they send you to all these other doctors, they send you here and they send you there and then they send you to pain management and then they send you this. So I had about nine doctors that I was seeing on a monthly basis for years. And I would bring my sheet of paper in. I kept an Excel spreadsheet of all these drugs I was on and I would bring it in to each and every doctor down there in Florida. And I would say, okay, I say, “These are all the drugs I’m on. This is what I’m experiencing.” “Oh, okay. Well we’re going to go ahead and give you some Lyrica because this is all, sounds like this is a lot of fibromyalgia related, so Lyrica should do it.” Then they would just put another pill on me and then I would specifically ask them, “Well, are these pills okay with that one?” “Oh yeah, those are all fine.”
Tim Pickett:
Yeah.
Donna Froncillo:
But they really, really weren’t. And none of them said anything bad. They all said moderate indicator moderate, mild. But I knew in my brain that something was happening.
Tim Pickett:
Yeah. Well, I’m so glad that you found yourself again, through this whole experience.
Donna Froncillo:
Yeah.
Tim Pickett:
And now you’re able to really be an advocate for cannabis as a real medicine with your own experience. I really appreciate you coming on and talking about it. It’s been really great.
Donna Froncillo:
Yeah. And especially for the CF people, because the cystic fibrosis community, they think smoking, that’s what they’re always thinking. Smoking, smoking, smoking. I was very fortunate to be under UCSF and Stanford and UCSF and Stanford and California both do recommend edibles or tinctures or patches. They never, ever recommended smoking but at least they were open-minded enough to say, we can put this on, some of our patients can be on this. But there is a lot of people that don’t understand in the cystic fibrosis community that have children or have teenagers or have 20 something year olds that it’s not about them trying to seek a high.
Donna Froncillo:
I’m a mother. I have a 30 year old and I understand where they’re coming from, but they’re also hearing from a mother that’s telling them that this is a medication that can help with their inflammation and they don’t have to be in the hospital every other month or three or four times a year. It doesn’t have to be like that. And they don’t have to get down to 85 pounds. There’s something that might help. Cannabis.
Tim Pickett:
Yeah. Yeah. I appreciate you saying that. And do you have, so your favorite strain in Utah, is it the Who Dat Orange Crush?
Donna Froncillo:
That one’s really good for daytime indica use, but the other one I have is it’s just a normal cush, something. Sorbet. That’s a good one for sleep. That’s the one that knocks me right out. So, so far I’d say that those are probably my favorites so far. And then of course this tincture, this it’s called myrcene Terpineol.
Tim Pickett:
Myrcene Terpineol is a Boojum tincture. Mm-hmm (affirmative).
Donna Froncillo:
Yeah. And this really knocked me out.
Tim Pickett:
Yeah. It’s strong.
Donna Froncillo:
Yeah.
Tim Pickett:
That stuff, it is really strong.
Donna Froncillo:
You’ll need a half a drop of that and you’re out. And so I don’t know if I could ever make mine that strong, I doubt it. And that was what I’m doing.
Tim Pickett:
Yeah. Yeah. Well, I’m glad that you came on and told your story. Donna, this has been really fun. It’s very fun to listen to you and your experience in getting off these medications.
Donna Froncillo:
Well, thank you for having me.
Tim Pickett:
You bet, for any of you who are listening Utah in the Weeds podcast, subscribe on any podcast player that you have access to Donna Froncillo, thanks for being with us today. And everybody stay safe out there.
Regular listeners of the Utah in the Weeds podcast have heard our very own Tim Pickett discuss the concept of taking regular breaks from Medical Cannabis. The idea behind doing so is to address cannabis tolerance, which occurs naturally and develops with regular cannabis use.
Tolerance is not a bad thing. It is one of the body’s many defense mechanisms designed to keep things in balance. Yet tolerance isn’t ideal for Medical Cannabis patients because it reduces the effectiveness of their medicines. Taking regular breaks reduces tolerance so the patients don’t continually have to increase dosage and frequency.
Cannabis isn’t the only drug that can produce tolerance. Tolerance is reality with a variety of pain medications, sleep aids, antidepressants, etc. Where cannabis is concerned, tolerance is the result of how THC affects the brain.
THC’s psychoactive effects occur when the cannabinoid binds to cannabinoid receptors in the human body. A receptor is a cellular structure that binds to certain molecules. So cannabinoid receptors bind to cannabinoids, like THC and CBD.
Here is the problem: the body can get used to having a certain amount of THC in the system. As that happens, the body produces fewer receptors in an attempt to balance things out. The result is that the same Medical Cannabis dosage doesn’t produce the same effect.
Tolerance in Medical Cannabis patients isn’t ideal because it ultimately means they need more medicine. When you consider just how expensive Medical Cannabis is, having to continually update your dosage is not a good thing. Your tolerance could be such that you simply cannot afford to medicate any longer. That’s what we’re trying to avoid when we recommend taking regular breaks.
Above and beyond being quite expensive, another possible outcome of unchecked tolerance is that Medical Cannabis eventually becomes less effective as a medicine. Then what? Going back to less effective prescription medications doesn’t seem like a particularly good option.
By now you have figured out that taking regular breaks from cannabis is a way to address tolerance. But what is actually happening physiologically? For that answer, we go back to cannabinoid receptors.
Just as the body produces fewer receptors in order to accommodate an expected level of THC in the system, it will begin producing more receptors as THC levels drop. By taking a break for 3 to 7 days, you are giving your body a chance to readjust. You’re giving your body the opportunity to start producing receptors again.
There are no hard and fast rules dictating how often you should take a break and for how long. A general rule of thumb among Medical Cannabis patients is to tolerance breaks at least once every three months. See our “Reset Your Tolerance” guide for details on getting the most out of your next tolerance break.
If you are a long-term cannabis user and you find that your consumption has increased to the point where you believe the drug is no longer helping you as it should, you might want to consider a longer break. It is not unheard of for long-term patients to take a break of up to a week or longer. Just be prepared to approach cannabis more slowly after your break is over. You’re going to feel the effects of the drug like you used to, so you don’t want to jump back in too fast.
Tolerance is a reality of Medical Cannabis use. It is also a natural biological function. However, it is nothing to worry about, and it can be managed just by taking regular breaks.
Episode 92 of Utah in the Weeds features Rich Oborn, the director of Utah’s Center for Medical Cannabis.
We started the episode with Rich’s thoughts on Utah’s 2022 legislative session, which resulted in a few changes to Utah’s Medical Cannabis Program. [02:28]
Senate Bill 190, sponsored by Sen. Evan Vickers, will prohibit over-the-counter sales of hemp products with a combined total of THC or THC analogs of 10 percent or more of the product’s total cannabinoid content. However, those types of products will continue to be available for sale at Utah’s cannabis pharmacies. [05:28]
SB 190 further clarifies packaging requirements for products containing synthetic THC, and it removes the prohibition of cannabis pharmacies employing convicted felons. [09:00]
SB 190 also adds “aerosol” as an approved Medical Cannabis dosage form in Utah. Rich says such products exist in other markets, but they’re expensive to manufacture. He doesn’t expect local companies to start making cannabis aerosol products right away. [15:22]
Another change in SB 190 will make it easier for cannabis pharmacy agents to work in Utah’s Electronic Verification System (EVS). [17:07]
Senate Bill 195, sponsored by Sen. Luz Escamilla, expands access to Utah’s Medical Cannabis program by requiring hospice programs to have at least one Qualified Medical Provider. It also adds acute pain as a qualifying condition, making cannabis available as a post-surgery pain relief treatment. [24:09]
Next, Tim and Rich talked about the current state of cannabis research, including an upcoming study to be funded by Utah. House Bill 2, an appropriation bill, sets aside $538,000 for a study on cannabis and chronic pain. [34:24]
Lawmakers did not approve “opioid use disorder” as a qualifying condition for Medical Cannabis in Utah. Instead, medical providers will need to consider a patient’s past drug use when writing a Medical Cannabis recommendation. As Tim points out, this is already a best practice for medical providers. [39:53]
Next, Tim and Rich talked about THC-infused drinks. Senate Bill 190 excludes “liquid suspensions” of cannabis branded as beverages. Tim estimates such drinks will continue to be sold in Utah until some time around November. Liquid suspensions of 30 mL or less will continue to be available. [44:37]
Senate Bill 195 also modifies the state’s advertising standards for Medical Cannabis, allowing cannabis companies to place more types of ads than previously allowed. [46:51]
Rich says Utah’s Medical Cannabis community is growing by about 1,000-2,000 new cardholders per month. At the end of February, there were 44,800 active cardholders registered in the program. About 30% of cardholders do not renew their cards. [52:15]
Next, Rich told us about some of Utah’s educational and informational resources on Medical Cannabis. The state has educational material for both patients and providers. There is also a website to monitor the cost of Medical Cannabis evaluations at clinics throughout the state. [54:55]
This year, the Utah Department of Health is developing an analysis of Medical Cannabis inventory across the state. UDOH will share the results of that analysis with industry professionals in an effort to identify and address any shortages for in-demand products. The Utah Legislature is also working on a governance study to analyze the administration of the Medical Cannabis program. [57:50]
Tim Pickett:
Welcome everybody out to episode 92 of Utah in the Weeds. I am your host, Tim Pickett. And today we have what is becoming our annual legislative update with the Department of Health Director of Medical Cannabis, Rich Oborn. Rich is here to discuss the updates to the legislation in the Medical Cannabis Program. And we will discuss in this conversation the hemp changes and the changes to the CBD and the over-the-counter hemp sales. What has happened with that? How we’ve been able to decrease the amount of THC or delta-8 in those products available to really be purchased by children, which increased patient safety. There was some controversy. And we talk about that as well. Talk about the advertising changes to the program and the added condition that has been added to the Medical Cannabis Program for patients. Is a great conversation, feel free to reach out and comment as this will be posted on YouTube with any questions that you have about the legislation, and we’ll answer them all.
Tim Pickett:
Other than that, subscribe to Utah in the Weeds on any podcast player that you have access to. We’re on all of the platforms. We release these, we try to release these every Friday at 4:20 AM. Last week, we took a little bit of a break and we’re back in the swing of things now. We’ve got a lot of updates coming up for you. The CEO of High Times and partner in Beehive Farmacy coming up in April. We’ve got a special episode coming up with my sister, who I’ve been teaching a little bit about medical cannabis with her condition. Just a lot of good content coming out. Season four of Discover Marijuana is also getting ready to launch in the next month. Of course, April and 420 celebrations are coming. Stay tuned and subscribe to Utah in the Weeds and enjoy this conversation with Rich Oborn. How was the legislative session? I mean, from a workload standpoint?
Rich Oborn:
Yeah, it was heavy I’d say. We had three bills that had direct impact on us. And in the past some time… I guess if I compare it to last year, I don’t think there was as many amendments that we were tracking within the bills. There were two bills last year that had some direct impact on us. And this year there were two main ones, but then there was the third one with SB 153, the medical cannabis governance structured bill. That was one that we tracked and were providing input on throughout the session.
Tim Pickett:
It seemed like this session, there was more work up front. There wasn’t as much work on changes at the back end.
Rich Oborn:
Right, right.
Tim Pickett:
Was that your experience?
Rich Oborn:
Yeah, yeah, yeah. That’s how it should be. We don’t like to see a lot of flurry of things going on at the end, because that’s when you don’t have time to think through things logically, right? You don’t want to see stuff put together in a rush as much as possible.
Tim Pickett:
Sure.
Rich Oborn:
Sometimes that happens no matter what, but… Yeah. Yeah. So, yeah, I’d say that’s a good way to say it. There was some work that went on at the beginning and there are a few tweaks we had to make throughout. And on most of those, we were able to get them in the bills. So that was good.
Tim Pickett:
Yeah. Now, as of this recording, Governor Cox has not signed the bills that we’re going to talk about today, but is there any chance he doesn’t really? I mean, there’s always a chance.
Rich Oborn:
I feel like if there was a possibility, I would’ve probably heard about it. Last year, you’re probably familiar with the bill that was vetoed that related to the hemp program, Department of Agriculture and Food and the Hemp Industry. And that was a big deal that it was vetoed. And so this year they’ve had some time to work on some things, and I don’t expect there to be a veto on any of the bills, including the HP 365, which was the one that related to the hemp issue primarily. But then there’s also SB 190 that does have some hemp components to it.
Tim Pickett:
Let’s jump into that one because it seems like, and I did a little update a couple episodes back of 190 and 195. But 190 was Vickers’ bill and that was the one that was primarily hemp. And it seemed like that was more to do with things that involved the Department of Agriculture. And then there was a lot of controversy over this delta-8 and even the naming of things, right? You can’t even name it. Let’s talk about this because it seems like there’s a lot in this bill that people were a little upset about.
Rich Oborn:
It’s a little more controversial.
Tim Pickett:
It is a little more controversial.
Rich Oborn:
Sure.
Tim Pickett:
So talk about this, what’s the change from what’s before with this delta-8 or over-the-counter psychoactive substances derived from cannabis, I guess? Is that a good way to put it?
Rich Oborn:
Yeah. Yeah. And I want to emphasize the Department of Health, while we are indirectly involved because we oversee the medical cannabis pharmacies that sell these products, the Department of Agriculture is more directly involved in the oversight of these hemp industry. And the Department of Health doesn’t have any jurisdiction over the hemp retailers and growers, but [inaudible 00:06:58] does. And so after December 1, 2022, hemp products in Utah cannot have a combined total THC and any THC analog that exceeds 10% of the total cannabinoid content. So if you’re comparing the different cannabinoids that are in a specific product’s profile, THC or an analog of THC cannot exceed 10% when compared to the other cannabinoids in that product.
Tim Pickett:
Okay.
Rich Oborn:
So that was a critical change. If you’re a hemp retailer, you would not be able to sell those products legally under state law. Medical cannabis pharmacies continue to be able to sell these products to medical cannabis cardholders within the medical cannabis industry pipeline. So it’s not like patients won’t be able to access these products, they will. But it’s only through-
Tim Pickett:
It’s just that the 16-year-old can’t go down the CBD store and buy it over the counter. But this is also added to the already 0.3% total weight.
Rich Oborn:
Right.
Tim Pickett:
Right. This particular piece, you could buy a 1:10 THC tincture, and this would fit that, right? It would have 10 times the amount of CBD than THC, and it would fit this thing. But you add to that 0.3% by weight, and now you have to have a Gatorade bottle full of liquid in order to have, I think it’s 6 or 10 milligrams of THC. So it really, really dilutes the ability to sell. Really they’re called PUCK gummies and they were being sold kind of all over the place.
Rich Oborn:
Yeah. Yep. And the basis of this was to help with product safety and patient awareness so patients are aware of the contents of the medication they’re purchasing. And in the medical cannabis pipeline, those type of products that the processors under SB 190, they’re required to ensure that the label identifies each derivative or synthetic cannabinoid as a derivative or synthetic cannabinoid. So the processor is required to be transparent about which of those cannabinoids are synthetic and which are natural.
Tim Pickett:
This is going to be good, I think, for that garage chemistry. And I’ve talked about this before that a lot of the delta-8 is made by some organic garage chemistry that leaves some byproducts. And I think this helps with the labeling, keeping bad actors out of the market essentially.
Rich Oborn:
Right. And there are some additional restrictions that the Department of Agriculture and Food places on processors in the medical cannabis industry when compared to the hemp industry. And so I think that’s critical to keep in mind that these are medications, and there’s a rigorous scientific approach to these products. We don’t want to have people compromise their medical condition or their safety by consuming products. And so as a regulator, I know the Department of Agriculture does what they can to ensure that those patient protections are kept in mind as there’s different tests for contaminants and different tests are run to ensure that the ingredients of the products are actually what they claim to be on the labels. And also that there’s no misrepresentation or misunderstanding about whether a cannabinoid is synthetic or not. So that’s something that’ll be new that we’ll be rolling out with SB 190.
Tim Pickett:
So that includes the… Does that include the Medical Cannabis Program too that they’re now going to be required to label synthetic versus derived cannabinoids? In most of the packaging that I see, they’re already labeling it as such.
Rich Oborn:
Right. Right. I think that’s important to emphasize is that they’re already labeling it as such, but this just clarifies the law in relation to medical cannabis processors and pharmacies that there’s this more clear requirement that that label must identify whether that cannabinoid is a synthetic, when it is a synthetic. So you can still purchase THC products that are synthetic THC, but when you do that, you’ll be informed on the label that that’s the type of product you’re purchasing. And there were processors that were, I think, already doing a good job of that, but this just clarifies the law, makes it so-
Tim Pickett:
It standardizes it.
Rich Oborn:
… Right.
Tim Pickett:
So this was passed really as a patient safety and a consumer safety issue, the delta-8 controversy and having young people being able to buy psychoactive products that were potentially dangerous to their health. So personally as a provider, I like this. I can see there was some arguments about low income folks not being able to access their medicine. And this helps people go into the… It kind of forces some of those people into the medical market, but that’s… And I mean, it increases patient safety overall. And so I tended to support this piece despite the controversy of it.
Rich Oborn:
Yeah. And I think there’s some things that the legislators are doing and also private entities are doing to make medical cannabis more affordable in Utah. I think the ideal is still not in place, which would be that insurance would be able to help someone purchase this type of medication. But while we wait for the Federal Government to take action on that, I think there’s some good options out there. Although we know everybody maybe is not aware of those options. And so I feel like private identities, they can take it upon themselves to share information about the options that are out there to get help for making the medication more affordable to them. And it’s great to see that entities are stepping up to play that role and people are willing to donate money to assist others in affording medication that’s not as affordable as other medications.
Tim Pickett:
Right. So still staying on this SB 190, there was another thing with felony convictions. If somebody had a felony over 10 years ago, they weren’t able to work in a medical cannabis pharmacy before, but now that’s not prohibited. That seems like a really good idea.
Rich Oborn:
Yeah. And that was actually something we had contacted lawmakers about. We had a case or two come up where we did have to deny an individual from being able to obtain a pharmacy agent card because of the fact that they did have a felony. And there was this prohibition of any employee of a medical cannabis pharmacy having a felony of any type and it didn’t place a timeframe on it. So the law’s been amended to allow for that. And I think that’s a step in the right direction. Although if you do have a felony within the 10 years, it can still stop somebody from getting a pharmacy agent card. Having a felony within 10 years doesn’t prohibit you from getting a pharmacy agent card. It’s a factor that the Department of Health considers.
Tim Pickett:
Yeah. And then we added some dosing forms, inhaler, nasal spray, nebulizer. I mean, I can see the nasal spray for sure. That actually is a product that I’ve heard that a few people are developing. But the nebulizer and the inhaler, I don’t know of any products out there even in other states that are that type of delivery system, like an albuterol inhaler, right? Or a meter dose inhaler.
Rich Oborn:
Right. They exist, but they’re not that common because they are expensive to manufacture. That’s my understanding. And so we don’t expect any companies to be chomping at the bed to do this immediately. But as I think the program matures, it’ll be a possibility and a processor could decide, “Hey, we feel like there’s a market for this. There’s enough patients that are asking for it.” And it would begin to be a legal dosage form [crosstalk 00:16:28].
Tim Pickett:
It’s extremely useful from a meter dosage in an inhaler form is one of the big problems with moving inhaled cannabis products into the traditional medical market because it’s just hard to dose, right? There’s only very few products that will measure the amount you inhale and they’re $300. And so meter inhaled product, while you’re right, I’m sure it’s really expensive to manufacture. From a medical standpoint, it’s going to be nice. I could think of a lot of patients who could really use it. And then there was this technicality change in 190 where they had EVS… The pharmacy agents couldn’t access the EVS, only the pharmacist could. And I remember thinking, “Oh, that’s interesting because our MAs can access EVS as a proxy.” So this codifies that with 190 and allows them access. Are they going to act as a proxy or do they just have visual access or is that something that the department is kind of yet to determine?
Rich Oborn:
They will have their own role within the electronic verification system. And for those of you who don’t know what that is, it’s the system that… Is the patient registration system that pharmacies rely on in order to verify if someone has a medical cannabis card or not. It’s also the software that a medical clinic and a QMP, qualified medical provider, uses to make a recommendation for a specific patient to receive a medical cannabis card. So pharmacy agents that work every day in the medical cannabis pharmacy, who make up the majority of the employees at a medical cannabis pharmacy, they’ll begin to have access to the EVS. And the way that’s being set up is that a pharmacist in charge for the specific medical cannabis pharmacy location will be able to authorize agents. There will be some agents that the pharmacist in charge may decide should have that access to edit and to view that information.
Rich Oborn:
But there could be some pharmacy agents that really have no role in the EVS they do. They maybe just have a niche in the pharmacy of a certain type that doesn’t require that they get access to the EVS. So that’ll be something that a pharmacist in charge, the PIC, would would determine for a specific location. And so it’ll take some time to work without [ vendor 00:00:19:13] and execute this change in the EVS, but we’ll be engaging with medical cannabis pharmacies and the pharmacists who work there and pharmacy agents on how this is set up and we’ll get their input and ensure that we inform them of when it’s an [ in production 00:19:31] and actually able to be used by pharmacy agents. And one thing that’s coinciding with this requirement is that pharmacy agents will begin to have to complete continuing education course on confidentiality and the protection of patient information.
Rich Oborn:
And I’m sure that there are some pharmacy agents that are already generally familiar with HIPAA and protection of confidential medical information, but there could be some that have no clue about it. So it’s important that anybody that works in a medical facility like a medical cannabis pharmacy has at least an intermediate level training on protection of that information and how patient information must be safeguarded. And how, for example, in the EVS, it would never be appropriate to search for a neighbor’s name in the EVS if they’re not a patient. You have no business doing searches like that in a medical type software like this. And other medical facilities have these same standards. And so these standards also apply to medical cannabis pharmacies, although they’re still selling a federally illegal product.
Tim Pickett:
Right. Yeah. But in the normal pharmacy down the street from me, I mean, all of the techs are all going to have some HIPAA training. They’re all going to understand the privacy, the confidentiality. That’s just standard. And I knew that that was one of the reasons why the pharmacy agents didn’t have access before. And so it’s nice to see because there’s an issue frankly with… There was a little bit of a weird thing where the pharmacy agent couldn’t transfer the dosage recommendation from a provider into MJ Freeway because they couldn’t access EVS. And it was kind of a big logistical kind of thing where it brought this up, or it was one of the things that brought this up as something to kind of solve.
Rich Oborn:
Right. And one of the plans we already had in place, regardless of what happened during the legislative session, was to have an integration of information from the EVS regarding the dosing recommendation be sent to the MJ Freeway software. So a pharmacy agent wouldn’t have to go to the EVS to get information about the recommendation. They’d be able to view that within the MJ Freeway software that they use for their patient profile and purchases and point of sale system. So that was already in the works. But this, I think, is just another way that a pharmacy will be able to be efficient in helping customers and supporting them and having a good experience there at the medical cannabis pharmacy as they come in.
Rich Oborn:
One thing that I want to point out though that’s critical is that there will be information regarding a QMP’s notes that they have. Potentially a QMP may want a pharmacy to be aware of a specific patient’s treatment history or medication history. And that type of information, it’s the option of the QMP to pace that into the software. And they would need to advise the patient of this choice they’re making to share this information with an outside party at the pharmacy. So there’s patient consent needed in that type of a case, but there are many QMPs that do choose to keep the pharmacist informed of the other medications that the patient is taking and some details that they feel are relevant about the condition. That helps the pharmacist make the decision about what specific product may be the best for treating that specific condition.
Rich Oborn:
So the pharmacy agents will have access to that information. It’s sensitive information, and we need to treat it as such. And so it’s important that the pharmacy agents go through the training and learn more about how to ensure that they provide the best service to patients as they protect the confidentiality of their medical information.
Tim Pickett:
Let’s switch over now to… That’s a lot of the big items kind of in SB 190, the bill that was kind of on Senator Vickers’ side. Senator Escamilla, she was the one who put out SB 195. That has to do with the Medical Cannabis Program a little bit more on… There was some additions to making the program a little more inclusive. We’re making the general medical community more inclusive of the program. One was the addition of the… If you run a hospice program, you have to have at least one medical provider that’s registered in the system as a QMP.
Rich Oborn:
Right.
Tim Pickett:
I thought that was kind of an interesting addition.
Rich Oborn:
Yeah. The requirement does not begin until January 1 of 2022, or excuse me, 2023. But, yeah, every hospice program has to have at least one medical provider registered with the Department of Health to recommend medical cannabis to patients. Now, one thing that’s critical though is that if the facility accepts federal or insurance money, they would want to consult with their legal counsel and third party reimbursement to determine if the facility may allow for delivery and possession of a federally illegal drug while they’re in that type of a facility. So although they have to have at least one medical provider that is registered as a QMP, there are some things that they should be aware of as it relates to reimbursement of funds from a federal source or insurance money. This doesn’t mean that they are obligated to recommend medical cannabis at that facility. It just requires that they have a qualified medical provider registered with the Department of Health that would be able to do it if they chose to.
Tim Pickett:
And this is every hospital, hospice facility, nursing home, or not in the state?
Rich Oborn:
Well, it’s hospice program. So there’s only so many of those, it’s a specific type of facility. It’s a hospice program that must have at least one medical provider registered with the Department of Health as a QMP. Okay? But then a separate requirement is that an assisted living facility, a nursing care facility or a general acute hospital, the law was modified to allow them to receive deliveries of medical cannabis products from a medical cannabis courier for a patient who is a medical cannabis cardholder. But if that facility accepts federal insurance money or insurance money, I would think that they should consult legal counsel about third party reimbursement because there could be some specific guidance from the federal agency regarding acceptance of those types of products, because they are still federally illegal.
Tim Pickett:
Yeah. Because the idea is that you might have a employee of the facility receive these products in order to hand them to somebody else. And that action of receiving the product is essentially an action of receiving a Schedule I drug. So we need to make sure that that’s on the… You need to talk to your lawyer for sure.
Rich Oborn:
Right.
Tim Pickett:
This kind of goes along with the, and I don’t know if we have this, this kind of goes along with this same idea that we are going to allow schools. There was some clarification on the school system being able to store medical cannabis for a patient that was in the school system. Not that the employee of the school would then handle that if they needed to, but it’s allowed from state statute.
Rich Oborn:
I’m glad you brought that up because that was taken out of the bill.
Tim Pickett:
Ah, because I heard the committee meeting and I heard Senator Escamilla kind of defend that. And there was some very interesting questions, right? One of them was, so basically, are we going to just let this child show up with it in their backpack? And I know of cases where the school district is questioning this because they have a child with a condition and a card. This is a real sticky situation because you want the child to have access and you want the schools to be protected. And by the way, I would mention that schools are like pharmacies. They have a ton of medications that they deliver in store for other conditions, right? This is not something that’s not done, right? We have controlled substances there for children who need them.
Rich Oborn:
Right. But they’re also federally funded.
Tim Pickett:
Yep. So they pulled that out.
Rich Oborn:
They did.
Tim Pickett:
So as of now, the child would essentially need to be removed from the school property to dose their cannabis with their caregiver and then be brought back to school.
Rich Oborn:
Well, I think a general approach would be ensure that you vet this with legal counsel and the school authorities, the school district. There could be some school districts that handle it differently than other school districts. I can’t speak for them, but yeah.
Tim Pickett:
Yeah. I’m glad we talked about that because I thought that had stayed in, but it hasn’t. So that’s good to know. The other thing that was interesting to me is we added acute pain as a qualifying condition. So this means that a person who is about to get a knee surgery, if the provider, the orthopedic surgeon says, “You know what? This is going to cause a lot of pain. I don’t want you on as many opioids and I’m going to offer to recommend a short term card.” Am I thinking of that correctly?
Rich Oborn:
Yes. So any cards issued with acute pain as a qualifying condition, they will always expire after 30 days. Just as when a medical provider prescribes opiates for a limited duration because of a surgery, it’s acute pain. So they’re not going to prescribe opiates for a long period. It’s for a specific condition of some acute pain that’s coming up because of that surgery. So, yeah, a medical provider would generally prescribe opiates for limited duration, but now they’d be able to recommend medical cannabis as an alternative to opiates. And we expect that medical providers will exercise this with great discretion and in cases where they feel like it would be a better alternative medically for a certain type of patient. They’re now able to have that as an option.
Tim Pickett:
So these two things we’ve just talked about, the hospice and this acute pain thing, this doesn’t sound like something that the Department of Health they were… It sounds like this was something that you were told was going to be proposed in the bill and not something that the Department of Health would’ve had a horse in the race, so to speak.
Rich Oborn:
Right. I mean, there’s certain things where we contact the legislature and we see if they might be able to tweak something that we feel would help promote public health, very rarely do we come out in opposition to specific provisions publicly. And so we’re just typically neutral on some of those provisions that maybe don’t have as much evidence as others for being an effective type of treatment. And then we’re responsible to execute the laws that are passed by the legislature. So we want to ensure that they’re implemented in a way that’s fair and easy for patients to take advantage of if their provider chooses to recommend them.
Tim Pickett:
You’ve done a very good job of… I’ll shoot an opinion here about this particular qualifying condition. I personally think this is kind of silly. I can see why an advocate would propose this condition. As a provider who recommends cannabis, I think that 99.9% of the time, if you’re getting your knee replaced and you need a 30 day card, you certainly qualify for a medical cannabis card in the original system. And evidence with acute pain is different than evidence with chronic pain, but there you have it from Tim and I’m not a employee or a regulator. So I get to voice my opinion a little bit more freely about this one. I like expansion of the program; that I’m certainly for. I think this was kind of a funny one myself.
Rich Oborn:
Yeah. We just hope it’s exercised with wisdom and that providers are careful with how they exercise it, just as we hope with every other type of recommendation they do what we hope that they-
Tim Pickett:
And it will be good to study… This will be a unique thing to kind of study how many of these are issued? What’s the progress? How many of these cards get converted to a regular longer term card? What’s the success of reducing opioids after surgery? We could design some really interesting studies around that. And in fact, not to skip through and go right to the bill that funds a study, there was a bill that funds a study.
Rich Oborn:
… Right. Yeah. So Senate Bill 2, that was a big appropriation bill. And in that bill, the legislature appropriated $538,000 to fund a study of medical cannabis and chronic pain. And that was proposed by representative Ray Ward. And the Department of Health was able to provide some general thoughts about how that should be done, and we’re working out details of that. But it’ll be done through an RFP process where academic researchers at universities have an opportunity to bid on receiving these funds. But we’re very serious about funding research, and we’re excited about the legislature having an interest in doing it. And so we want to ensure that it’s done in a way Utah can be proud of, that can be shared with other states and help them learn as well as we move forward with trying to understand more about medical cannabis and its impact on chronic pain, without federal funding. It’s not easy without getting federal grants to do research.
Tim Pickett:
Is $538,000 a large amount for a study, a small amount? Do we have perspective on that?
Rich Oborn:
That’s a good question. It depends on what type of study, because there’s double blind studies that really cost thousands more than that of dollars beyond the $538,000. So this won’t be something like that. It’ll be something on a lower scale, but it will still be, I think, something that researchers and providers in Utah and outside of Utah will find helpful. We want it to be not just something that’s tucked away, but is something that providers can learn from and patients can learn from and pharmacists at the medical cannabis pharmacies can apply to work they’re doing. Although, we defer to those studies that have a lot more funding that are published as studies that just have more resources to do something that’s even more extensive. Those are exciting to see, and we hope to see those happen even more outside of Utah. We see some of those in other countries, Israel and Canada, or to the countries that we see them more in than within the United States.
Tim Pickett:
Yeah. And I’m interested in why, I know Ray Ward was very interested in getting a little allocation for some research to be done. There was talk about whether to research a condition like this, or to research the program itself and how it was working. So it’ll be interesting to get this process started. I think there’s a ton of research on cannabis. I find it interesting that the medical community still says, “Oh, there’s no evidence” when there’s thousands of studies being done. Like you say, Israel and Canada has some fairly decent, if not excellent, research on some of these things already. But Utah is unique. We like our own programs, right? We like to see things done our way, and this is the beginning of doing that. It’s kind of a culture thing, I think. We like to see ourselves.
Rich Oborn:
Yeah. I think most people agree though is that when you compare the studies done on other drugs to those on cannabis, there is more of a volume of studies of scientific rigor on other types of medications that we don’t see on cannabis yet. There’s just a bigger volume. So it’s just the nature of dealing with a federally illegal drug that there’s not as much research on it, even if you add the research in other countries. So that’s one of the sources of some of the reluctance of some providers to join in and make recommendations regarding medical cannabis. There’s been some good literature that has taken a look at studies not just in United States, but these other countries.
Rich Oborn:
And even combining all of that, there’s still some weakness when compared to other drugs. So I think that that’s important to keep in mind. I don’t want that to take away from some of the, I think, positive experiences people are having with medical cannabis as they treat their medical conditions and finding more success in treating their conditions with medical cannabis compared to other drugs. We don’t want to take away from those experiences and Utah law allows for those experiences to happen legally, which is great. But we still want to be able to continue to add to the evidence out there regarding treatment of A, B and C condition with medical cannabis.
Tim Pickett:
In a really rigorous way, I agree. There’s not comparison studies and the double blind studies, and there’s a huge amount of inclusion bias in cannabis studies, which is always kind of an issue in medicine. So when we added a little bit of history, they weren’t able to get opioid use disorder as a condition. So it seems like we compromised or the advocates kind of compromised here and added this language that we’ve got to now consider the patient’s qualifying condition history of substance use or opioid use disorder when we’re doing this. This seems like something we’re already doing, but-
Rich Oborn:
It should be. Right. Yeah.
Tim Pickett:
… This should be something. If they have opioid use disorder, this would be a reasonable alternative to opioids.
Rich Oborn:
Well, I think the purpose of this amendment to the law is to have a medical provider be more careful in their consideration of a recommendation when they learn about a patient’s history of substance use or opiate use disorder. Because there are some studies that find that individuals that have those conditions, that they have the propensity to overuse medical cannabis in some cases beyond it’s medical purpose.
Tim Pickett:
Yeah.
Rich Oborn:
So [crosstalk 00:41:20] interacts with those disorders. And there’s some studies done that show that it actually exacerbates or makes them worse when used in the wrong way. So it’s important that there be a screening done. I think this is the best practice and people ask, “Well, what’s screening?” Well, there’s a few types of screenings that are out there. People that work at these type of facilities are very familiar with the types of screenings and different types you do. But as a medical provider, it’s just important that there be an awareness of the patient’s substance use or opiate use disorder history if there is one. And if there is one take, take a step back, consider whether recommending medical cannabis should still be done in light of that patient’s condition.
Tim Pickett:
Yeah. I’ve had patients who we have removed their ability to access all forms, right? Reduced it to… Been asked by a patient frankly to reduce their forms to only topicals because they were having trouble, they were spending too much money, consuming too much, had a history of addiction to other substances. And it’s… Yeah. I do think it’s real. I think there’s about a 9%, I think the statistics are between 8- and 9% of cannabis users can become addicted, which interestingly is just barely below the number for opioids. But I think that just goes to show that people get addicted to things. They like… Humans, we like the dopamine.
Rich Oborn:
Right. And I think researchers out there have said there’s little evidence that it works as an effective treatment of substance use or opiate use disorder. There’s mixed results in the studies that show that. And in fact, there’s some studies that show that it makes them worse. So we want to see providers take a step back, consider that recommendation in light of the patient’s qualifying condition if they have a history of substance use or opiate use disorder. This is what a provider does when they recommend controlled substances outside of the Medical Cannabis Program for other drugs that are federally illegal, they consider, “Okay, how does this drug impact these other conditions that this person may have, right?”
Tim Pickett:
Yeah, we’d even call other providers and say, “Hey, I’m about to prescribe your patient or our patient now. When you’re a specialist, we’re going to add this to their drug list. And what do you think? The neurologist, the psychiatrist.
Rich Oborn:
Right.
Tim Pickett:
Create more of a team approach. I like the idea. I think it does create a little bit of increased liability on the provider to make sure that they’re doing their due diligence. And so providers shape up, right? Let’s see. Oh, the drinks. I keep getting emails about the drinks. When are the drinks going away? When are the drinks going away? So currently you can buy a drink, you can buy a Seltzer, you can buy something in a can, there’s a few of these around, and we’re going to take that back down to 30 MLs. So basically a tincture bottle or a little oil bottle. There was some controversy on this too.
Rich Oborn:
There was. And I think I can’t speak for policy makers, but naturally they weigh benefit and harm. And they decided there was more risk to liquid suspensions being above 30 milliliter than there was benefit. And I think it’s easier to abuse the use of a medical cannabis liquid suspension when it’s above 30 milliliter-
Tim Pickett:
Yeah. And I’ll say it, I mean, a can of spiked Seltzer with THC in it just looks wreck. It just looks more recreational as a product than a tincture oil, or even a Select Squeeze where Curaleaf makes that drink additive. Even that looks less recreational or [ adult 00:00:46:05] use than a four pack or a six pack.
Rich Oborn:
… Sure. And you don’t typically see from a Walgreens, you don’t go to the pharmacy and purchase a liquid suspension to treat the types of conditions that are [crosstalk 00:46:23] conditions in the state of Utah.
Tim Pickett:
NyQuil doesn’t come with a can that you crack open.
Rich Oborn:
Right. Right. Yeah. There’s a reason why it is the way it is. It’s for patient safety.
Tim Pickett:
Sure.
Rich Oborn:
So same goes in this respect.
Tim Pickett:
Patients have until the end of November. Basically Thanksgiving, folks. They’ll maybe be on the shelves till then, but I doubt they’ll make any more of them. I bet they just clear out their inventory and then that’s kind of it.
Rich Oborn:
Right. Yep.
Tim Pickett:
Let’s talk about advertising because this was something that got changed a little bit, not a ton. I see you’re getting out your cheat sheet here because this is wholesome co-delivery, doesn’t the delivery third party… Explain the advertising changes.
Rich Oborn:
Yeah. So I think there was a lack of clarity in the current law and with these bills that goes it into place with SB 195, there’s more clarity as it relates to advertising and the limits that are placed on medical clinics and medical cannabis pharmacies. And so the law states that a medical cannabis pharmacy, they’re able to advertise in any medium. So there’s no longer restriction on the type of medium they can use for advertising. In the past there was, but with SB 195, there will not be. But they’re able to include information in their advertising such as a service available at the pharmacy, the best practices that the medical cannabis pharmacy upholds, education materials, they can advertise those obviously. That’s important.
Rich Oborn:
And their inventories, they can advertise their inventories obviously. And a medical cannabis pharmacy may provide information regarding subsidies for the cost of medical cannabis treatment to patients who affirmatively accept receipt of the subsidy information. So all those things are really important. Pharmacies will be able to do those things, some of which they could not do in the past because they were restricted in the type of mediums that they could engage with patients in. So that, I think, will have an impact on patients for the good. There’ll be information that’ll be more accessible about education materials and best practices that the medical cannabis pharmacy upholds. So I think it clarifies some of that.
Tim Pickett:
You’re not passing out coupons at the county fair, right? You’re having to essentially be a patient and opt in to those communications to receive a coupon, a subsidy program.
Rich Oborn:
Right. Right. So a pharmacy would not be able to advertise promotional discounts or incentives. They would not be able to advertise a specific medical cannabis product in their advertising. And they would not be able to advertise an assurance regarding an outcome related to medical cannabis treatment, for example. Those are some things that they would be prohibited from doing. So those are some of the advertising limits that will be in place under SB 195.
Tim Pickett:
Yeah. I think that clarity is somewhat helpful. We’ve already run into it with utahmarijuana.org with billboards and [ reagan 00:00:49:56] and everybody’s kind of trying to shift and adjust and making sure that everybody’s in compliance. And so I’m sure you’ll have a lot of questions coming up. In fact, I was talking to Cole today who was like, “Oh, you’re talking to Rich, ask him about the advertising.”
Rich Oborn:
One thing that I think is great is that a nonprofit that offers financial assistance for medical cannabis treatment to low income patients, they may advertise the organization’s assistance if the advertisement doesn’t relate to a specific medical cannabis pharmacy, or a specific cannabis product. So there is this emphasis on allowing the nonprofits to do that.
Tim Pickett:
Yeah. I don’t know that you can register a 501(c)(3) related to cannabis yet, but certainly our uplift program that subsidizes low income Medicaid and terminally ill patients was one of the things that I know the lobbyists and the activists kind of made sure to mention to the legislators that said, “Hey, we’re bringing people through the program who can’t afford it because it is costly for a lot of people.” And the program essentially was designed for these low income folks and terminally ill and really chronically ill patients. And yet there’s a bunch of them who can’t afford to even get into the program as it is. So helping those patients, it’s been surprising how interested the growers, retailers, processors are in giving back to those programs and subsidizing that, which kind of, I don’t know whether some people think it’s ironic, right? That they’re using their profits to help subsidize the poor. But on the other hand, you kind of have to have fire… The cashflow is fuel to the fire. This thing has to run.
Rich Oborn:
Yeah. And so we’ll be working with the industry on putting together some additional standards and rule that relate to some of these advertising standards that are in the statute. We’ve got some authority to do that. And so we’ll be reaching out to get some of that input.
Tim Pickett:
Cool. So let’s talk about the growth before I let you go. What are we up to cardholder wise?
Rich Oborn:
Yeah. So as of the end of February, we were at 44,800 active medical cannabis cardholders. And that represents a growth of, I’d say, between 1000 and 2000 cards per month new active medical cannabis cardholders. And so we’ve seen a steady rate of growth happen, which is good to see, although we know that medical cannabis isn’t for everybody. And so when we did an analysis, we found that there was about a 70% card renewal rate. And there’s lots of reasons why people would choose to renew their card. And a lot of reasons why they may not choose to renew their card. They may find that, “Hey, medical cannabis isn’t working for me, but these other medications do or these other treatments do. So I’m not going to renew my card. I’m going to work with my provider on these other medications or treatments that are looking better for my chronic pain.” Because, like anybody, people just don’t want to buy something. To buy it, it’s expensive. So also-
Tim Pickett:
Yeah, and I know cost is a significant answer we get when people let their card lapse. Cost of the QMP visits, cost of the product, whether or not all of that’s justified or not, that’s just a big reason people leave the program.
Rich Oborn:
… Right. One of the most critical things that the Department of Health has been implementing just recently is the limited medical provider recommendation program. And there have been approximately 50 limited medical provider recommendations since January 19th, 2022, when it was launched. And these are providers who are not registered with the Department of Health, but who choose under the state law to recommend medical cannabis to up to 15 other patients.
Tim Pickett:
There’s something like 16,000 controlled substance license holders in Utah, right?
Rich Oborn:
Right.
Tim Pickett:
Available for the limited medical provider program.
Rich Oborn:
Right. Any MD, DO, APRN, PA or podiatrist falls under that. And so we’ve seen just a steady growth, but it’s been a slow growth just because naturally it takes time for providers to feel comfortable, I think, with a new program. And so we’ve done some webinars just recently. We’ve done four webinars since January to help providers who are interested in learning more about limited medical providers and how they can recommend cannabis in an easy way. There’s information on our website that a patient could direct their regular physician to if they wanted their physician to explore that possibility of recommending to them and making them one of their 15. And so that’s one thing that I think is helping patients make a medical cannabis visit more affordable because in some cases, in the past, there have been some clinics that I think have been charging a lot more than other clinics for a similar service.
Tim Pickett:
I did a podcast and the guy’s in the $5,000 range over the two years because of a clinic that was having him come up every 90 days for 400 bucks. It was the worst I’d heard about, but there still are. And now there’s a website people can go to where they can see a little bit of this. They only see the cost, but there is a website where people can look at the initial visit cost, right?
Rich Oborn:
Right. So policy make were listening and they thought this is not right. We need to do something. So they created this limited medical provider program as just one strategy to address this concern. A second strategy was to require that the Department of Health work with the state auditor’s office on gathering data from all the medical clinics that have QMPs who advertise publicly that they offer medical cannabis evaluations, that they report those fees to us that they charge. And that those fees be posted on the state auditor’s website. And so we’re getting about 200 to 400 visits a week to that website, which is a good sign. We like to see that people are using it. And this is not just for people that are wanting to get a medical cannabis evaluation for the very first time. But it’s for those that have been in the program for a long time.
Rich Oborn:
Maybe they joined in March, 2020, and they, at this point, are ready to just learn more about what some other clinics are charging and they want to compare some of those costs. And as you know, Tim, there’s different reasons why clinics charge different fees. Some clinics take more time with their patients and maybe have more training than other providers do on a particular subject related to medical cannabis.
Tim Pickett:
Yeah. Not a bad place to start your search. Definitely not a place I would say to end your search in who to go see.
Rich Oborn:
Right.
Tim Pickett:
But more information is always better.
Rich Oborn:
Right.
Tim Pickett:
What’s some of the plans for 2022 in the program that the Department of Health has?
Rich Oborn:
Yeah. So one thing that we’re excited about is putting together an analysis of medical cannabis product inventory across the state. And I think there’s from some concern about not finding a certain type of product in Utah, and we want to be able to do an analysis that actually relies on some of the actual inventory available across the state to really see if some of those concerns are valid. And then we want to share that analysis with clinics, with pharmacies, with the industry in hopes that they would find creative ways to address some of those gaps that may exist throughout the state.
Tim Pickett:
Yeah. We’ve heard of those where we’ll send a patient for a certain product and then it’s not there. But, yeah, it’d be very interesting to know and be able to kind of look at whether or not that’s really true.
Rich Oborn:
And we understand there are some unique conditions that people suffer from that require unique types of products. And so there may not be a market right now in our program, but as the maturity of the program increases and there’s more patients, there may be a market in a year or two for certain types of products to be worth it for a processor to manufacture such as a breathalyzer or something like that.
Tim Pickett:
Yeah.
Rich Oborn:
We also want to do additional outreach to medical providers, medical clinics and stakeholders to ensure that they’re receiving accurate information about the laws in Utah and also best practices. And there’s some great information in a publication that the Cannabinoid Product Board has put together that we feel is underutilized and could be, I think, shared more universally and distributed with providers. And we want to share it in a way that’s easy for them to digest and it’s not complicated. So I think we’ll do some additional outreach. And we’re excited about those plans. We’ll be helping lawmakers with a medical cannabis governance study during the next year. There was Senate Bill 153 in the past that required that lawmakers put together a committee that will study the feasibility and the benefits, potential benefits, of having the responsibilities of the Department of Health under a single agency with the responsibilities of the Department of Agriculture and Food.
Rich Oborn:
And other states have that type of a governance model where it’s all under one single agency. And there’s reasons why that could work, there’s reasons why it may not work, but legislature wants to do this study and we’re happy to help them conduct that. And they plan to include not just us in it, but I think even more importantly, patients and providers in the industry and getting input on how things are put together long term. And the legislature plans on putting together this study and conducting it. I think the deadline is October 2022. And then potentially taking action, legislative action, during the legislative session of 2023 that the study has recommendations that lawmakers want to take action on.
Tim Pickett:
Sounds like you got a busy year, and you got to upgrade the EVS system.
Rich Oborn:
Yes.
Tim Pickett:
Right?
Rich Oborn:
Yeah. I know that’s something that’ll impact pharmacies quite a bit and also providers in clinics as they are the primary users of that system. And we want to make things just easier for people to get access to information so they can spend more time with patients and help them get through some of the things they’re dealing with with medical conditions. And we want patients to be able to just have better access to the counseling that’s available at the pharmacies. And sometimes it starts with improving the softwares that they use to allow for more time that they can spend one on one with the patient. So that’s one goal we have.
Tim Pickett:
Well, there’s a lot that’s updated. This has been a great conversation. I think we’ve gone through a lot of this stuff that people will be interested in hearing about. If you’re not subscribed to Utah in the Weeds, you can subscribe on any podcast player that you have access to. Anything else we’re missing?
Rich Oborn:
No, that was quite a bit. We’re excited that [crosstalk 01:02:59].
Tim Pickett:
Last year we ended up taking a long time as well. So this is turning into our annual legislative update with Rich Oborn, the Department of Health Medical Cannabis Program Director. And appreciate your time today.
Rich Oborn:
Yep. Good to chat with you, Tim.
Tim Pickett:
All right, everybody. Stay safe out there.
